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Abstract
Breast cancer is the world’s most prevalent type of cancer among women. Statistics
indicate that breast cancer alone accounted for 37% out of all the cases of cancer diag-
nosed in Nigeria in 2012. Data used in this study are extracted from patient records,
commonly called hospital-based records, and identified key socio-demographic and
biological risk factors of breast cancer. Researchers sometimes ignore the hierarchi-
cal structure of the data and the disease when analyzing data. Doing so may lead to
biased parameter estimates and larger standard error. That is why the analyses un-
dertaken in this study included the multilevel structure of cancer diagnosis, types,
and medication through a Generalized Linear Mixed Model (GLMM) which con-
sider both fixed and random effects (level 1 and 2). In addition to the classical statis-
tics approach, this study incorporates the Bayesian GLMM approach as well as some
bootstrapping techniques. All the analyses are done using R or SAS for the classical
statistics approaches, and WinBUGS for the Bayesian approach. The Bayesian anal-
yses were strengthened by advanced analyses of convergence and autocorrelation
checks, and other Markov Chain assumptions using the CODA and BOA packages.
The findings reveal that Bayesian techniques provide more comprehensive results,
given that Bayesian analysis is a more statistically strong technique. The Bayesian
methods appeared more robust than the classical and bootstrapping techniques in
analyzing breast cancer data in Western Nigeria.
The results identified age at diagnosis, educational status, grade tumor, and breast
cancer type as prognostic factors of breast cancer.
—————————————————————————–
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Human life is exposed to the risk of various diseases across the globe. More specif-
ically, a large percentage of the Nigerian population is being hit by a number of
diseases whose incidences are rising at an alarming rate. Wide-ranging efforts to
curb the rising incidence of these diseases, enhance societal awareness concerning
their causes, and suggest various lines of treatment are being made. The rapid
advancement of medical technologies, treatments, and research have significantly
aided these efforts and helped in bringing the world to a point where many of these
diseases are no longer considered as threatening to human life and well-being be-
cause they can now be prevented and/or cured. However, in the case of breast
cancer, prevention strategies still require significant improvement and strengthen-
ing so as to reduce its rise in Africa and the world at large. The main constraint in
managing breast cancer patients in Nigeria is the limited availability of equipment
due to insufficient finances of health sector. This makes patients bear the burden
of paying unreasonably large amounts of money for cancer treatment in a country
where financial resources are already severely limited.
Cancerous cells arise due to mutations and alterations in DNA of normal healthy
cells (Jackson & Bartek, 2009). Sometimes, a cyst develops around these cells and
cell replication stops. This is known as the benign state. When these cells continue
to grow rapidly and out of control, they are referred to as being malignant. Breast
cancer risk factors are sometimes explained in relation to incidence and mortality.
Therefore, there is need to distinguish between these two and to put into consider-
ation different ways in which they can be modified. Breast cancer incidence is the
number of new cases and is modified by the level of exposure to carcinogens, while
breast cancer mortality is the number of deaths recorded from breast cancer, repre-
senting the risk of developing malignant breast lesion from the disease and as well
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1.1. Background
as the probability of dying as a result of it.
Research over the years have focused on treatments and drugs to stop the spread of
breast cancer. A correct cancer diagnosis is needed for adequate and effective treat-
ment because different cancer types have different requirements of a treatment regi-
men that encompasses one or more modalities like surgery, radiotherapy, chemother-
apy, and so on. The ability to determine the suitable and best modality of treatment
and palliative care for breast cancer patients specifically in western Nigeria will go
a long way to help women of this geopolitical zone to manage their lives. The pri-
mary aim is generally to cure cancer or to considerably prolong life. Improving the
patient’s quality of life is also an important goal. With advancements in medical
technology, advances have been made in the treatment of breast cancer in Nigeria
regardless of the site of the cancer. However, better treatment for breast cancer pa-
tients is difficult to define.
The literature has revealed that elderly women are sometimes not included in clin-
ical treatment trials, probably because of their age (Townsley et al., 2005). Since
breast cancer biology differs from patient to patient with respect to factors like age,
variations in response to treatment, and substantial competing risks of mortality (Bi-
ganzoli et al., 2012; Mieog et al., 2012; Kiderlen et al., 2015), the exclusion of some
patients might have led to invalid/unreliable results. This implies that the exclusion
of elderly women in trials probably led to an untrue representation for the general
older population (Jolly, 2015). Consequently, an evidence-based treatment strategy
for women with breast cancer is needed.
1.1.1 Breast Cancer
A significant increase in the incidence of breast cancer has been noticed (GLOBO-
CAN, 2012). This increment cuts across all continents of the world, and particularly
Africa. Cancer of the breast is now the most dangerous disease common to women
globally, and is a significant cause of cancer-related mortality in women across the
world (Agboola et al., 2012). Therefore, it has increasingly become a focal point of
research across the globe. On comparing the latest versions of the World Health Or-
ganization (WHO) and International Agency for Research on Cancer (IARC) reports
on breast cancer (GLOBOCAN, 2008 & 2012), it was discovered that the number of
new cases increased from 12.7 million in 2008 to 14.1 million cases in 2012. In addi-
tion, approximately 1.4 million women were diagnosed with breast cancer in 2012.
There are 6.3 million women alive who have been diagnosed in the previous 5 years
in relation to 2015 (Torre et al., 2015). This corresponds to an age-standardized rate
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of 43.3 new cases per 100,000 (Ferlay et al., b). Thus, since the 2008 estimates, breast
cancer incidence has increased by more than 20%, while mortality has increased by
14%. In western Nigeria, breast cancer accounted for 37% of all the cancer cases
among women (OLUGBENGA et al., 2012), while in other geopolitical zones of
Nigeria, reports suggest that breast cancer alone constituted about 35.41% of all can-
cers in women Afolayan (2008). Although breast cancer is thought to be a disease
of the developed world, literature reveals that about 58% of deaths that occur as
a result of breast cancer are traced to less developed countries (Ferlay et al., 2010).
There are countless factors contributing to breast cancer which vary with respect
to socio-economic, area, race, and life style differences. The role of lifestyle factors
is well-illustrated in migrant studies, where breast cancer risks were compared be-
tween female migrants from low-to high-incidence countries and their offspring,
showing that the risk increases in the following generations as a change in lifestyle
is adopted (Ziegler et al., 1993; Shimizu et al., 1991).
Breast cancer stages have been shown to be one of the major prognostic factors (Møller
et al., 2016; Jedy-Agba et al., 2017), particularly in an African setting. In addition, in
contrast to breast cancer diagnosed in developed countries, the stages of breast can-
cer diagnosis in Nigeria as well as other African countries have been reported to be
too late. The factors associated with this late diagnosis of breast cancer in Africa, and
particularly in Nigeria, need to be studied in order to reduce the menace of this dis-
ease. Moreover, other factors that influence the prevalence of breast cancer among
women in western Nigeria need to be studied for a better view of its epidemiology.
A statistical study of this disease will be helpful in determining its prognostic risk
factors, socio-economic factors, and related medical factors. This research examined
the risk factors of breast cancer in Nigeria. The Nigerian setup is quite different from
other parts of the African continent in many respects. For instance, unlike in Sub Sa-
haran African (SSA), smoking is rarely observed among women of Nigeria.
Several studies have establised that breast cancer risk increases with an increase in
age. Thus, age is an established risk factor for breast cancer. It has been discovered
that poor socio-economic condition is also one of the factors causing an increase
in breast cancer in Nigeria (Ojewusi & Arulogun, 2016). Those with highest socio-
economic status and education have a twofold greater incidence than those with the
lowest status. Some studies further showed that higher socioeconomic status (SES)
is associated with higher breast cancer incidence (Pudrovska & Anikputa, 2012;
Krieger et al., 2010; Vainshtein, 2008). Additional studies have provided a possible
explanation for these findings, in that women with high SES are more likely to obtain
routine breast cancer screening as a result of better access to preventive healthcare,
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hence, increasing the detection rate of breast cancer (Akinyemiju et al., 2015). This
study will explore these breast cancer determinants among Nigeria women.
Cancer of the breast can be diagnosed in a woman of any age. However, the liter-
ature shows that the risk of developing breast cancer increases with age, and most
cases (approximately 80%) of breast cancer occur in women over the age of 50 years.
Other risk factors attributed to the increase in womans risk of breast cancer include
hormonal and reproductive factors, obesity, alcohol, and physical inactivity. Ac-
cording to (McPherson et al., 2000), early age at menarche, older age at first birth,
reduced parity, lack of breast feeding, and late menopause have all been associated
with an increased risk of developing breast cancer in the developed world. Also, in
2003, it was reported by (Collaborators et al., 2003) that the use of oral contraceptives
and hormone replacement therapies (HRT) have been shown to increase the risk of
breast cancer for up to five years after discontinued use before the risk returns to
the same levels as women who have never used hormone therapy. Moreover, it was
mentioned in the literature that obesity in post-menopausal women (Reeves et al.,
2007) and excessive alcohol consumption (Baan et al., 2007) have been found to in-
crease risk of breast cancer, while engaging in some physical activity offers some
protection (Chan et al., 2007). Statistics have indicated that approximately 10% of
all female breast cancer is attributed to a genetic mutation (McPherson et al., 2000).
There are two main genes that account for most genetically-linked breast cancer:
BRCA 1 and BRCA 2. They have also been linked to ovarian, colon, and prostate
cancer. From the literature, it was observed that women with a genetic mutation are
more likely to have a strong family history of breast cancer and to be diagnosed at
a younger age than the general population (McPherson et al., 2000). This has raised
many unanswered questions, which motivated the initiation of the current research.
One major research question is, ”How do we establish prognostic factors associated
with breast cancer among women of western Nigeria?” Many subsidiary questions
spring up from this research question: What are the explanatory and socio-economic
factors of the prevalence level of breast cancer in the national and geopolitical zone
of Nigeria? What are the attempts already made in the reduction of breast cancer?
And what are the current and future consequences of breast cancer if more attention
is not given to the menace? This research will attempt to show how breast cancer
is associated to the events that occur among Western women of Nigeria. It will
also explore the risk of breast cancer due to the relationships among the risk factors
themselves, and help in estimating the preferred treatment given to breast cancer
patients in this geopolitical zone of Nigeria. The cancer data in Nigeria shows that
breast cancer is hitting the largest proportion of the entire population. The high
incidence and mortality rates for breast cancer may be attributable to number of risk
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factors that are to be explored for the Nigerian woman population. We have selected
two sets of data from two hospitals for this study. The two hospitals are entirely
different in their management and facilities for the patients. One is managed by the
Federal government, while the other one is managed by state government. The two
hospitals jointly represent the patients from all the prognostic factors levels.
Cancer
The human body is made up of billions of cells, and every one of them contains
twenty-three pairs of chromosomes. These chromosomes contain myriads of dif-
ferent information that inform the body how it should grow, function as well as
behave. Given the fact that chromosomes reproduce themselves every time a cell di-
vides, there are many opportunities for something to go wrong during this process.
Sometimes, something goes wrong with some cells and they do not die. They divide
out of control and may grow into a tumor known as cancer. During the cell division,
a process called a mutation alters one of the genes. The altered genes now begin to
send wrong messages to other parts of the body. Thereafter, a cell begins to grow
and multiply until it forms a lump called a malignant tumor or cancer. This tumor
may be benign or malignant in nature. It is only when these cells start to divide
uncontrollably, forming tumors or growths, that we have one of the more than 200
diseases called cancer. The major differences between malignant (cancerous) and
benign (non-cancerous) tumors are that malignant tumors can spread into the sur-
rounding tissue, destroy the surrounding tissue, and cause other tumors to develop.
The major ways through which cancer spreads are outlined below.
• Invasion: The tumor grows into surrounding tissues or structures.
• Spread via the bloodstream: Cancer cells break away from the tumor, enter the
bloodstream, and travel to a new site within the body.
• Spread via the lymphatic system: Cancer cells break away from the tumor and
enter via the lymph vessels and lymph nodes to other parts within the body.
There are various types of cancers in relation to the site, namely, lung cancer, skin
cancer, prostate cancer, bassal cell cancer, breast cancer, etc.
1.2 Research Problem
According to WHO, breast cancer is the most commonly diagnosed cancer among
women worldwide, claiming the lives of thousands of women each year and af-
fecting countries at all levels of modernization. Studies have shown that out of all
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the cases of cancer diagnosed in 2016, breast cancer alone accounted for 29%. This
makes breast cancer to be the most frequently diagnosed cancer in women globally.
The fight against this disease is given priority all over the world. Statistics regarding
the issue unveil the need for intensive efforts towards addressing the menace of this
disease in Africa in particular, because this chronic disease also affects this continent.
In 2012, statistics indicated that 1.7 million women were diagnosed with breast can-
cer and the prevalence stood at 6.3 million women with 40 Nigerian women dying
as a result every day (WHO, 2012). Although in the past, cancer of the breast used
to be called a disease of the developed world, the literature reveals that almost 58%
of deaths that occur as a result of breast cancer are traced to less developed coun-
tries (Ferlay et al., 2010). The level of breast cancer incidence in the world reflects
the huge gap between rich and poor countries. This situation creates an additional
problem related to the monitoring and measuring of the impact of undertaken ac-
tions against some prognostic factors of breast cancer in the Western part of Nigeria.
As such, this bring a lot of serious confusion among data users at all levels about the
real incidence level of breast cancer in the country. Statistics indicate that the occur-
rence and distribution of breast cancer among the southwestern citizens accounted
for 37% of all cancer cases. The consequences of high breast cancer prevalence are
enormous in each of the geopolitical zones of Nigeria.
Although not only of concern to biostatisticians, most researchers are trying to find
the suitable methodology, with the smallest possible bias, to modeling breast can-
cer. Indeed, finding a lasting solution to this menace requires deeper knowledge
on the phenomenon and the provision of reliable indicators reflecting the certainty
of different geographical locations of the country. Different techniques have been
used such as classical and non-parametric statistics, but they still have important
limitations and need to be improved. Few studies have used Bayesian techniques to
analyze breast cancer data in western Nigeria.
As with most social issues, the reliability of approaches differs from one country
to another, depending on the specific socio-demographic. In Nigeria, the menace of
breast cancer is significantly difficult for researchers to tackle because of its complex-
ity, lack of data, and where the data exists, its usual poor quality. Another concern
for researchers and policy makers is the representation of breast cancer, which in-
volves a statistical model that is difficult to implement because of the weaknesses of
existent data. In addition to these difficulties, we noticed an important insufficiency
of scientific works related to this issue in western Nigeria. However, estimating the
prevalence of breast cancer in the country and by zones is an important scientific
issue and researching the factors explaining the problem is a challenge. Therefore,
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several techniques have been proposed for modeling and analyzing breast cancer
data. These approaches differ in the conditions underlying their use, the data re-
quirements, the inference objectives that they accommodate, statistical efficiency,
computational demands, and the skills required for their implementation. This het-
erogeneity means that no single approach can be considered as best, or even opera-
tional, in all situations. To contribute improving knowledge in breast cancer issues
in Western Nigeria, this thesis has set out the main objective of providing statistical
information about the incidence and prognostic of breast cancer in Western Nigeria.
1.3 Aim and Objectives
Specifically, the objectives of the research are:
• To describe the patterns and distribution of breast cancer prevalence among
western women in Nigeria as well as to establish factors which most contribute
to breast cancer prevalence.
• To explain the variations in breast cancer (via a modeling technique) using
socio-demographic and biological factors of the population, taking into con-
sideration the hierarchical structure of the data via both classical and Bayesian
techniques.
• To assess the association between breast cancer patients and some socio-demographic
and biological factors.
• To develop a model based on the socio-economic determinants of breast cancer
cases for Western Nigerian women.
1.4 Significance of the Study
Different established factors in relation to cancer of the breast have been investigated
from the literature that are not similar to the Nigeria situation. Meanwhile, there
exists a wider knowledge on the correlation between socio-demographic, reproduc-
tive, and risk factors and breast cancer in Nigeria. It was discovered that there exists
at least some variation in breast cancer prevalence rates globally (Bray et al., 2004).
This variation is attributed to a range of socio-economically correlated differences
in the population of many hormonal and reproductive factors. Previous research
on immigrants has showed the aforementioned environmental determinants as part
of the factors which may contribute to breast cancer prevalence based on observed
international and inter-ethnic differences. The study by (Ziegler et al., 1993) high-
lighted the successive increases in risk for migrants from low-risk Asia to high-risk
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United States, mostly when the migration occurred in childhood.
Globally, women in developing countries (or women living in poor areas) are prone
to higher risks of breast cancer upon migration because of changing exposures to re-
productive and nutrition-related determinants. The most significant increments are
observed in developing countries, where breast cancer risk has historically been low
relative to industrialized countries (Bray et al., 2004). Moreover, few attempts have
been seen in the literature that quantify the magnitude of risk between populations
that might be explained by unique factors (Parkin et al., 2005). Although the relation-
ships between various breast cancer risk factors have been studied elsewhere, their
findings may not be applicable to the Nigerian situation due to differences in pop-
ulation. Therefore, there is a need to explore the risk factors associated with breast
cancer among women in western Nigeria using datasets from two different hospi-
tals, and establish such associations. The establishment of such factors may help
in the implementation of prevention strategies against the disease. In addition, the
knowledge of the female population at risk will help target breast cancer screening
interventions and improve advocacy for protective practices. This improved treat-
ment outcome is necessary as most breast cancer diagnoses in developing countries
are done at last stage of the disease.
In conclusion, knowledge about associated and established breast cancer-related
factors will give insights about the possible causes of the disease among women
of western Nigeria and as well strengthen the role of healthcare workers, improve
prevention, early diagnosis and treatment modalities, thus reducing its menace. In
addition, this study employs the Bayesian approach due to its wide range of applica-
tions and advantages over classical statistics. Most of the studies on breast cancer in
Nigeria were based on classical statistics. However, researchers have recently found
some shortcomings with the classical method of analysis and proposed the Bayesian
method. For instance, in a study conducted by (Ojo et al., 2017) to established risk
factors of tuberculosis (TB) in South Africa by comparing the result of Bayesian and
classical statistics, they found that the Bayesian approach helps in selecting the more
significant factors related to the risk of TB better than the classical approach.
1.5 Thesis Layout
In the light of the above-mentioned objectives, the following content has been as-
signed to the document. This thesis is concerned with the performance of the Bayesian
Generalized Linear Mixed Model (BGLMM) for the breast cancer disease. It is di-
vided into six chapters: Introduction, Literature Review, Research Methodology, Re-
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sults, Discussion, and Conclusions and Recommendations based on the main results.
The first chapter focuses on the presentation of the issue of breast cancer as well as
the explanation of the rationale for undertaking a research on this disease. The sci-
entific, social and economic importance of this study from international, national
and sub-national perspectives is highlighted. The socio-political, socio-cultural, and
economic context in which the study is conducted is also presented. In the second
chapter, the issue under study is explored within its scientific context by review-
ing existent literature on breast cancer. We also discuss the risk factors based on its
socio-demographic and medical factors. We subsequently give an overview of ex-
tant scientific research on the prevalence of breast cancer in Nigeria as well as on the
African continent. Generally, this chapter entails a summary of the existing body of
knowledge about the causes of breast cancer and the identification of some aspects
that have been of little interest in previous studies, but which demand close atten-
tion. In chapter three, we focus on the research methodology. A deeper explanation
of the dataset chosen for this study is given, and the conceptual and analysis scheme
as well as statistical techniques of analysis used are presented. We include in this
chapter the reasons behind the choice of the datasets and methodology, the qual-
ity of the datasets, the methodological limits of the research, as well as their impact
on the findings. In chapter four, results of the descriptive and multivariate analysis
(classical and Bayesian approach) of breast cancer are provided. In addition to the
identification of the significant determinants of breast cancer, their mechanism of
action as well as contributions are pointed out. In chapter 5, results from the analy-
ses in chapter four are reviewed in tandem with knowledge from literature reviews
and the context of the study. Acceptance of results and contribution of these find-
ings to knowledge are discussed in detail. The last chapter provides conclusions and
recommendations for improved actions against breast cancer prognostics in Western
Nigeria. The main results of this research and scientific contributions are highlighted
in the conclusion. The WinBUGS code for the entire thesis is provided in appendix
E. In appendix D, R software code is provided which is used in the classical statistics
while in appendix E, SAS code for other part of classical statistics is presented.
1.5.1 Thesis Contributions
A summary of the contributions of this thesis is outlined below
• Previous studies on breast cancer modeling in Western Nigeria use ordinary
logistic regression and χ2 test to model breast cancer, which implies they didn’t
consider the hierarchical nature of the dataset. This research moves further by
incorporating the hierarchical structure into our models.
• Another contribution of this thesis is a comparison between Bayesian multi-
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nomial models, classical multinomial models, and bootstrapping technique.
Their results were compared, and the findings highlight the fact that the Bayesian




The problem of breast cancer is not a new scientific problem across many fields and
among researchers. Most researchers from medical sciences, sociology, epidemiol-
ogy and other disciplines have studied the problem for many years, and investi-
gations are still ongoing. This chapter aims to provide a synthesis of the literature
about the specific points of interest defined in our objectives. We aim to review the
literature on breast cancer prevalence, its explanatory factors, as well as their mech-
anisms of influence. Highlighting methodologies and results of past researches on
breast cancer could help to better orientate this study and make use of this informa-
tion to push forward knowledge in the subject.
2.1 Context of the Study
A presentation of the context of this thesis is important to clarify the problem and
deepen the understanding of the issue of breast cancer. The context within which
this study is undertaken, and the location of the data used supports the importance
of, and need to carry out this research. In this section, the context of Western Nigeria
women in relation to breast cancer is highlighted.
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2.1.1 Area of Study
Nigeria a country in West Africa bordered by the Bight of Benin and Gulf of Guinea
in the south. It shares maritime borders with Equatorial Guinea, Ghana, and So Tom
and Prncipe. With an area of 923,768 km2, the country is almost four times the size of
the UK or slightly more than twice the size of the U.S. state of California. According
to the last census, the country had about 200 million people, with more than half its
people under 30 years of age (Source:NPC).
Figure 2.1. Map showing geopolitical zone of Nigeria
2.1.2 Global Prevalence of Breast Cancer
As we go through different stages in life, our bodies are subjected to many negative
things. One of such negative things is a disease called cancer. Cancer is a generic
term for a large group of diseases that affect any part of human body. Breast cancer
is a form of disease that characterized by cells in the breast, becoming abnormal, and
multiply uncontrollably, resulting in a tumor. In a situation where the tumor is not
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treated on time, malignant cells can spread beyond the original tumor to other parts
of the body, leading to a process called metastasis. Different types of cancer of the
breast are identified by the cells in the breast that become malignant. A tumor may
be malignant (cancerous) or benign (not cancerous). A cancerous tumor is malignant
in nature if it grows and spreads to other parts of the body, while benign tumor can
grow, but will not spread.
Cancer is one of the leading causes of morbidity and mortality among women glob-
ally, with approximately 14 million new cases diagnosed in 2012 (Ferlay et al., 2013a).
The incidence of major cancers is rising globally. There is a great disparity among
population segments. The higher incidence and mortality rates of cancer among
blacks as compared to whites represent social, economic, environmental and educa-
tional factors rather than racial or genetic (Ries et al., 2006). In addition, being black
also correlates highly significantly with being poor, less educated and deprived of a
safe healthy environment. In a situation where all these factors are put together, the
risk of cancer rises significantly. For a higher percentage of newly diagnosed cases of
female breast cancer across the world, it has been observed that cancer of the breast
is a neglected disease in terms of other numerically more frequent health problems.
Some other school of thought regarded it as an orphan disease because very detailed
information about tumor characteristics and the necessary host biology capable of
providing basic care is absent. However, in some developed countries, Ginsburg
et al., (2011) have documented the progress with the declines in mortality of breast
cancer.
Globally, (GLOBOCAN, 2012) as reported by (Torre et al., 2015) showed that the
impact of breast cancer has been rising in most continents of the world. In the
same vein, there are wide gaps between rich and poor countries as noticed by Wild
(2013). Among the developed countries, the incidences remain highest, while mor-
tality rates are relatively much higher in less-developed countries. Findings show
that the burden of breast cancer will increase in the years to come, not only because
of the steep increase in incidence, but because of the increase in population in these
countries (Taib et al., 2014; Jemal et al., 2011; Porter, 2008) found that an increase
in life expectancy is believed to be an outcome of a reduction in mortality from in-
fectious diseases by 2020. Therefore, Wild (2013) requested for proper attention for
prevention and control measures to offset lifestyle changes that makes cancer of the
breast the leading cause of cancer death and malignancy among women, particu-
larly in developing countries like Nigeria. To reduce the menace posed by breast
cancer, (Ferlay et al., 2010) called for the implementation of practical and afford-
able methods of diagnosis, early detection, and treatment of breast cancer among
women of less developed countries. According to (Vineis & Wild, 2014), it is crit-
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ical that mortality and morbidity rates in developing countries be brought in line
with the progress made in recent years in more developed parts of the world. Im-
provements on the management of breast cancer patients in the developed countries
have resulted to a reduction in mortality rates in (Yip & Taib, 2014; Taib et al., 2014).
However, in developing countries, death from breast cancer continues to rise due to
late presentation of the disease and lack of access to appropriate healthcare (Cough-
lin & Ekwueme, 2009; Taib et al., 2014). The higher breast cancer mortality rate for
women in less developed countries noticed in the literature is partly because clinical
advances to combat the disease are not available for women (Forman et al., 2012).
This is attributed to the lack of early detection and poor access to treatment as a result
of lack of awareness, lack of education, and deficient infrastructural and healthcare
facilities. According to (Youlden et al., 2014), the report of GLOBOCAN (2012) in-
dicated an alarming disparity in breast cancer incidence and mortality between the
United States and the rest of the world. In United States, incidence of breast cancer
remained stable from 2001-2010, with a 15.6% reduction in mortality across the life
span; whereas globally, breast cancer claimed almost 522,000 women’s lives in 2008,
a figure that increased by 14% in 2012. (Youlden et al., 2014) adds that while in-
cidence rates remain highest in more developed countries, the GLOBOCAN (2012)
data showed that mortality rates are highest in less developed countries. He pro-
vided a fourfold explanation for this observation, and called for the application of
the strategies that were successfully employed in the West to bring down the breast
cancer mortality rate in developing countries, so as to save millions of lives among
women.
It was mentioned in the literature that the most common cancer in the United King-
dom (UK) is breast cancer, which account for 31% of all cancers in women (Parkin,
2011a). The UK cancer research center estimated that about 47,693 women were di-
agnosed in 2008 with breast cancer (Coleman et al., 2011) and approximately 12,000
women died from breast cancer in the UK, representing about 16% of all female mor-
talities from cancer.
Despite the threat that breast cancer poses to human health, particularly Africa,
(Vineis & Wild, 2014; Sylla & Wild, 2012) observed that few countries in this region
have breast cancer-related data. For instance, most of the breast cancer incidence
data in Sub-Saharan Africa (SSA) in recent times were based on reports from reg-
istries (Curado et al., 2007; Jedy-Agba et al., 2012a). It was further mentioned that
the incidence rate of breast cancer in their study was higher than that reported by
GLOBOCANs (2008) estimate of 38.7% per 100,000. Due to the prevalence of risk
factors for these cancers, the reported increasing incidence may be real as reported
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by (Forouzanfar et al., 2011). The need for high quality regional cancer registries to
serve a vast country like Nigeria has been highlighted so as to adequately inform
policy and the allocation of resources for breast cancer treatment (Jedy-Agba et al.,
2012b). Past studies (Afolayan, 2008; Jedy-Agba et al., 2012a; Ferlay, 2004) have in-
dicated and predicted an increment in breast cancer incidence and mortality rate
for Nigeria. In developed countries such as Canada, reports showed that fewer of
their women are dying from breast cancer. In the same vein, the Canadian Cancer
Society reported a reduction by 42% since the peak in 1986 (Canadian Cancer Statis-
tics, 2014). It was indicated further that Canadian women who are diagnosed with
breast cancer are living longer than ever before, based on a 5-year survival rate of
88% (Canadian Cancer Statistics, 2014). In Nigeria, the situation is different where
there is a prediction of more than a 100% increase in incidence and mortality rates of
cancer of the breast by 2030 (Jedy-Agba et al., 2012b; Sylla & Wild, 2012). With the
disparities in breast cancer outcomes between developed and developing countries,
it is imperative that action be taken to understand some of the prognostic factors
associated with late presentation of breast cancer in Nigeria and address them ap-
propriately.
Based on the GLOBOCAN estimates in 2008, about 12.7 million cancer cases are
estimated to have occurred, and out of these, breast cancer alone contributed al-
most 23%. Statistics show that it is the leading cause of cancer death among females
in less-developed countries (Siegel et al., 2015). According to cancer statistics re-
leased in 2017 in the United States, breast cancer alone accounts for 29% of all can-
cers in women (Siegel et al., 2017). Approximately 1,700,000 new cases of breast
cancer were diagnosed worldwide in 2012. This represents about 25% of all can-
cers among women (Thrift, 2016). No definite cause has been attributed to breast
cancer, but some researchers outlined genetic factors, personal history, etc as role
players. A report by (Ferlay et al., 2010), indicated that more than 1,100,000 cases
of breast cancer are diagnosed and more than 410,000 result to death among the
patients globally. The situation is however different in developed countries where
about 55% of the global burden is currently experienced, and incidence rates are
increasing more rapidly in developing countries. In another development, Stewart
et al (Stewart et al., 2003), reported that most of the new cancer cases are now oc-
curring among women from low and middle-income countries, where the incidence
is increasing by as much as 5% per each year and there are about three-fourths of
breast cancer deaths occurring globally. Out of the 411,000 breast cancer deaths that
occurred in 2002 across the globe, 221,000 (representing 54%) occurred in low- and
middle-income countries (LMCs) while the situation is different from China where
the incidence rose from 126,227 cases in 2002 (Ferlay et al., a) to over 169,000 in 2008.
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The incidence and mortality rates of female breast cancer vary greatly by region. In
Western Europe, the mortality has declined from around 1980, but in parts of some
European countries such as Georgia, the the burden continues to rise (Autier et al.,
2010; Forouzanfar et al., 2011). The age-adjusted incidence rate for breast cancer for
all women in Georgia in 2008 was reported to be 38.5 per 100,000 women while the
mortality rate was 19.5 per 100,000 (Forman et al., 2012). Available data from the
Georgian National Cancer Center (GNCC) in 2010 (which is the most recent year for
which data is available) mentioned that 1221 women were diagnosed with breast
cancer, out of which 598 women died, indicating a 0.5 mortality-to-incidence ratio,
which implies that there are approximately 5 deaths for every 10 newly diagnosed
cases, compared to a ratio of 0.2 in the United States (DeSantis et al., 2011; Fritsch
et al., 2012; Harford et al., 2011). The survival rate of breast cancer patient aged (14-
49) years in Georgia was 18.9% compared to 89% in the United States (Fritsch et al.,
2012). The situation is different in neighboring countries like Russia and Ukraine
where the survival rates were found to be 50-54% between 1994-2004 and 80% in
Western Europe for the same period (Hirte et al., 2007). The higher fatality rates of
breast cancer in low- and middle-income countries have been attributed to a lack of
awareness regarding the benefits of detection and treatment and late stage diagnosis
among other risk factors (Shulman et al., 2010; Dvaladze, 2012).
In general, breast cancer survival rates have improved worldwide, though survival
rates vary from country to country. This is because breast cancer is diagnosed at an
earlier and localized stage in countries where patients have access to medical care,
and there is progressive improvement in treatment strategies. In many countries
with advanced medical care, the five-year survival rate of early stage breast cancers
is 80 - 90 percent, which falls to 24 percent for breast cancers diagnosed at a more ad-
vanced stage. However, this is not the case in some parts of African countries where
most of the public healthcare sector is poorly resourced and managed as a result of
political unrest, corruption, and economic situations. For instance, in Tanzania, it
was reported that 30% of the countrys healthcare professionals leave the health sec-
tor after receiving medical training because of poor incentives (Bryan et al., 2010).
On the African continent, a serious challenge is the lack of cancer registries by most
countries. The World Health Organization (WHO) estimates that the incidence rate
of breast cancer in Africa has increased steadily over the years (Ferlay et al., 2013b).
As reported by (Anderson & Jakesz, 2008), there is also a higher mortality rate
among breast cancer patients in most African countries. For instance, the five-year
breast cancer survival rate in Gambia stood at 12.5% (Jemal et al., 2011). Consid-
ering the cases of breast cancer in low-to-middle-income countries like Nigeria, the
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breast cancer burden and its mortality rates are increasing at an alarming rate as
reported by (Jedy-Agba et al., 2012a; Pruitt et al., 2015). The delays in diagnosis
and treatment in Nigeria have contributed to the rise of this menace (Oluwatosin &
Oladepo, 2006). There are many factors that prevent Nigerian women from seek-
ing treatment when they first notice a breast cancer symptom, such as misconcep-
tions about breast cancer and its treatment outcomes, and economic and logistic
obstacles (Anyanwu, 2008; Karayurt et al., 2008). Cultural and social factors such as
stigma and inadequate healthcare infrastructure have also been linked to this behav-
ior among women (Bello, 2012; Pruitt et al., 2015).
2.2 Breast Cancer Risk Factors
Available data from the World Health Organization (WHO) put breast cancer as the
most frequent type of cancer in women, accounted for at least half a million deaths
per year globally. Breast cancer is about a hundred times as frequent among women
as among men, but survival rates are equal in both sexes. Several factors, including
age, family history, age at first full-term pregnancy over 30 years, early menarche,
late menopause, postmenopausal obesity, use of postmenopausal hormones, alco-
hol consumption, the use of contraceptives, hormonal treatment after menopause,
lack of a breastfeeding history, obesity, and physical inactivity are associated with
increased risk of breast cancer (Zare et al., 2013). It is estimated that 5-10% of breast
cancer cases result from inherited mutations or alterations in the breast cancer sus-
ceptibility genes BRCA1 and BRCA2. In this thesis, breast cancer risk factors are
categorized as socio-demographic and medical for a proper understanding.
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2.2.1 Socio-Demographic Factors
• Age: In all countries of the world age is strongly related to breast cancer. It is
extremely rare below the age of 20 years, but thereafter, the incidence steadily
rises so that by the age of 90 years about 20% of women are affected by this
disease.
• Personal history of breast cancer: An individual who has already been diag-
nosed with breast cancer has a higher risk of developing it again, either in the
same breast or the other breast, than if they never had the disease.
• Race and geographical areas: From the literature, it can be observed that white
women are slightly more likely to develop breast cancer than African Ameri-
can women. Asian, Hispanic, and Native American women have a lower risk
of developing and dying from breast cancer.
• Family history: This is as a result of genetic mutation. Genes can be recessive or
dominant, and when dominant in a patient, there is higher risk of them getting
breast cancer. Hence, if they have a first-degree relative (mother, daughter,
sister) who has had breast cancer, or multiple relatives affected by breast or
ovarian cancer (especially before they turned age 50), they could be at a higher
risk of contracting the disease.
• Inherited factors: the risk of breast cancer increases with age. If the trait is
inherited, then as the age increases above 50 years, there is a tendency for
some of these inherited genes to mutate (change). This mutation is abnormal,
and the multiplication can cause breast cancer.
• When a woman starts menstruation at an early age before 12 years or reaches
menopause at an older age after 55years, they have high risk of breast cancer
due to a longer life time exposure to hormones. There are some hormones pro-
duced by the female organ, such as estrogen, which when produced in large
quantity by the body will be deposited at the lymph nodes, multiply, and pos-
sibly cause breast cancer.
• Education and Exposure: The risk of getting breast cancer can increase with
increase in education or exposure to a more ’advanced’ life. It has been ob-
served that people in this class may one way or the other have exposed their
chest or breasts to radiation therapy for treatment of diseases such as Hodgkins
Lymphoma or even during registration in school using an X-ray machine. This
radiation has an increased chance of breaking cells in the body, leading to these
cells rapidly multiplying and becoming cancerous.
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• Other factors are late or no pregnancy. Pregnancy after 30 years can increase
the risk of breast cancer, as sex hormones like estrogen must have accumulated
too much over the period of years instead of being used for pregnancy or child
birth.
• Obesity and dense breasts can also be a factor. When there is too much con-
nective fatty tissue in the breast resulting from fatty foods or an unhealthy
feeding lifestyle, it becomes difficult for mammograms to detect any lump in
the lymph nodes in the breast.
2.2.2 Medical factors
• Oral Contraceptive: Pills that control conception can also be a factor that in-
creases chances of breast cancer. These pills work on the organs and hormones,
some increasing blood flow for days, which only occurs when some hormones
have been over produced. This abnormal multiplication can result in cancer-
ous cells.
• Hormone Replacement Therapy (HRT): The International Agency for Research
on Cancer (IARC) found that the use of combined oestrogen-progestogen hor-
mone replacement therapy (HRT) for menopausal symptoms is as a highly
probable cause of breast cancer. IARC has classified the use of oestrogen-only
HRT as a possible cause of breast cancer, based on limited evidence (Chi et al.,
2015). An estimated 3% of female breast cancers in the UK are linked to HRT
use (Parkin, 2011b). A report from (Reeves et al., 2006) has shown that breast
cancer risk is also higher in oestrogen-only HRT users. These findings are sup-
ported by the findings of (for the Women’s Health Initiative Investigators et al.,
2002), which indicated that 5 years of combined HRT was associated with a
26% increased risk of invasive breast cancer in post-menopausal women.
• X-rays: Ionizing radiation has been established as a risk factor of cancer. In the
case of breast cancer, the risk increases linearly with the radiation dose accord-
ing to (Ronckers et al., 2004). This has been noticed with diagnostic, therapeu-
tic and accidental exposures to ionizing radiation. In addition, epidemiologi-
cal studies of atomic bomb survivors and of medically irradiated populations
reveal increased risk of female breast cancer with relative risks ranging from
1.0 4.3 per Gray (i.e. Gy, which is the standard unit of absorbed inonizing-
radiation dose). The risk is higher if the exposure occurs in childhood and
adolescence rather than in adulthood; it is minimum to zero if exposure oc-
curred in the post-menopausal period (Andrieu et al., 2006).
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• Dietary factors: According to (Holmes & Willett, 2004), the impact of specific
dietary factors in breast cancer causation has not been completely dealt with it.
In fact, trends show that breast cancer prevalence rates vary widely across the
globe, and that the offspring of those who migrate from lower-incidence coun-
tries to those with higher incidence take on the higher rates of this disease.
Moreover, observations promote the hypothesis that nutrition is an environ-
mental determinant of breast cancer. This is supported by (Bray et al., 2004),
who reports that there is a long established correlation between breast cancer
and dietary fat intake, though the true relation does not seem to be strong and
consistent.
• Breast density: The risk of breast cancer among women with the most dense
breasts is higher compared with the least dense as reported by (Pettersson
et al., 2014). Breast density is generally higher in younger, pre-menopausal
women with lower body mass index (BMI) and lower parity, but there is also
a genetic element (Boyd et al., 2002).
• Exposure to estrogen. Because the female hormone estrogen stimulates breast
cell growth, exposure to estrogen over long periods of time, without any breaks,
can increase the risk of breast cancer. Some of these risk factors are not under
the individual’s control, such as: starting menstruation (monthly periods) at
a young age (before age 12) going through menopause (end of monthly cy-
cles) at a late age (after 55) exposure to estrogens in the environment (such
as hormones in meat or pesticides such as DDT, which produce estrogen-like
substances when broken down by the body).
2.2.3 Context of Breast Cancer in Nigeria
The incidence of breast cancer in Nigeria has risen significantly (Jedy-Agba et al.,
2012a). The age-standardized incidence rate for breast cancer in the period between
1960-1969 was 13.7 per 100,000. It rose to 24.7 per 100,000 by 1998-1999; more or
less a doubling of incidence over four decades, or an approximately 25% increase
in rate per decade. The rate in 2009-2010 was 54.3 per 100,000. This represents a
100% increase in the last ten years (Jedy-Agba et al., 2012a). The incidence of breast
cancer in Nigeria in 2012 was (estimated age-standardized incidence rate (ASR) =
50.5 per 100,000) only half that in the United States (US) (ASR = 92.9 per 100,000),
but estimates of mortality rates from this cancer were higher in this West African
country than in the US (ASR = 25.9 vs. 14.9 per 100,000, respectively) (Jedy-Agba
et al., 2017; Gathani et al., 2014), accounting for poorer survival (Jedy-Agba et al.,
2017; Ferlay et al., b). In 2012 (OLUGBENGA et al., 2012) reported for western Nige-
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ria the highest incidence of breast cancer for any western women while the hospital
relative frequency data from the North-Central geopolitical zone in Nigeria also in-
dicated a high frequency of breast cancer (Afolayan et al., 2012). A study conducted
by (OLUGBENGA et al., 2012) in western Nigeria on the frequency of tumors of
various sites, placed breast cancer at the top of the list of all types of cancers. The
age-pattern of the incidence of breast cancer in Nigerian was similar to that found
in studies of female breast cancer in other populations (Adebamowo & Adekunle,
1999; Ikpat et al., 2002; Ebughe et al., 2013a).
Breast cancer is the most common malignancy among Nigerian women (Jedy-Agba
et al., 2012a). The incidence of breast cancer in Nigeria women increased from 13.5-
15.3 per 100,000 in 1976 to 53.6 per 100,000 women in 1992, reaching the level of
116 per 100,000 women in 2001. As reported by (Akarolo-Anthony et al., 2010), it
is now the leading cause of death among women in Nigeria. In the case of Afo-
layan et.al (Afolayan et al., 2012) they observed a steady increase in the incidence of
breast cancer within a ten-year (1999-2008) period of study. There were occasional
drops in incidence that coincided with periods of national or regional industrial un-
rest when public health facilities were closed. In the context of Nigeria, cancer of
the breast is characterized by regional variation (Agboola et al., 2012). Nigeria is
subdivided into different geopolitical zone. In the North Western geopolitical zone
of Nigeria, breast cancer is reported to be second to cervix cancer. The situation is
different in the Western geopolitical zone where breast cancer is the leading cause
of malignancy among women (Jedy-Agba et al., 2012a; Afolayan et al., 2012). This
situation is further different at Ilorin which is one of the cities in the North Cen-
tral geopolitical zone, where breast cancer constituted 22.4% of new cancer cases
registered in five years, and accounted for 35.41% of all cancers present in women.
According to (Jedy-Agba et al., 2012a) cancer of the breast in Nigeria is associated
with high mortality rates. As reported by (Forbes, 1997) with the adoption of West-
ern lifestyles by African women, the incidence of cancer of the breast will continue
to rise if proper measures are not taken, while an increase in mortality rate would
follow. This growth as predicted by (Taib et al., 2014). According to (Afolayan et al.,
2012), unfortunately, there is a no much data and sparse literature review on the
trends of breast cancer in Nigeria. There are very few cancer registries in Nigeria,
most of which are either hospital-based or pathology-based, instead of the preferred
population-based cancer registries as in the case of developed countries. However,
in low-resource countries like Nigeria, hospital-based cancer registries have been
serving as a fundamental source of information on cancer prevalence (Curado et al.,
2007).
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Most of breast cancer cases in Nigeria are diagnosed late (Okobia et al., 2006; Anyanwu,
2008) as a result of poor utilization of screening facilities and lack of education on
the part of patients. The peak age of breast cancer presentation in Nigeria is between
10-15 years later, compared to what is observed among Caucasians and African (and
African American) women, where it occurs between the ages of 35-45 years (Oko-
bia et al., 2006; Frempong et al., 2008). The major influences on breast cancer ap-
pear to be certain reproductive factors and diet. The level of cumulative incidence
seemed to be higher in Nigeria compared to other African countries, most especially
sub-saharan africa (SSA). The genetic, environmental, lifestyle, race, age and dietary
differences could have contributed to these differences (OLUGBENGA et al., 2012;
Ebughe et al., 2013a). Despite the threat that breast cancer poses to public health
especially in sub-Saharan Africa, few countries in the region have data on breast
cancer incidence (Sylla & Wild, 2012; Vineis & Wild, 2014).
2.2.4 Epidemiology of Breast Cancer
Age is an important factor in determining a woman’s risk of having breast can-
cer (Ikpat et al., 2002). The probability that a woman will be diagnosed of cancer
of the breast increases throughout her life span, and most of it occurs during the
postmenopausal period. It was mentioned in the literature that woman with high
socio-economic status (SES) have higher risk of having breast cancer (Akinyemiju
et al., 2015), and that it is common among women who delay having children into
their 30’s.
A late age of first birth, early age oral contraceptive use, as well as proliferative be-
nign breast lesions have been associated with a higher risk of breast cancer among
younger people (under 40) rather than older women (greater than 40). In addition,
an inverse association was studied between the number of full term pregnancies
and risk of breast cancer, and was found that women who gave birth four times or
more had only one half the risk of women who gave birth just once. Many stud-
ies (Hulka & Moorman, 2001; Key et al., 2001; Colditz et al., 1993) have identified
increasing age and a family history of breast cancer as established risk factors. A
consistent increase in the risk of cancer of the breast was observed among women
with a first-degree relative (mother, daughter, sister) who had the disease through
pregnancy. In the case of women with a family history of breast cancer, the adverse
effect was maintained up to age 70 years; parous women were at higher risk of breast
cancer than nulliparous women. In the category of women without family history
of the disease, first pregnancy was associated with a smaller increase in risk and
early pregnancy and higher number of births were each correlated with a reduced
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breast cancer prevalence (Antoniou et al., 2003). An antecedent history of breast
cancer and benign breast lesions in a woman were found to be a significant factor
that can increase the risk of the disease (Deane & Degner, 1998; Hislop & Elwood,
1981). Available statistics indicated that about half of the breast cancer in Italy are as
a result of a high level of education and family history of the disease (Tavani et al.,
1997). From the epidemiological evidence, breast cancer risk has also increased in
subjects with family history of the disease (Antoniou et al., 2003).
It has often been stated that breast cancer risk is associated with socio-economic sta-
tus (like income, educational status, etc). The reasons behind this are enormous.
According to (Landman et al., 2010), when examining mortality, there is need to put
into consideration the fact that survival is lower in lower classes, and secondly, that
most of the gradient can be explained by the differing prevalence of common risk
factors among the social classes. The variation in risk by educational status is almost
entirely explained by the differential distribution of factors like parity, obesity and
so on for the United State (US) case (Shaw et al., 2011).
The effect of reproductive factors as well as menstrual factors in the epidemiology
of breast cancer have long been recognized.
The risk of breast cancer is higher in woman who had their first live birth at age 30
or higher, compared with nulliparous women (Nelson et al., 2012; Anderson et al.,
2010). But older age at first delivery (greater or equal to 28 years) was shown to
be moderate risk of breast cancer, mostly among premenopausal women, compared
with the risk among women who had their first delivery at age less than or equal
to 22 years old (Ritte et al., 2012). According to (DeSantis et al., 2011), they found
that parity and age at first birth are correlated with the incidence of breast, as well
as with the stage of diagnosis. In women aged 25-54, the opposite was observed,
as there was no association between risk of breast cancer and age at first full term
pregnancy (Cibula et al., 2010; Dite et al., 2010).
Moreover, a womans age at the time of her first full term pregnancy and the number
of pregnancies have seen as an important determinant of breast cancer risk. (Nelson
et al., 2012), in their stud,y found a significant reduction in the risk of breast cancer
for women who had their first child at an early age. In the case of women whose
first pregnancy occurred at ages 30-34, they were shown to have the same risk as
nulliparous women. Pregnancies after 35 years are associated with an increased risk
compared with nulliparous women (Flenady et al., 2011; Brown et al., 2010).
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Some studies (Almeida et al., 2015; Buchanan et al., 2013) have found that the fo-
cus of etiology of exploration for cancer of the breast has shifted from dietary risk
factors back to body size as well as reproductive factors. The difference in environ-
mental risk factors was found to be the major difference in the incidence of breast
cancer in Africa compared with Western countries (Jemal et al., 2010). Most of the
studies on epidemiology (Van Den Brandt et al., 2000; Hsieh et al., 1990) found a
positive association between obesity and breast cancer risk. Other studies (Saldova
et al., 2014; Bhaskaran et al., 2014; Zheng et al., 2011) have found that a high body
mass index (BMI) is positively associated with an increased risk of breast carcinoma.
Some women add weight during menopause (Jensen et al., 2003; Simkin-Silverman
& Wing, 2000; Mamun et al., 2010). The body mass index (BMI) remained insignif-
icant with breast cancer for both premenopausal and postmenopausal women. A
higher risk of breast cancer has been associated with women having a higher body
weight and height, with the trend more pronounced for height (Hsieh et al., 1990;
Onland-Moret et al., 2005). A study by (Colditz et al., 1995; Thompson et al., 2009)
found that BMI, weight, and breast density were differently correlated with risk of
breast cancer among postmenopausal women. It was also reported that height and
obesity (BMI greater or equal to 30) were positively associated with breast cancer risk
among postmenopausal women while in premenopausal women the opposite was
observed (Ellison-Loschmann et al., 2013; Adebamowo et al., 2003; Amadou et al.,
2013).
Socio-economic status has been observed as one of the risk factor of breast cancer.
For example, age has been documented as one of the major risk factors for breast
cancer across the world. In a study conducted by (Arora & Simmons, 2009), it was
found the that age group 35-49 faced a major risk of breast cancer. A possible expla-
nation for this may be the use of contraceptives and hormonal imbalance, which is





This chapter presents the research methodology used to reach the objectives of the
study. It explains the adequacy of the methodology employed and the efficiency of
the choices adopted. We also present our exploratory data analysis and the statistical
methods. Furthermore, we present an explicit approach through which our data
exploration and statistical tools helped to achieve the objectives of this study. In the
first section, the datasets used in the study are presented and discussed extensively
for a better understanding of their use, as well as to highlight their adequacy. In the
second section, the methodological choices and their pertinence are developed. We
present the data used for the analysis of this thesis. In particular, the variables and
their respective significance to breast cancer research are explicitly detailed. The free
software R, SAS and WinBUGS 14 are used to implement the statistical models, test
the hypotheses, and plot data.
3.1 Data
This study aimed to study the performance of Bayesian analysis in modeling breast
cancer among Western Nigeria women. The data was extracted from the cancer reg-
istry of Federal medical teaching hospital, Ekiti State, Nigeria. The data included
information on demographic characteristics and socio-economic factors. Other in-
formation contained in our data is the number of cases of women diagnosed with
histologically and pathololgically confirmed cancer of the breast. The data extracted
were for two different hospitals. One is federally owned, while the other is managed
by a state government. An identification index, including each patient’s name, resi-
dence, age, date of visit to the hospital and the identification number of each patient
were used in order to uniquely identify the breast cancer patients from the cancer
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records.
With respect to the quality of the data obtained from the records of the breast cancer
cases, the major concern was the proportion of hospital records in which some of
the relevant variables were missing. Information relating to variables like weight,
height, age at first full term pregnancy, and age at menopause were missing. Factors
considered in the analysis of this thesis include age at diagnosis, socio-demographic
characteristics, marital status, and patients with pathologically and histologically
confirmed cases. With regards to the quality of the data collected for the breast
cancer patients, the primary concern was the high proportion of hospital records in
which one or more variables were not recorded.
Research Scope and Methodology
In this thesis, the research is primarily focused on performance of the Bayesian
Generalized Linear Mixed Model technique on breast cancer data in Nigeria. We
employed an MCMC algorithm in estimating the required probability and likeli-
hood functions, when exact computation were impractical. This technique shows
great promise for providing a means of performing analyses which are practical in
terms of computational time and which therefore can incorporate model complex-
ities which currently are infeasible because of computational constraints. The con-
tributions of this thesis is to be methodological with broad applicability of Bayesian
technique compared to classical and Bootstrapping.
3.2 Classical and Bayesian Logistic Regression Model
Initially, all the categorical variables for the breast cancer data were examined in or-
der to observe the true pattern of the data. The data was scrutinized so as to improve
its quality before proceeding further in the analysis. The analysis was started with
the descriptive statistics so as to exhibit the prevailing pattern in these variables.
We performed logistic regression analysis by using both the exact logistic regression
and conditional approaches. The categorical variables were studies at the stage of
primary analyses by suitable statistical tests. Box-plots were used to examine the
outliers or extreme values in where any appeared. The values obtained were then
critically examined to rule out any distortion of the data. The criteria for includ-
ing an individual variable into the model formulated was based on its statistical or
biological significance. Logistic regression was used to test for the statistical sig-
nificance of each variable. The conditional distribution of each response variable
such as ϕ =1 or 0 was also studied so as to decide relevant transformations of such
variable in case of linear regression model. Generalized linear models (GLM) for cat-
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egorical responses were initially developed as well in order to meet the need for the
analysis of the datasets. These models explain the relationship between a response
variable and some explanatory variables. Where the response variable is binary, the
techniques for analyzing such responses are usually based on the assumption of a
binomial distribution.
Logistic Regression Models
Suppose a binary random variable y follows a Bernoulli distribution, that is, y takes
either the value 1 or the value 0 with probabilities ηi(x) or 1-ηi(x) respectively, where
x= (x1, ........, xk) ∈ <k is a vector of k explanatory variables. In addition, ηi repre-
sents the conditional probability p(y = 1|x) of y=1, given x. Based on the binary out-
come variable, we use the logistic distribution (Hosmer & Lemeshow, 2000b). The













where x= (x1, ........, xk)T and λ= (λ0, ........., λk)T . The transformation of η(x) is







Under the above transformation, the regression model in equation (3.1) is written as
logit(η(x)) = xTλ. (3.3)
3.2.1 Maximum Likelihood Estimate (MLE) of the parameters
Suppose we have a sample of n independent observations {(yi, xi)}, such that i=
(1,2,....,n)∈({0, 1} × <k+1)n, where yi denotes the value of a dichotomous outcome
variable, and xi is the value of the explanatory variables for the ith individual. As-
sume
yi ∼ Ber(1, η(xi)) i = 1, 2, ....., n.
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Based on a set of data, we estimate the parameter vector λ= (λ0, ........., λk)T ∈ <k+1
to fit the logistic regression model in equation (3.1). To obtain the ML estimator of λ,
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. (3.6)
Furthermore, we find the ML estimates, λ̂, of λ by maximizing the log-likelihood
















Odds and Odds Ratio
The odds ratio is a measure of association which quantifies the relationship between
being diagnosed with a particular disease or outcome and the health exposure under
investigation. It is expressed as the ratio of the odds in favour of having the disease,
if exposed, to the odds in favour of having the disease, if not exposed. Hence, it is
necessary to introduce the terms odds and odd ratio so as to explain the binary data
and to interpret the logistic regression coefficients. For a probability η of success, the




In a 2 by 2 contigency table, the probability of success is η1 in row 1 and η2 in row 2.
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Interpretation of the parameter
For the purpose of this study, we consider a single explanatory variable coded as
either 0 or 1 for a better understanding of the logistic regression coefficients inter-
pretation. The odds of the outcome being present among individuals with x = 1 are
expressed as η(1)1−η(1) . Also, the odds of the outcome being present among individu-
als with x = 0 are expressed as η(0)1−η(0) . Therefore, the possible values of the logistic
probabilities are shown in the table below.
Table 3.1: Values of the logistic regression model when the independent variable is binary
Response variable













From the above table, we define the odds ratio as the ratio of the odds for x = 1 to


















= eλ1 . (3.9)
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Equation (3.9) means that the odds on the event that y equals 1 increase or decrease
by the factor eλ1 among those with x=1 than among those x=0. According to (Hos-
mer & Lemeshow, 2000b), this is the major reason why logistic regression has been
chosen as a reliable statistical tool for medical research.
Bayesian Binary Logistic Regression Model
In the context of this study, we consider Bayesian logistic regression modeling from
a generalized linear modeling (GLM) framework as described. In general, a gener-
alized linear model (GLM) technique, as first introduced by (Nelder & Baker, 1972)
and modified by (Fan & Gijbels, 1996), provides a flexible and unified approach to
analyzing both normal and non-normal data. Initially, the application of the GLM of-
ten took a classical approach. However, the availability of complex and high- speed
software routines has stimulated a rapid growth in Bayesian analyses carried out
through GLMs. The fundamental idea of a GLM assumes that the underlying dis-
tribution of responses belong to the exponential family of distributions, and a link
function transformation of its expectation is modeled as a linear function of observed
covariates. Furthermore, it is assumed that the variance of the response is a speci-
fied function of its mean. The exponential family of distribution has a pdf which is
generally of the form
f(ζ, θ, φ) = exp
{





where θ and φ are the location and scale parameters respectively, while a(φ) and c(φ)
are known functions. Generally if W(ζ) = ζ, then







The expression above gives the mean and variance of ζ as E(ζ) = ∂b/∂θ and var(ζ) =
a(φ)∂2b(θ).
For the GLM method, the mean denoted by µ is related to the covariates through a
link function ψ(µ). Hence, ψ(µ) is defined as follows





where β is the vector of parameters and is represented as β= β0 + β1+, ..... + βj
and the maximum likelihood estimates are obtained as iterative solutions of the log
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For the Bayesian paradigm, the conditional probability of a series of events approx-
imates the product of the probability of events as well as the probability of a given
event (Rekkas, 2009). Considering a given parameter θ denoted by P(θ), with y as
a set of observed data. Therefore, P(θ|y) is the conditional probability of θ when y
is true. Since the binary logistic regression model can only assume a yi taking two
values 1 or 0, yi(i = 1, 2, ......n), which follows a Bernoulli probability function.
P (Y = 1) = ρ
P (Y = 0) = 1− ρ
where ρ is the proportion of patients in the category 1 of the response variable and
1−ρ is the proportion of patients in the category 0 of the response variable. Assume
we have n samples {(yi, xi), i = 1, 2, ......n}. The binary logistic regression model for
the data under current study is represented by
yi|ρi = Ber(ρi)
ρi = Pr(yi = 1) = F (x
k
i β) (3.12)
where xi = (xi1, ......., xik) is vector of known covariates associated with ith indi-
vidual, and β = (β1, ........., βk) is the regression parameter. The logistic function
transformation is specified by:
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The likelihood function of expression in (3.13) is derived as follows:






















To continue with the Bayesian analysis, it is essential to derive a joint prior distribu-
tion over the parameter space. In reality, this is very hard to do because the relation-
ship between the data and the parameters is very complex. The easiest way to over-
come this difficulty is to propose either an informative prior or a non-informative
prior, but with small precision, avoiding any complaint about the specification of
subjective beliefs (O’hagan et al., 1990). In this thesis, we use non-informative nor-
mal priors with extremely small precisions which were set to the parameters. There-
fore, the next procedure is to obtain the posterior distribution, since the inference is
based on the information provided by the posterior distribution.
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Now, we found that expression (3.15) is a complex function of the parameters, and
numerical approaches are required in order to obtain the marginal posterior distribu-
tion for each of the model parameters. Approximations can be obtained via numeri-
cal integration (Naylor & Smith, 1982). Simulation-based methods have proliferated
in the last ten years or so, yielding two popular approaches known as importance
sampling (Zellner & Rossi, 1984) and Gibbs sampling (Dellaportas & Smith, 1993;
Albert & Chib, 1995). Re-sampling techniques, applied to logistic regression for ran-
domized response data, were alternatively proposed by Souza and Migon (2004).
3.2.2 Other Classical Logistic Regression Statistics
In this section, we discuss the goodness of fit to our data. After fitting the logistic
regression model parameters, there is need for assessing the significance of each
variables with regards to predicting the response variable. Some of the tests we
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employed are discussed as follows:
• Deviance analysis of model fit
The principle here is that the observed values of the response must be com-
pared with the estimated values from the models with and without the vari-
able under consideration. The comparison between the observed values of the
response variable to the predicted values is based on the log likelihood func-




pilog[π(ηi)] + (1− pi)log[1− π(ηi)]
}
. (3.16)
The comparison of observed to the predicted values using log-likelihood is






which we expressed as
D = −2[log(Lr)− log(Lt)], (3.17)
where log(Lr) is the log-likelihood for the extended model and log(Lt) is the
log-likelihood for the simpler model, and D is the deviance. With large sam-
ple sizes, deviance (D) approximately follows a chi-square distribution with
(t− r) degrees of freedom. Where t and r are the number of parameters in the
saturated and proposed models, respectively. Deviance is used for the assess-
ment of the model’s goodness of fit. The combination of the above expressions,
















• Akaike Information Criteria (AIC)
This statistical test measures the relative value of a statistical model for a given
set of data. AIC is expressed as
AIC = 2δ − 2ln(L),
where L is the likelihood of the model and δ indicates the number of parame-
ters on the model under consideration. AIC is used to select the best model in
a set of data. The model with the lowest AIC value of should be given prefer-
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ence.
• Wald test






where β̂1 is the estimate of the coefficient of the explanatory variable and
SE(β̂1) is the standard error of β̂1.
• Cox and Snell Pseudo R2 The R2 for logistic regression is estimated by Cox


























n , and n is a vector whose elements are the weight for the
ith case.
• Likelihood Ratio Test








where Ao is the maximum value for the likelihood function of a simple model
and A1 is the maximum value for the likelihood function of a full model. Ac-
cording to (Hosmer & Lemeshow, 2000a,b), a simple model has one variable
dropped, while a full model contains all the parameters of interest.
• Deviance Information Criteria (DIC)
The ability to fit complex multilevel models using Markov Chain Monte Carlo
(MCMC) techniques presents a need for methods to compare alternative mod-
els. The standard model comparison techniques such as AIC and BIC require
the specification of the number of parameters in each model. For multilevel
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models which contain random effects, the number of parameters is not gener-
ally obvious and as such an alternative technique of comparison is demanded.
The most widely used of such alternative technique is the Deviance informa-
tion Criteria (DIC) as suggested by Spiegelhalter et al. (2002). The DIC statistic
is a generalization of the AIC, and is based on the posterior mean of the de-
viance, which is also a measure of model complexity and fit. The deviance is
defined as
D(θ) = −2 log f(y|θ).
since DIC is a measure of model complexity, it considers a measure of the ef-
fective number of parameters in a model, and is defined by
pD = D̄(θ)− ˘(θ).






and ˘(θ) is the deviance evaluated at some estimate θ̆ of θ. Therefore, we now
define the deviance information criteria (DIC) by
DIC = D̄(θ) + pD = 2D̄(θ)− θ̂. (3.19)
where D̄ is the posterior mean of the deviance that measures the goodness of
fit, and pD represent the effective number of parameters in the model. In the
case of the Bayesian and bootstrapping models, low values of D̄ imply a better
fit, while small values of pD imply a parsimonious model. pD is higher for a
more complex model, and DIC appears to select the correct model. The best
fitting model is one with the smallest DIC, as suggested by (Spiegelhalter et al.,
2002; Lesaffre & Lawson, 2012).
3.2.3 Assumptions on Model Adequacy
For the classical statistics, we examined different diagnostic plots to assess the per-
formance of the fitted model. The Statistical Analysis System (SAS) produces a set
of diagnostic plots as summarized in Table 3.2. The plots either indicate how close
the fitted model is to the actual model that can produce the exact values obtained, or
highlight the effect of some observed values on the model building.
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Table 3.2: Summary of diagnostic plots for a fitted model evaluation
Diagnostic Plot Usage
Cooks D statistic versus observation number Evaluate influence of an observation on the entire
parameter estimate vector
Dependent variable values versus predicted values Evaluate adequacy of fit and detect influential
observations
Externally studentized residuals (RStudent) versus
leverage
Detect outliers and influential (high-leverage)
observations
Externally studentized residuals versus predicted
values
Evaluate adequacy of fit and detect outliers
Histogram of residuals Confirm normality of error terms
Normal quantile plot of residuals Confirm normality and homogeneity of error terms,
and detect outliers
Residuals versus predicted values Evaluate adequacy of fit and detect outliers
Residual-fit (RF) spread plot side-by-side quantile plots of the centered fit and
the residuals show how much variation in the data
is explained by the fit and how much remains in the
residuals
SOURCE: SAS system Guide 9.4: The RSREG Procedure
3.2.4 Bayesian Prior Distributions
This thesis make use of a full Bayesian approach in estimation, with prior distribu-
tions assigned to all the parameters. Bayesian statistics differs from classical statistics
in the sense that parameters are regarded as random variables in the former, while
a prior distribution has to be specified in order to make inference in the latter. The
major challenge in Bayesian statistics is the correct specification of a Bayesian prior
distribution, because appropriate prior specification is key in Bayesian modeling.
(Gelman, 2002) indicated that the prior distribution is an important part of Bayesian
inference, representing information about an uncertain parameter θ which is com-
bined with the probability distribution of the likelihood of new data to produce the
posterior distribution. This is then used for future inference on θ. Therefore, neces-
sary precaution should be taken in selecting priors because inappropriate choices of
priors may result to wrong inference (Institute et al., 2008).
In specifying priors, a number of points need to be considered. A key point among
them is the fact that priors can be tentative. Because inference is assumed to be de-
pendent on prior choice, alternative priors are examined to explore how sensitive
the main conclusions are to alterations in the prior. Also, it is important and neces-
sary to allow prior beliefs to be influenced by data. There are different types of prior
distributions, some of which are discussed below:
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• Non-informative and Informative prior distributions
As earlier mentioned, the most key important aspect of Bayesian statistics is
the setting up of the right prior to include in the model. It is important at
this point to explain the major differences between non-informative and infor-
mative prior distributions when specifying the Bayesian prior distributions.
Non-informative (vague) priors are used if either little is known about the co-
efficient values, or one wishes to make sure that prior information plays very
little role in the model. This simply means the data is allowed to remain in-
fluential in the analysis under consideration. As a result of the objectivity of
non-informative priors, the majority of researchers in statistics prefer to make
use of it compared to informative priors. The most common choice of non-
informative priors is the flat prior, which assigns equal likelihood to all possi-
ble values of the parameters. On the other hand, an informative prior distri-
bution summarizes the evidence about the parameters of interest from many
sources and often has considerable impact on the posterior distribution.
In addition, for our data to remain influential, this thesis utilizes non-informative
priors that will not influence the posterior distribution. We assume a multivari-
ate normal prior on β with a large variance (σ2 = 1000) and mean (µk = 1),
except otherwise stated.
β0 ∼ N(b0,Σ20).
The variance (σ2) needs to be transformed before it is introduced into the
model. Hence, we use τ =0.001 as the transformed variance. In the case of
the Bayesian multilevel regression model, each random effect uses a gamma
distribution with α =0.1 and β = 0.01. This thesis utilizes a multivariate nor-
mal (b0,Σ0) prior density for the parameter vector β. We also assumed that
the prior for the ith component be normal (b1, S21), while the priors for each



































Since a multivariate normal prior does not have to be made up from inde-








b1 = Σ1|Σ−1ML|β̂ML + Σ1|Σ−10 |b0.
where ΣML is the covariance matrix of the maximum likelihood estimate (MLE)
vector, and its inverse is represented as
Σ−1ML = XΣ
−1X
while β̂ML is the maximum likelihood vector and Σ−10 is the prior precision
matrix.
The posterior distribution refers to the distribution of the parameters after data
observation. The estimates of Bayesian inference are obtained by sampling
from the posterior distribution. In terms of the Bayesian approach, we can
write the posterior distribution as
p(β|yi) ∝ p(yi|β)p(β)
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When the integral over the sample space does not converge, the probability
distribution specified for θ is assumed to be improper.
p(θ) ∝ 1,
As argued by (Lancaster, 2004), an improper prior distribution can lead to pos-
terior impropriety. To establish whether a posterior distribution is proper, past
studies indicate that the normalizing constant
∫
p(y|θ)p(θ)dθ is finite for all ys.
When an improper prior distribution leads to an improper posterior distribu-
tion, inferences based on the improper posterior distributions are not valid (In-
stitute et al., 2008).
• Prior for fixed effects
Fixed-effect parameters have no constraints, and as such can assume any value.
A prior distribution for such parameters will need to be defined over the whole
real line. The conjugate prior distribution for such parameters is the normal
distribution.
• Normal prior with huge variance
As the variance of the normal distribution is increased, the distribution be-
comes locally flat around its mean. As earlier mentioned, fixed effects can
assume any value. However, a close examination of the data can narrow the
range of values and a suitable normal prior can be found. Generally, the nor-
mal prior, p(θ) ∝ N(0; 104) will be an acceptable approximation to a uniform
distribution. If the fixed effects are very large however, a suitable increase in
the prior variance may be necessary.
3.2.5 Bayesian Posterior Distribution via Markov Chain Monte Carlo
The Bayesian approach was first introduced by the Reverend Thomas Bayes. Today
the Bayesian concept has gained popularity among many researchers across differ-
ent fields as a result of its ability to handle complex models. Bayesian methods have
also been embraced in other fields of science due to their ability to handle com-
plexity in real-world problems. From the literature it was observed that Bayesian
inference has many advantages over classical inference. In addition, Bayesian in-
ference has means of incorporating prior knowledge about the parameters under
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consideration since they influence the posterior inference. One of the major differ-
ences between classical and Bayesian inferences is that the former regards data as
random and considers parameters to be fixed. This means that the values of the pa-
rameters are estimated from data using estimations that are random variables. In
the case of Bayesian methods, parameters are assumed to follow a probability dis-
tribution while model parameters are considered as random variables. The main
object of interest in Bayesian inference is the posterior distribution. Classical infer-
ence estimation depends solely on approximations as well as asymptotic results. In
cases of missing data, classical inferences sometimes replace the missing observation
with guesses and the analysis of the data on whether the missing observation were
known. In this thesis, we develop some methodologies for the current data which
deal with multilevel and complex likelihood functions.
It is important to emphasize the specification of both prior mean and variance. The
Inclusion of a prior mean provides a prior point estimate for the parameter of in-
terest, while the uncertainty about the estimate is expressed by the variance. There-
fore, it is necessary for priors to be selected carefully so that they represent the best
knowledge about the parameters. Since we want our data to remain influential in
all the analysis carried out, this thesis makes use of non-informative priors. Once
there is enough information in the likelihood, a non-informative prior can be con-
fidently used. By Baye’s rule, we can express a posterior distribution, as presented
by (Ntzoufras, 2011), as:
P (θ|y) = P (y|θ)P (θ)
P (y)
∝ P (y|θ)P (θ). (3.22)
where P(θ) is the prior distribution, and P(y|θ) is the posterior distribution. A poste-











ηyi(1− ηi)1−yi . (3.24)
In the context of simulation, sampling directly from the posterior may not be easy in
complex models, and as such, there are some alternative sampling techniques which
may be helpful. The most commonly used of these sampling techniques are:
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• Gibbs sampling
• Markov Chain Monte Carlo (MCMC)
The above two techniques were discussed extensively by (Brooks et al., 2011; Nt-
zoufras, 2011; ONeill, 2002). They recommended the Markov Chain approach for
high-dimensional problems. Some of their recommendations for solving high-dimensional
problems are utilized in this thesis. The MCMC technique is one that allows samples
to be drawn from a distribution which has the posterior distribution as its station-
ary distribution. The MCMC techniques operate by defining a Markov chain whose
equilibrium and target density are equal. After the chain has been simulated for
the required amount of time for convergence occur, samples are drawn from the
simulated chain. For the implementation of Markov Chain Monte Carlo, different
algorithms have been developed, such as:
• Gibbs sampling algorithm
• Metropolis-Hasting algorithm
Markov Chain Monte Carlo Sampling Algorithms
The two most common Markov Chain Monte Carlo (MCMC) algorithms are the
Metropolis Hastings and the Gibbs samplers. These two algorithms have many vari-
ants and extensions that have been developed. These forms and extensions are more
advanced and sometimes more peculiar to some problems. In this section, we dis-
cuss in detail the Gibbs sampler together with its variants and extensions. The Gibbs
sampling algorithm is a special case of the Metropolis-Hastings algorithm in which
parameters are drawn from distributions with 100% acceptance rate. It is an alter-
nating conditional sampling. The joint posterior distribution is decomposed into a
sequence of simpler conditional distributions, where the target is to generate a data
point from the conditional distribution of each parameter, conditional on the cur-
rent values of the other parameter. The Gibbs algorithm implements MCMC meth-
ods using the WinBUGS software. The default option in the WinBUGS software for
well-behaved models with log concave densities is the Gibbs sampling algorithm.
The procedure for the Gibbs sampling algorithm is as follows:
Stage 1: From the conditional posterior distribution, sample a new set of fixed effects
p(λ|y, ϑ2m, ϑ2n,m) ∝ ψ(y;λ, ϑ2n)p(λ)
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(yij −mj − (xijλ)2)
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Suppose we use a multivariate normality for λ with covariance matrix V0. Then we
sample from
λ ∼ N(λ̂∗, Σ̂∗).



































Stage 2: In the second stage, a new set of residuals can be sampled and each residuals
(mj) is assumed to have a prior distribution mj ∼ N(0, ϑ2m). We can now derive the
following posterior distribution
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Hence, we can sample from
























Stage 3: Here a new level 2 variance is sampled. Within this area of research, the
choice of an appropriate prior distribution is an issue that hasn’t been resolved. In
this study, we adopted an inverse gamma prior, since it does not produce biased
estimates like uniform priors. We can now sample from
ϑ−2m ∼ Gamma(νm, ζm).





















Stage 4: a new level 1 variance is sampled:
ϑ−2n ∼ Gamma(νn, ζn),
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Stage 5: Compute the level 1 residuals.
For Bayesian analysis in WinBUGS, there is need to specify the model, likelihood,
prior, and observed data, and set the initial values. WinBUGS then produces an
appropriate Markov chain. WinBUGS requires much less MCMC programming than
if one was to program the MCMC simulations by directly. In addition, there is need
to ensure that a sequence has reached convergence before inferences are collated.
The number of iterations performed for a practical convergence to equilibrium is a
function of many factors such as:
• complexity of the model
• whether the prior and likelihood are conjugate
• closeness of the initial values to their respective posterior means
• kind of sampling method adopted
The Metropolis-Hastings algorithm is an iterative algorithm. It produces a Markov
chain and allows empirical estimation of posterior distributions as well as the gener-
ation of samples from a probability distribution. The Metropolis-Hastings algorithm
steps are outlined as follows:
• step1: starting values K for the parameter: θi=0 = K, where i=1
• step2: draw a candidate parameter θi from a proposal density ∝ (.)
• step3: compute the ratio J = f(θi)∝(θi−1|θb
f(θi−1)∝(θb|θi−1
• step4: compare J with a T (0, 1) random draw, t. If J > t, set θi = θb, otherwise,
set θi = θi−1
• step 5: set i = i+ 1 and return to step 1 until enough draws are obtained.
Metropolis- Hastings algorithm increase the efficacy with the utilization of a random
walk process through the parameter space.
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MCMC techniques via WinBUGS
WinBUGS is a is a product of Bayesian Inference using Gibbs Sampling (BUGS)
that is managed by the Medical Research Council (MRC) of Biostatistics Unit in the
United Kingdom. It is a free software that uses MCMC methods in complex Bayesian
techniques (www.mrc-bsu.cam.ac.uk/bugs). WinBUGS models can be implemented
in two ways namely by using the
• BUGS language
• graphical feature, Doodle BUGS, which allows the specification of models in
terms of a directed graph.
The model types that can be fitted using WinBUGS are wide-ranging. A wide variety
of models, including the multilevel, multinomial Dirichlet models can be fitted using
WinBUGS. WinBUGS is a very powerful tool in fitting complex models, although it
is a difficult and frustrating package to master. One of the main issues of WinBUGS
is that there is a great amount of embedded statistical theory associated with MCMC.
The other issue associated with Bayesian modeling is the choice of priors and initial
values. The Bayesian analysis using WinBUGS requires three major tasks:
• model specification
• running the model
• bayesian inference using mcmc output
In WinBUGS, there are three types of nodes: constant, stochastic and determinis-
tic. Constant nodes are meant for the declaration of constant terms, while stochastic
nodes represent data or parameters that are assigned a distribution. Deterministic
nodes are logic expressions of other nodes. In addition, WinBUGS expects each node
to appear exactly once on the left-hand side of an equation. After MCMC simulation,
WinBUGS provides several numerical and graphical summaries of the parameters.
Convergence is assessed by either trace plots, Geweke, Gelman-Rubin or autocor-
relation plots. CODA/BOA packages are also accessible from R for further conver-
gence analysis. The Brooks-Gelman-Rubin (BGR) convergence statistic is used to
assess the convergence of models and operates on multiple chains. Convergence is
based on the equality of within-chain variability and between-chain variability, since
simulations from multiple chains are independent.
Because of the complexity of the posterior distribution, it is difficult to directly sam-
ple from, and becomes even more complicated when random effects are included
in the model. We employed the MCMC approach to the simulation of the random
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numbers from the posterior distribution. In reality, a posterior distribution is often of
higher dimension and analytically intractable, and when the posterior distribution
comes from a distribution that is complex, the MCMC approach offers a better alter-
native for summarizing the posterior distribution. The quality of the MCMC sample
depends on how quickly the sampling procedure explores the posterior distribution.
3.2.6 Markov Chain Monte Carlo Simulation
MCMC methods are an established suite of methodologies that enable samples to
be drawn from some target density that is only known up to proportionality. It is a
technique of drawing values of θ from approximate distributions and then correct-
ing those draws to better approximate the main posterior distribution p(θ|y). These
samples are drawn sequentially with the distribution of the sampled draw, depend-
ing on the last value drawn. This results into a Markov chain. The success of the
MCMC technique depends on the approximate distribution which is improved by a
simulation of each step until a convergence of the posterior distribution is achieved.
The two most popular used algorithms: Gibbs sampler and Metropolis-Hastings are
special cases of the MCMC algorithm.
The approach is to take a Bayesian framework and carry out the necessary numerical
integrations using simulation. Instead of calculating exact or approximate estimates,
the computer-intensive techniques generate a stream of simulated values for each
quantity of interest. We focus here on one of such techniques, the Gibbs sampler,
which has emerged as the most widely used. Gibbs sampling is an MCMC method
for obtaining marginal distributions from a non-normalized joint density. It is a sim-
ulation tool for generating samples from the joint posterior distribution of unknown
quantities in a model, conditional on the observed data.
In Bayesian inference, the model assumes that data are fixed and regards the param-
eters as random variables. Suppose we consider a given parameter θ and a set of
observed data, the interest of the Bayesian approach is the probability of the param-
eter θ given the set of observed data y. This is written as P(θ|y). The next procedure
involves obtaining the posterior distribution of the unknown parameter θ, given the
observed data y. This procedure is achieved by multiplying the prior distribution
with the likelihood function.
Markov Chain Convergence Diagnostics
For any simulation to be carried out properly, it is necessary that the MCMC algo-
rithm be supplied with different starting values. The non-convergence problem in
MCMC simulations may be as a result of the simulations not being a true represen-
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tation of the desired distribution, based on the influence of initial values in the early
part of the chain and the inability of the within-chain serial correlation. According
to (Gelman et al., 2014b), these difficulties are dealt with by simulating multiple
chains with different starting values distributed through the parameter space, mon-
itoring convergence, and discarding the early iterations of the simulation. Autocor-
relation can be reduced by applying thinning, which results in keeping some parts
of the simulation after discarding some. There are several ways to assess or mon-
itor whether parallel chains have converged or not, some which are explained by
(Gelman et al., 2003). The Gelman-Rubin statistic is used to assess the convergence
of chains separately for all parameters under consideration (Gelman et al., 2014a,b;
Brooks & Roberts, 1998). In a situation where the sampling is to continue indefi-
nitely, convergence will be monitored by estimating the factor by which the scale
parameter might shrink.
Suppose we have N samples of ω from each of C chains and represent this as wnc.


































After that, we construct two estimates of the variance of w. The first estimate of the
variance of w is expected to underestimate the var(w) if the chains have not ranged








is an estimate of the var(w) that is unbiased when equilibrium (stationary) con-
ditions are reached, but is an overestimate when the starting points were over-
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R̂ is called the estimated potential scale reduction factor (PSRF) and measures the
degree to which the posterior variance would decrease if we were to continue sam-
pling by increasing N. If the potential scale reduction factor is greater, say above 2,
then further simulations are required, but when R̂ → 1, say R̂<1.1 is an indicator
of convergence. This simply means the variance between the chains is similar to the
variance within each chain. The corrected version of the R̂ statistic was defined by
Brooks and Roberts (Brooks & Roberts, 1998), and is expressed as R̂c = a+3a+1R̂, where
a is the estimate of the degrees of freedom for the pooled posterior variance estimate.
Raftery and Lewis’s diagnostic (Brooks & Roberts, 1998) determines the minimum
number of iterations based on minimal autocorrelation, and the required sample size
and length of burn-in process for a single chain. The Geweke diagnostic compares
values in the first part of the Markov chain analysis to those in the latter stage to
detect failure of convergence (Ntzoufras, 2011). Gewekes statistic has an asymptoti-









→ N(0, 1), n→∞. (3.27)
where S1(0) and S2(0) are respectively classical estimates of the respective variances
An inability to reach convergence in MCMC sampling may reflect problems in model
identifiability due to overfitting. To overcome such problems, running multiple
chains often helps by diagnosing poor identifiability. This is illustrated mostly when
identifiability constraints are missing from a model, such as in discrete mixture mod-
els that are subject to label switching during MCMC updating (Frühwirth-Schnatter,
2001). One chain may have a different label from others, so that obtaining the
Gelman-Rubin (G-R) statistic for some parameters is not sensible. A choice of diffuse
priors tends to increase the chance of poorly identified models, especially in complex
hierarchical models or small sample datasets as revealed by Gelfand et al. (1995).
Correlation between parameters within the parameter set = (θ1, ..., θk) increases
the dependence between successive iterations, while informative priors may help in
identification and convergence. As reported by (Zuur et al., 2002) re-parameterization
measures aimed at reducing correlation such as centering predictor variables in re-
gression usually improve convergence. According to (Heidelberger & Welch, 1983),
the Heidelberger-Welch (HW) diagnostic is an automated test for checking the sta-
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tionarity of the chain and further evaluating whether the length of the chain is suf-
ficient to ensure the desired accuracy for the posterior means of the parameters in
Bayesian analysis. This test is based on the Cramer-von Mises test statistic which
decides to either accept or reject the null hypothesis that the chain is from a station-
ary distribution. The test will first check for stationarity, and thereafter determine
the accuracy of the model parameters.
The advantage of the Bayesian method is that when the posterior distribution is
simulated, the uncertainty of the parameter estimates is taken into account. That is,
the uncertainty in the parameter estimates for the fixed part is taken into account
in the estimates for the random part. Moreover, simulating a large sample from the
posterior distribution is useful because it provides not only point estimates of the
unknown parameters, but also confidence intervals that do not rely on the assump-
tion of normality for the posterior distribution. Hence, credible intervals are also
accurate for small samples dataset (Tanner & Wong, 1987). The number of MCMC
iterations required are very large when the sample size is very small, since MCMC
techniques do not perform very well with small datasets. This may lead to high auto-
correlation among the parameters, particularly when estimating the mean. This is
why up to 1,500,000 iterations were run in all our Bayesian models with a lag of 60
to reduce autocorrelation, which may have necessitated even more iterations.
Many other diagnostic tools have been proposed by (Ntzoufras, 2011) to assess con-
vergence, and compared by (Brooks & Roberts, 1998). Convergence can also be im-
plemented in the CODA/BOA package for R. Four different diagnostics are pro-
vided by CODA as indicated by (Little & Wang, 1996; Erkanli et al., 1999; Dunson
& Colombo, 2003; Heidelberger & Welch, 1983). In this thesis, visual of diagnostic
plots and Gelman-Rubin diagnostic (R̂→ 1) were the main approaches to assessing
convergence.
3.2.7 Some key points derived from the classical statistics
• The parameters of the population are unknown fixed constants.
• Statistical procedures have a long-term meaning, like an infinite repetition of
the same experiment.
• Probabilities are interpreted as a frequency after a long number of experiments.
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3.2.8 Some key points derived from the Bayesian inference
• Parameters are regarded as random variables, as we are not certain of the real
values.
• The way to make inference is just the use of the rules of probabilities.
• The inclusion of a prior in the Bayesian model varies across individual re-
searchers.
• There can be a continuous revision of our beliefs as data come to our hand.
That last two points of Bayesian inference makes them even more related to real life
situations, and as a result, a more sensible and natural way of quantifying problems.
3.3 Advantages and Disadvantages of the Bayesian Approach
Bayesian and classical statistics both have advantages and disadvantages, as well as
some similarities. When the sample size is large, Bayesian statistics often provides
results that are equivalent to those obtained by classical statistics.
3.3.1 Advantages of Bayesian Statistics over Classical Statistics
Some advantages of using Bayesian statistics over classical statistics are outline as
follows (Bolstad & Curran, 2007; Institute Inc, 2008)
• Bayesian statistics uses a single tool, Bayes Theorem, which is applicable in all
situations. This contrasts to classical statistics that require many tools.
• Bayesian statistics allows for the incorporation of prior information in addition
to the data that helps in strengthening inferences about the unknown parame-
ters and can help in reducing necessary sample sizes.
• Bayesian statistics include uncertainty in the probability model, which leads to
a more realistic prediction. Classical statistics do not include the uncertainty of
the parameter estimates, which makes them produce less realistic predications
compared with Bayesian statistics.
• Bayesian statistics estimate the full probability model, while classical statistics
do not.
• Bayesian statistics have an axiomatic foundation that is uncontested by classi-
cal statistics. In addition, Bayesian statistics are coherent to a classical statisti-
cian.
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• Bayesian statistics have the strength to compare multiple models with different
techniques using Deviance Information Criteria (DIC), including multilevel
models, but classical statistics cannot.
• Bayesian statistics are unaffected by the overfitting of a model, unlike classical
statistics where the overfitting of model is a serious problem.
• Bayesian statistics use credible interval to make decisions, which makes their
conclusions more robust than classical statistics which use confidence inter-
vals.
• Bayesian inference via MCMC is unbiased with the size of sample size but
classical statistics is biased when the sample size is small and the sample is
sparse.
• Bayesian statistics via MCMC algorithms have a theoretical guarantee that the
MCMC algorithm will converge if it is run long enough, unlike classical statis-
tics where there are no guarantees for the convergence of the MLE.
3.3.2 Advantages of Classical Statistics over Bayesian Statistics
• Classical statistics models are not difficult to specify, since there is no need to
specify prior distribution, initial values for numerical approximation, and the
likelihood function, as is the case with Bayesian statistics.
• Bayesian statistics does not specify the approach to be taken in selecting a prior,
which means there is no correct way to choose a prior.
• Bayesian statistics can produce posterior distributions that are strongly influ-
enced by the priors. From a practical point of view, this leads to a lot of argu-
ment among many researchers.
• Classical models have a much shorter run time compared to Bayesian meth-
ods, particularly when the Bayesian method uses the WinBUGS software. For
instance, simple classical statistics models may be run in minutes, which is not
possible in the case of Bayesian statistics.
3.4 Generalized Linear Models
This section gives a brief description of the development of generalized linear mod-
els. In most cases, when responses are not distributed normally, a linear model may
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not be appropriate. From a Bayesian point of view, the challenges of any model fit-
ting are developing a methodology for estimating the parameters of the model, as
well as predicting any unobserved random variables. The simplest model, and the
most widely used, is the linear model. Its main assumptions are that (i) the obser-
vations are independent, (ii) the mean equals a linear combination of the predictors,
and (iii) the variance of the response is constant for every observation. An addi-
tional fourth assumption is sometimes made, that (iv) the observations are a sample
from the Normal distribution. Procedures for fitting linear models which are very
easy to implement have been developed. However, the above assumptions are not
always satisfied, therefore the use of more general models is necessary. Such mod-
els include the Generalized Linear Model (GLM) and the Generalized Linear Mixed
Model (GLMM). The theory of linear model was generalized by (Nelder & Baker,
1972) to a family of models called generalized linear models (GLMs). In the concept
of linear model, E(ζ) = ηβ. The Link function g(.) was introduced by (Nelder &
Baker, 1972) in order to transform the mean of the model to a linear scale. This is
written as
g[(ζ)] = ηβ. (3.28)
The response variable ζ in a generalized linear model is no longer restricted to being
normally distributed. Instead, it follows a wider class of distributions such as the
exponential distribution.
3.4.1 Model Formulation
A member of the exponential family has a probability density function represented
as follows:
f(ζ) = exp{W (ζ).Q(θ)−B(θ) + C(ζ)} (3.29)
where W (ζ) is sufficient statistic, Q(θ) is the natural parameter and B(θ) is the nor-
malization factor. Generally, an exponential distribution cannot have a support that
varies according to a parameter; it must remain the same across all distributions in
the family. If Q(θ) = θ, one can simply convert the exponential family distribution to
canonical form. In addition, if vector θ in the above expression turns to a scalar, the
expression becomes
f(ζ, θ, φ) = exp
{
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where θ and φ are the location and scale parameters respectively, while a(φ) and c(φ)
are known functions. Generally, if W(ζ) = ζ, then







The expression above gives the mean and variance of ζ as E(ζ) = ∂b/∂θ and var(ζ) =
a(φ)∂2b(θ).
Components of the Generalized Linear Model
The components of Y are independent normal variables with constant variance σ2
and
E(Y ) = µ, µ = πβ, (3.32)
The expressions above are slightly rearranged to the three (3) components of a GLM:
Random component: the components of Y are independent normal variables with





xjβj j = 1, .....p.
Link function: The link between the two foregoing components of a generalized
linear model is given by the identity η = µ. Thus, the formula for the components of
the linear predictor in terms of a so-called link function is written as
ηi = h(µi) i = 1, 2, ......., n,
where h(.) is the link function. This is an expression which connects the parameters
of the response ζ with the linear predictor and explanatory.
Table 3.3: Some common distributions of exponential dispersion family with their link
functions (Ntzoufras, 2011)
Distribution Link name Inverse link Variance function
Normal identity η φ
Binomial logit eη/(1 + eη) µ(1− µ)/N
Poisson logarithms eη µ
Gamma reciprocal e−η φµ2
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3.4.2 Parameter Estimation
Once a particular model is selected, there is need to estimate its parameters. In the
case of the GLM, the estimators of the parameters are obtained by using a maximum
likelihood method.
The Maximum Likelihood Method in GLM
The log-likelihood function for each of the components of the random vector ζ is







where we consider li (θi, φ; ζi) to be a function of θi and φ with ζi being given. The
log likelihood components of response ζ is
`(θ, φ, ζ) =
n∑
i=1
`i(θi, φ, ζi). (3.34)










































The MLE β̂ of the vector of parameters is then obtained as follows:
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3.5. Family of Binomial Logit Link Function with Hierarchical Structure
where Ŵ = diag{ω(µ̂i, ......., ω(µ̂n} to both sides of expression (3.33) and rearranging,
we obtain
(XT ŴX)β̂ = XT Ŵ Ẑ




µ̂i, i = 1, ...., n
3.5 Family of Binomial Logit Link Function with Hierarchi-
cal Structure
Overview of Hierarchical Model
Multilevel regression models are common in many areas including political, social,
and health research. Multilevel models have been illustrated (Gelman & Hill, 2007)
in political research by developing a model to estimate state-level opinions from
national polls, and also modeling the relationship between income and voter pref-
erence by state. Most examples of multilevel models in social science research have
been put together by (Gelman & Hill, 2007), including a multilevel model of po-
lice stops data. An example of multilevel models in a health-related issue is given
by (Gary-Webb et al., 2010), who modeled neighborhood and weight-related health
behaviors. The usefulness of multilevel models has also been discussed in a research
work credited to public health (Diez-Roux, 2000). Multilevel regression models give
coefficients that vary by group a probability model, which allows the variation be-
tween groups to be modeled. This differs from the traditional regression approach
which accounts for varying coefficients by using indicator variables. The probability
models for the coefficients can themselves be given a probability model, and so on.
Suppose we have a simple regression model
yi = β0 + β1xi + ε, i = 1, ..., n (3.37)
Assuming the data is divided into J groups, then the regression model in expression
(3.37) becomes
yij = β0j + β1jxij + εij , i = 1, ..., n, j = 1, ....., J (3.38)
The model can be expanded to a multilevel by giving probability models to β0j , β1j
or both. For instance, the second level model could be
β0j ∼ N(β0, σ2β0)
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and
β1j ∼ N(0, σ2β1).
A more complex model sometimes places regression models in the intercepts as well
as slopes, such as
β0j = α0 + α1w + ϑj
and
β1j = π0 + π0w + υj
for some predictor, w, and error distributions for ϑj and υj .
3.5.1 Multilevel Generalized Linear Models
Generally, a generalized linear mixed model (GLMM) assumes the distribution of
the random effects, b, to be multivariate normally distributed. Such an assump-
tion can be relaxed to allow other random effect distributions. An approach was
proposed by (Lee & Nelder, 1996), called hierarchical generalized linear models
(HGLM), to loosen assumptions about the distributions of random effects in the
models. Hierarchical generalized linear models (HGLM) extend GLMMs in such
a way that the distribution of random effects needs not be normally distributed, but
can be a member of the exponential family of distributions with the link function.
Other ways by which HGLM extended GLMM are as follows: the mean and disper-
sion can be modeled jointly; additional random effects are allowed to be added into
the linear predictor for the mean so that the random effects can follow any conjugate
exponential family of distributions, termed the generalized linear model distribu-
tion; and structured dispersion components that depend upon covariates and the
visualization of model diagnostics can be made. Given the dispersion components,
estimating both the fixed and random effects reduces to estimating an augmented
GLM. Given the fixed and random effects, estimating dispersion components with
the use of an adjusted profile h-likelihood reduces to a second interlinked GLM. That
is, HGLM can be expressed as two interlinked GLMs: one GLM is for the mean,
while the other is for the dispersion, φ. HGLMs have several merits, two of which
are that a single algorithm is sufficient to fit all models of the class, and that model fit-
ting requires neither numerical integration methods nor prior distributions as used
in marginal likelihood and Bayesian methods, respectively. Table3.4 below shows
the commonly used distributions and link functions (Lee & Nelder, 1996)
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Table 3.4: Some common distributions with their link functions
Model Link function,g(µ) b distribution Link, v(b)
LMM identity normal identity
Binomial GLMM logit normal identity
Poisson GLMM logarithms normal identity
Gamma GLMM logarithms normal identity
3.5.2 Multilevel Logistic Regression Model
Multilevel models are regarded as extensions of linear regression models, which ac-
counts for the nesting of data within higher order units as in the case of this study.
In this section, we consider a model where the hospital is regarded as a level-2 unit,
while the patient is a level-1 unit. Failure to account for the nesting of observations
can result in wrong interpretation of results. The multilevel solution is to improve
on the ordinary regression model by including error an parameter, so that we can
capture group level dependencies in our data. Let j denote the level-2 units (hospi-
tals), and i, the level-1 units (individuals). We assume that there are j = 1, ..........T
level-2 units and i = 1, ...tj level-1 units nested within each level-2 unit. Then, the
total number of level-1 individuals across level-2 units is represented by t =
∑T
j=1 tj .
Assume Yij is the value of the dichotomous response variable, coded as 0 or 1, as-
sociated with a level-1 unit, i, nested within a level-2 unit, j. The logistic regression
model can now be written in terms of the log odds of the probability of a response,
represented as Pij= Pr(Yij)=1. Therefore, considering the normal logistic regression






ijβ + σj (3.39)
where xij is a cx1 covariate vector (includes a 1 for the intercept), β is a cx1 vector of
unknown regression parameters and σj is the random effect. These are assumed to
be distributed as N(0, σ2δ ). Considering the fact that our datasets are categorical in
nature, for computational simplicity mostly in models for categorical outcomes, the
random effects are normally given in standardized form. Therefore, δj= σδθj and the






ijβ + σδθj (3.40)
where σδ is the random effect variance term which is now included in the analysis
of the regression model. For the multilevel representation of our model with one
level-1 covariate and one level-2 covariate, we express the level-1 model in terms of
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= β0j + β1jXij (3.41)
where β0j = β00 + β01Xj + σ0j and β1j = β10.
Hence, model (3.41) is now
yij = β00 + β10Xij + β01Xj + σ0j . (3.42)
As shown in the model (3.42), the log odds of a patient i in hospital j taking surgery
is determined by the log odds of a particular patient in a particular hospital (β00),
the effect of the patient level (β10Xij) and the hospital level (β01Xj), as well as the





where Ψ is the logistic cumulative distribution while η is the log odds of taking
surgery.
3.6 The Multinomial Logistic Regression Model
The Multinomial logistic regression model is a technique of analysis which is ap-
plicable when the dependent variable under study consists of more than two cat-
egories. The multinomial response could be ordinal (ordered categories) or nomi-
nal (unordered categories). Multinomial logistic regression does necessitate careful
consideration of the sample size and examination for outlying cases. Sample size
guidelines for multinomial logistic regression indicate a minimum of 10 cases per
independent variable (Chan, 2005).
While a binary logistic regression model compares one dichotomy, a multinomial
logistic regression model compares a number of dichotomies. A multinomial ap-
proach outputs a number of logistic regression models that make specific compar-
isons of the response categories. Considering a situation where we have j categories
of the response variable, the model consists of j − 1 logit equations which are fit
simultaneously. The probability of a categorical variable in a multinomial model is
estimated using maximum likelihood estimation (Bayaga, 2010).
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Model formulation
Unlike binary logistic models, multinomial logistic regression models pair each out-
come category with a reference category. The last category or probably the most
common category is assumed to be picked as reference J Agresti & Kateri (2011).
Suppose xi = (xi0, ..., xim)T denote the explanatory variables for individual 1 ≤ i ≤ n
with m covariates X1, . . . , Xm and the outcome variable has t categories (t>2). The
βj = (βj0, . . . βjm), (1 ≤ j ≤ J − 1), a row vector, represent the regression param-
eters for the jth category. Suppose yi = (yi1, . . . , yiJ) denote a multinomial trial for
individual 1 ≤ i ≤ n. The trial yij is equal to 1 anytime a trial occurs in category j
and p(yij = 1|Xi) is the probability that the ith trial occurs in category j given a set
of covariates xi. Then the multinomial logistic regression model for Pr((yij = j)|X),
(1 ≤ j ≤ t− 1) is represented as (Agresti & Kateri, 2011):





= β10 + β
1
1b1 + · · ·+ β1kbk (3.43)





= β20 + β
2
1b1 + · · ·+ β2kbk (3.44)
...
Pr((yij = t− 1)|X) = log
(
Pr((yij = t− 1)|X)
Pr((yij = t)|X)
)
= βt−10 + β
t−1
1 b1 + · · ·+ βt−1k bk
(3.45)
where the category t is chosen as the reference category, βj0 denotes the intercept,
and βj1, . . . , β
j
i denotes the regression coefficients of b1, b2, ......bk in the jth category
respectively, (1 ≤ j ≤ t− 1).
Cumulative logit model
The object of interest in ordinal data is to model Pr(Y = j|xi), j = 1, 2..., t, where t
is the total number of ordered categories, with explanatory variables xi. This thesis
makes use of cumulative logistic regression models.
logit[Pr((Yi ≤ j)|xi)] =
Pr(Yi ≤ j|xi)
1− Pr(Yi ≤ j|xi)
= αj + x
T
i β, j = 1, . . . , t− 1 (3.46)
where αj = α0 < α1 < ........ < αt−1 < αt, Yi is the response for the ith individual
and β is the fixed effects parameter. Suppose we have a model with t ordered, it
implies that there are t− 1 logits. Then the jth cumulative probability is represented
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as follows
Pr((Yi ≤ j)|xi) =
1
1 + exp[−(αj + xTi β)]
, j = 1, ..., t (3.47)
when j = 1, 2, ..., t, its probabilities are
φj = P (Yi ≤ 1)
...
P (Yi = t− 1) = P (Yi ≤ t− 1)− P (Yi ≤ t− 2)
P (Yi = t) = 1− P (Yi = t− 1)
where
∑t





























1 + exp(αj + xTi β)
− exp(αj−1 + x
T
i β)
1 + exp(αj−1 + xTi β)
]δi,j}











1 + exp(αj + xTi β)
− exp(αj−1 + x
T
i β)
1 + exp(αj−1 + xTi β)
]
(3.50)





1 if yi = j where i = 1, 2, 3...,m, j = 1, 2, 3, ...t
0 if otherwise
(ζ|y) = (α1, . . . , αt−1, β)T .
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3.6.1 Model and Parameter Estimation in Multinomial
Suppose that Y is a categorical response variable with three categories, represented
as 1, 2, or 3. Since the outcome variable has three categories, we need two logit mod-
els, as the logistic regression model uses a binary outcome variable which parame-
terizes in terms of the logit y= 1 against y =0. We assume that there are k explanatory
variables, x = (x1, . . . , xk) in our model. The logit models for nominal responses pair
each response category to a baseline category and the choice is arbitrary. If we set















= λ20 + λ21x1 + · · ·+ λ2kxk = λ
′
2x.
Considering the above model, the response probabilities are set up as follows

























with parameters λ= (λ1, λ2) as the unknown. In the context of this thesis, the out-
come variables are recoded as follows
Y1 = 1, Y2 = 0, Y3 = 0 : Y = 1,
Y1 = 0, Y2 = 1, Y3 = 0 : Y = 2,
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Y1 = 0, Y2 = 0, Y3 = 1 : Y = 3.
Irrespective of the value Y takes, the sum of these outcome variables is
∑k
i=1 yi=1.
The conditional likelihood function, given the covariates for independent observa-















































i=1 yij =1 for each j.
The maximum likelihood estimators are obtained by taking the first partial deriva-
tives of `with respect to each of the unknown parameters and setting these equations
equal to zero. In addition, the estimates of the parameters and variance covariance
matrix can be obtained by any standard statistical computer package like SAS and R
(nnet package).
3.7 Bayesian Generalized Linear Mixed Model (GLMMs)
In this section, we discuss the approach of generalized linear mixed model (GLMM)
in the context of Bayesian analysis. The dataset used in this thesis is clustered, and to
account for this heterogeneity we use GLMMs which are an extension of generalized
linear models (GLMs). The main focus is on the Bayesian generalized linear mixed
model and prior distribution for Bayesian Hierarchical models, as it is applicable
to the Bayesian GLMMs. Effort was also given to the estimation of parameters and
the application of the model to the breast cancer data. The method of estimation
considered is the Markov chain simulation or MCMC, and we applied this method
on breast cancer data as discussed extensively in the results section.
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3.7.1 Generalized Linear Mixed Model
This thesis considers a multilevel logistic regression model formulated from a gen-
eralized linear mixed modeling (GLMM) framework. The generalized linear model
(GLM) is a collection of fixed-effects models that assume the non-dependence of out-
come response observations. Considering a dataset with hierarchical structures, this
assumption is not valid. In addition, the assumption of the random effects in a linear
mixed model must be Gaussian. GLMMs are extension of GLMs to correlated data
where observation dependence within a cluster is captured through the use of ran-
dom effect. The properties of both GLM and LMM are incorporated by GLMM. In
GLMM, the mean response is modeled not as a function of covariates alone, but as
being conditional of unobservable random effects. The inclusion of random effects
in GLMM is aimed at inducing the correlation between the observations marginally
when averaged over the distribution of the random effects.
Model Formulation
Unlike the linear mixed model, generalized linear mixed models assume that the
outcome responses are conditionally independent. Suppose the random effects bi,
and the set of covariates
E(Yij |bi, Xi, Zi) = h(Xiβ + Zibi). (3.52)
where i = 1, 2, . . . ,m; j = 1, 2, . . . ,ni, and h(.) is an inverse link function. Random
effects, bi are drawn from MVN(0,Di). Yij is the jth outcome, Xi is an ni × p matrix,
and Zi is an ni × q matrix (associated with random effects bi).
In terms of the link function, the expression (3.56) can be represented as
h−1[E(Yij |bi, Xi, Zi)] = Xiβ + Zibi,
where h−1(.) is a link function. The pdf’s of Yij are represented as




+ c(yij , φ)
}
. (3.53)
where θij is a canonical parameter of a linear predictor ηij , φ is a dispersion param-
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and a(.), b(.) and c(.) are known functions. The conditional expectation and variance
are stated respectively




V ar(Yij |ηij) = φ
∂2(θij)
∂θ2ij
We then obtain the estimation for random variance components by maximizing
the marginal likelihood, and by integrating out the random effects, b′is. According





fij(yij |β, φ) + f(bi|Di)dbi. (3.54)










fij(yij |β, φ) + f(bi|Di)dbi. (3.55)
The expression above involves the computation ofm integrals over the q-dimensional
random effects, bi. This computation cannot be obtained directly. Estimation of pa-
rameters are obtained by approximations of the above expression. We found that
in GLMMs, the handling of random effects indicates that they follow some distri-
butions like gamma, etc. Meanwhile, when Bayesian approaches via MCMC are
involved, such problems become unnecessary. Bayesian MCMC techniques will pro-
duce a huge number of random samples for fixed and random effects to the likeli-
hood functions instead of integrating intractable random effects. This technique is
robust and it produces a means of marginalizing random effects (Browne et al., 2006;




According to (Raudenbush & Bryk, 2002), there is no single way to estimate the pa-
rameters in a multilevel model. The most widely-used techniques for the estimation
include Maximum Likelihood Estimation (MLE), Restricted Maximum Likelihood
(REML), and Bayesian estimation. Most of these techniques of estimation can be
carried out through different algorithms. For example, Maximum Likelihood Esti-
mation (MLE) estimation can be achieved using any of these mechanisms: Expecta-
tion Maximization (EM) algorithm, the Newton- Raphson algorithm, Fisher scoring
algorithm and Iterative Generalized Least Squares (IGLS), while Bayesian estimation
will be carried out using Gibbs sampling in WinBUGS.
3.8.1 Maximum Likelihood Estimation
Maximum likelihood estimation is the most widely-used estimation method for para-
metric models. The main idea is to choose the value of the parameters that maxi-
mizes the joint density of the observations, called likelihood. In the case of linear
models, the calculations for deriving the MLE can be achieved analytically, but in
the case of a GLM or GLMM, numerical methods are adopted.
In case of the GLMM, the log-likelihood of the parameters (β, γ), given a set obser-
vations y, can be expressed in (3.60) as

















The integral in expression (3.60) does not have a closed-form solution, which makes
it difficult to obtain the likelihood accurately. In order to overcome these difficulties,
the MCMC algorithm is employed (Ngesa et al., 2014). The MCMC technique is
one of the techniques employed to generate the estimates of unknown parameters
θ and correct the values generated in order to have a better estimate of the desired
posterior distribution, p(θ|η) (Ojo et al., 2017; Ntzoufras, 2011).
3.8.2 Bayesian Multilevel
Bayesian multilevel modeling is a statistical modelling approach that involves mul-
tiple levels (hierarchical form) and estimates the parameters of the posterior distri-
bution using the knowledge of Bayesian technique. Bayesian multilevel modeling is
used when information is available on several different levels of observational units.
The sub-models combine to form the hierarchical model, and Bayes theorem is used
65
3.8. Estimation Methods
to integrate them with the observed data and account for all the uncertainty that is
present. The result of this integration is the posterior distribution, also known as
the updated probability estimate, as additional evidence on the prior distribution is
acquired. Frequentist statistics users, the more popular foundation of statistics, have
been known to contradict Bayesian statistics due to their treatment of the parameters
as a random variable, and use of subjective information in establishing assumptions
on these parameters (Gelman et al., 2004). However, Bayesianists argue that relevant
information regarding decision making and updating beliefs cannot be ignored, and
that hierarchical modeling has the potential to overrule classical methods in applica-
tions where respondents give multiple observational data. In addition, the Bayesian
model has proven to be robust, in particular when the posterior distribution is less
sensitive to the more flexible hierarchical priors. Bayesian analyses are especially
well suited for the analysis of multilevel models because of their flexibility in spec-
ifying multilevel structures of parameters using priors, as well as their ability to
handle small samples and model mis-specifications (an over-parametrization of the
likelihood can be resolved with well-chosen priors).
Bayesian Multilevel Estimation Procedure
One fact about statistics is that it is all about unpredictability. In classical statistics,
we express our unpredictability about how well an observed statistic estimates the
unknown population parameter by examining its sampling distribution over an in-
finite number of possible samples. Based on the fact that it is only one sample that
we have, the sampling distribution is assumed to be based on a mathematical sam-
pling model. The literature puts it that the use of Bayesian estimation techniques
for multilevel models for variance parameters when the fixed effects are estimated
was introduced by (Congdon, 2010). The key feature of Bayesian multilevel esti-
mation is that it provides an appealing choice for researchers working with sparse
datasets. This approach can be carried out using MCMC algorithms described at the
beginning of this chapter (i.e. Gibbs sampling algorithm). All MCMC algorithms are
iterative, and at each iteration, they are designed to yield a sample from the joint pos-
terior distribution of the parameters of the model. After running a specific number
of iterations either in WinBUGS or R, we get a sample of values from the distribution
of any parameter which can be used to derive any desired distribution characteris-
tic like the mode, mean and standard deviation. The mathematical formulation for
Bayesian multilevel models combines prior information about the fixed and random
effects with the likelihood based on the data under consideration. These parameters
are considered as random variables described by the probability distributions, and
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the prior information for a parameter is incorporated into the model via a prior dis-
tribution. Prior distributions must be specified, but these specifications of priors
vary from one researchers to another, as many researchers do not want the prior to
influence their results. The algorithm of Bayesian estimation in WinBUGS is very
computer-intensive and frustrating sometimes.
3.8.3 Priors for Bayesian Multilevel Models
Comparisons between classical and Bayesian techniques of fitting variance com-
ponent and random effect logistic regression models gave rise to Bayesian meth-
ods (Best et al., 1995; Best, 1996). The impact the prior distribution can have has
been indicated by simulation outputs with respect to bias, particularly in level 2
variances. Gelman (Gelman et al., 2014a) investigates this more compactly and gave
a recommendation on the use of a uniform prior for non-informative priors.
Conclusion
This chapter introduced the different methodologies adopted in this research. It
begins with the classical logistic models for both classical and Bayesian statistics.
When classical regression techniques are applied to multilevel data sets, the classical
regression models may fail to account for the dependency structure in the datasets.
Therefore, multilevel models are applied to ensure valid inferences. Thus, we pro-
ceeded to the multilevel logistic regression model in order to account for the hi-
erarchical structure in our datasets. We also observed that the multilevel regression
model is more complicated than the standard single-level multiple regression model.
This study employed two types of the multilevel models, namely, the classical and
the Bayesian multilevel models, and their results were compared. We introduced the
descriptions of both models and described how parameter estimation was carried
out for each of them. One of the interesting things about multilevel modeling tech-
niques is that they can deal with datasets in which the times of measurement differ
from subject to subject. The greatest advantage of Bayesian over classical statistics is
that Bayesian statistics help in selecting more significant predictors in a model com-
pared to classical statistics. They also make use of MCMC methods of estimation to
achieve a desired posterior distribution. But sometimes, it takes a long time to draw
a final decision from Bayesian models, which means that models should be run with
different priors on the model parameters. Moreover, to ensure that the choice of the
prior distribution does not affect the final results, there is need to assess the conver-
gence of the result to know whether it has reached a convergence level or not. The
strength of a multilevel model is that it can account for nesting in any dataset, and
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has a very good ability to separately estimate the predictive effects of an individual





The main purpose of exploratory data analysis (EDA) is to help us understand the
data in detail before proceeding to modeling and inference tasks. R Software was
used to explore the data in order to have an insight into the nature of the variables
used because of its flexibility, clear and neatness in multiple line and surface graphs
in this thesis. In particular, the variables and their respective significance to HIV
research are explicitly detailed. In this section, a detailed and extensive exploratory
data analysis is presented. The EDA focuses on the following:
• Determine association between the response variable and predictor variables,
• Providing a basis for further data collection through hospital record,
• Assessing assumptions on which inference will be based.
4.0.1 Descriptive Analysis Result of Breast Cancer
The descriptive statistics served to present the cancer data in general and more
specifically information related to breast cancer. This section comprised of univari-
ate and bivariate analysis. At univariate level of analysis, the data is presented with
focus on the measurement of central tendency (mean, median) and dispersion (stan-
dard deviation, inter-quartile range). At bivariate level, variables are taken two by
two to measure the association between each independent variable and the depen-
dent variable. We also made use of statistics hypothesis tests to check the associa-
tion or difference of means of each of selected prognostic factor. The responses and
their respective percentage frequencies to the measured variables are presented in
this section. From the descriptive statistics, we found that 192 cases accounting for
(81.01%) were malignant breast lesions, while 45 cases (18.99%) were benign giving
69
a ratio of 4.3:1 for malignant to benign breast lesion. The current study focuses on
the investigating the effects of demographic, socio-economic and medical factors on
breast cancer. We explore each of the factors that are thought to be risk factors of
breast cancer. The information obtained is useful for understanding how these fac-
tors determine attitudes of women of this part of Nigeria towards general health
services and behaviors that may reduce the spread of breast cancer.
Summary statistics shows that 50.21% (119) of patients were presented with grade 2






disease, followed by grade 1 disease (31.65%), with grade 3 disease being lease com-
monly seen (18.14%) in this part of Nigeria. Further descriptive statistics reveals that
the grade of disease was not seen to be significantly different amongst the different
age groups, tribe and breast cancer types (see Table 4.1).
Table 4.2: Distribution of histologic types of breast carcinoma
Grade Cases %
Infiltrating duct carcinoma 99 41.77
Lobular carcinoma 57 24.05
Mastocytosis 516 6.75
Others (mixed histologic type) 65 27.43
Total 237
Infiltrating duct carcinoma was the commonest histologic type of breast cancer seen
(41.77%). This is distantly followed by others (mixed histologic types) (27.43%), lob-
ular carcinoma (24.05%) while mastocytosis is the rarest type seen in the study pop-
ulation (6.75%). (see Table 4.8).
Table4.3 gives the number of respondents in each of the age groups categories. The
results in the table indicate that the proportion of respondents in each age group de-
creases with increasing age. Approximately 41% of the respondents were in the 20-34
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Table 4.3: Summary of the categorized age groups for the patients






years age group and approximately 27% were from the 35-49 years age group. Rela-
tively smaller proportions of respondents were drawn from the older age groups in
order to mirror the age structure of the breast cancer women in western Nigeria.
Table 4.4: Summary of the marital status for the patients





Table4.4 gives the results of the marital status of the patients. The data show that
almost all the women in population (93%) were married and those in categories sin-
gle/separated constituted 6% and 1% of the respondents.
Table 4.5: Summary of the employment status of the patients
Employed N Percentage
(%)
civil servant 46 19.4
retired 23 9.7
self employed 168 70.9
Approximately 70.9% of the respondents were self-employed whereas approximately
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19.4% claimed to be civil servant with about 9.7% of the patients have retired from
the active work as shown in Table 4.5.
Table 4.6: Frequency distribution of breast cancer grade by biological risk factors (n= 236)
Variables
Grade I Grade II Grade III Total
n(%) n(%) n(%) n(%)
Age Groups
20-34 29(30.21%) 47(48.96%) 20(20.83%) 96(100)
35-49 18(27.69%) 35(53.85%) 12(18.46%) 65(100)
50-69 19(32.76%) 29(50%) 10(17.24%) 58(100)
70+ 8(47.06%) 8(47.06%) 1(5.88%) 17(100)
Tribe
Igbo/Efik 2(28.57%) 5(71.43%) 0(0%) 7(100)
Yoruba 72(31.44%) 114(49.78%) 43(18.78%) 229(100)
Breast cancer
types
Malignant 59(30.73%) 98(51.04%) 35(18.23%) 192(100)
Benign 15(34.10%) 21(47.73%) 8(18.18%) 44(100)
Treatment
Surgery 50(29.76%) 86(51.20%) 32(19.05%) 168(100)
Others 24(35.29%) 33(48.53%) 11(16.18%) 68(100)
Table 4.6 shows the distribution of histologic grade by biological factors of breast
cancer. The grade of disease was not seen to be significantly different amongst the
different age groups, tribe, type of breast cancer and treatment modality. Table4.7
Table 4.7: Contingency table for educational status and breast cancer type by age group
Pry& Secondary Tertiary Malignant Benign
n % n % n % n %
20 - 34 81 71.7 16 12.9 68 35.4 29 64.4
35 - 49 32 28.3 33 26.6 56 29.2 9 20.0
50 - 69 - - 10 58 52 27.1 6 13.3
70+ - - 10 17 16 8.3 1 2.2
displays a educational status by age group contingency table. It is evident that the
patients aged 20 - 34 years had at least high school education constitute almost 71.7%
of the patients whereas a substantial proportion of those who had tertiary education
is 12.9% within the same age group.
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4.1 DETERMINANT OF BREAST CANCER TYPES
Abstract
The aim of this paper is to show how to handle Bayesian analysis of the binary re-
gression model using Gibbs sampler in WinBUGS and to illustrate some aspects of
model building and diagnostic checking via Markov Chain Monte Carlo (MCMC).
Bayesian inference assumes that there are specific free (parametric) distributions for
the unknown parameters. Bayesian fits probability of interest by incorporating prior
information concerning the unknown parameters as well as the likelihood function
of the observed data which helps in obtaining the posterior distribution. We de-
veloped a Bayesian binary regression model to established patients diagnosed with
malignant breast cancer in western Nigeria. Markov Chain Monte Carlo (MCMC)
methods are used to make inference and to evaluate Bayesian binary regression
models. By using R software and WinBUGS 14, a model for Bayesian binary logistic
regression model was fitted. The results of the Bayesian binary logistic regression
is compared with the classical logistic regression. Bayesian model offers better esti-
mates than the classical inference. The aspects of assessing convergence in Bayesian
analysis are extensively discussed, including the posterior distribution of parame-
ters. The methodological contribution of this paper is the strength to fit a Bayesian
binary logistic regression model with the current dataset using Bayesian inference
and classical statistics. It was established that breast cancer types is dependent on
one’s level of educational status and the age at diagnosis.
4.1.1 Introduction
Breast cancer (BC) is the commonest cause of mortality and morbidity among women
worldwide, and currently the most common cancer among Nigerian women (Ade-
bamowo & Ajayi, 1999; Ebughe et al., 2013a; Ojewusi & Arulogun, 2016; Oladimeji
et al., 2015; Banjo, 2004). The human breast is a pair of mammary glands composed
of specialized epithelium and stroma in which both benign and malignant lesions
can occur (Dauda et al., 2011). Previous findings in Nigewria affirmed that benign
breast constitutes the larger of the breast lesions but much concern is given to malig-
nant lesions of the breast since breast cancer is the most frequent malignancy in the
majority of the women (Uwaezuoke & Udoye, 2014). Available statistics show
that the annual incidence of breast cancer is increasing globally, and this is occurring
more rapidly in countries with a hitherto low incidence rate of breast cancer (Wilson
et al., 2004). Globally, breast cancer accounts for 18.4% of cancers associated with
women. In 2012, (Jedy-Agba et al., 2012a) reported that the incidence of breast can-
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cer in Nigeria has risen significantly with the incidence in 2009 - 2010 reported to
be at 54.3 per 100 000, thereby representing a 100% increase within the last decade.
The report about patients diagnosed with breast cancer in eastern Nigeria suggested
that every 1 out of 5, representing 23%, are malignant in nature (Yusufu et al., 2003).
Incidence rates of breast cancer vary from 19.3 per 100,000 women in Eastern Africa
to 89.7 per 100,000 women in Western Europe, and are high (greater than 80 per
100,000) in developed regions of the world. From literature, we found that previ-
ous studies only focused on benign breast cancer (Abudu et al., 2007; Adesunkanmi
& Agbakwuru, 2000; Forae et al., 2014; Guray & Sahin, 2006; Kumar et al., 2014;
Anyikam et al., 2008; Godwins et al., 2011; Ochicha et al., 2002).
The application of the Bayesian technique and its usage to analyze cancer data has
proliferated in recent years. Several researchers such as (Acquah, 2013) studied
the comparison of Bayesian and classical logistic regression estimation and found
that classical statistics has some limitation which requires an alternative approach to
overcome. (Yu & Wang, 2011) presented a work on the estimation of a mixed logit
model for simulated experimental data using Bayesian and classical logistic regres-
sion. They found in the classical estimation some unidentified parameters which
could not be estimated by a classical technique, but which the Bayesian technique
could correctly identify. A study on the prediction of panicle and shoot blight sever-
ity of Pistachio in California was carried out by (Mila & Michailides, 2006) using the
comparison of both Bayesian and classical logistic regression techniques suggested
that Bayesian gave a better result than the classical. They also found that Bayesian
method was able to produce new information which the classical approach did not
give. Other studies that have also shown similar result (Albert, 1996; Congdon,
2014; Marrelec et al., 2003; Dı́az & Batanero, 2016; LOZANO-FERNÁNDEZ, 2008;
Gordóvil-Merino et al., 2010)
In most case, studies comparing both methods find that Bayesian technique prof-
fers a better solution compared to classical and has greater capability to eliminate
the limitations encountered in classical regression. The Bayesian technique assumes
model parameters as random variables and not as constants, while the probability
of the unascertained parameters can be obtained via Bayes theorem (Bedrick et al.,
1997; Congdon, 2005; ONeill, 2002; O’Neill et al., 2000; Wong & Ismail, 2016). This
provides information regarding parameter uncertainty that might be very difficult
to obtain using the classical technique. Classical technique fits the logistic regres-
sion by means of an iterative approach like maximum likelihood method, fishers
scoring, or iterative proportional fitting. In some cases, as a result of this iterative
approach, convergence may be difficult to achieve. But the maximum likelihood es-
74
4.2. Materials and Methods
timation has a significant bias for sparse data, a limitation which can be addressed
by the use of Bayesian approach. The robustness and accuracy of the results pro-
duced by Bayesian approach makes its gain popularity in data analysis. As a result,
this paper investigate the significant predictors as well as characterizing patients di-
agnosed of benign and malignant breast cancer lesion using both classical approach
and Bayesian approach (with non-informative priors). We also presents diagnosis of
Markov Chain Monte Carlo (MCMC) Convergence.
4.2 Materials and Methods
4.2.1 Data Collection
Ethical approval was obtained from the ethics committee of the Federal Medical
Teaching Hospital, Ekiti State, Nigeria. This data was extracted from cancer reg-
istry of the Federal Medical Teaching Hospital. We accessed 237 records and 20
variables of breast cancer data. Some of these variables describe socio-demographic
and cancer-specific information on the incidence of breast cancer. Each record con-
tained patient-related tumor information. Extensive variable selection procedures
were performed on the 20 variables. The records of patients aged 20 years and
above were sorted out for this analysis. Information collected includes age, mar-
ital status, educational level, religion, race, type of breast cancer, occupation, Lab
number, case number, site of the female breast cancer, type of diagnosis and histo-
logical type. Other information recorded was the modality of treatment received:
surgery, chemotherapy, hormonal therapy, radiotherapy or combination of these.
With respect to the quality of the data obtained from the record of the breast cancer
cases, the main concern was the proportion of hospital records in which some of the
relevant variables were not recorded. Information relating to variables like weight,
height, age at first full term pregnancy and age at menopause were missing. For
input variable selection, we tried to limit the number of variables and select only the
clinically relevant ones. Logistic regression models were fitted to obtain indepen-
dent estimates of the risk of breast cancer. Modeling started with all the variables
followed by sequential deletion according to their statistical importance. Each vari-
able was assessed through the Shapiro- test so as to see whether the data follow
a normal distribution. The R software was used for the classical statistical analy-
sis and the WinBUGS14 software for the Bayesian analysis. As a requirement of the
Bayesian approach, several diagnostics tests were performed to answer convergence




Assessing Bayesian Markov Chain Monte Carlo (MCMC) and Convergence
We employed Gibbs sampling algorithm in order to obtain posterior distribution of
parameters (Ntzoufras, 2011). In this study, non-informative prior were assumed
in order not to influence the posterior distribution and it was assumed that λk ∼
N(1, 0.0001). All the Bayesian analysis in this study were carried out using Win-
BUGS 14 (Lunn et al., 2000). In our model, 1,500,000 Markov chain Monte Carlo
(MCMC) iterations were ran, with the initial 200,000 discarded to cater for the burn-
in period. The 5,000 iterations left were used for assessing convergence of the MCMC.
Several tests, both graphical and formal tests can be used to check convergence are
available via convergence diagnostics. These diagnostics are used mainly to check
for stationarity of the chain and verify the accuracy of the posterior summary mea-
sures. Various convergence diagnostics are available but for the current study, we
utilize the trace plots, the Geweke plots and the Heidelberger-Welch test as de-
scribed by (Brooks & Roberts, 1998; Lesaffre & Lawson, 2012). The diagnostic of
Heidelberger-Welch is used to test if the chain is stationary and convergence had
been reached during the burn-in period. This diagnostic test is applied by discard-
ing the first 10% of the chain if the test is failed while the remainder of the chain
is re-tested. This process is repeated until either the test is passed or only 50% of
the original chain remains. In this paper, we focus more on the techniques for de-
termining whether a particular Markov chain has converged to stationary or not.
The technique require only the output from one or more Markov Chain Monte Carlo
(MCMC) simulations algorithm.
4.3 Results
4.3.1 Descriptive analysis of breast cancer
The main goal of this paper is to investigate the significant predictors as well as
characterizing patients diagnosed of benign and malignant breast cancer lesions
and presents diagnosis of MCMC convergence for the analysis, comparing the clas-
sical approach and Bayesian approach. Various prognostic factors are considered
which include: intercept(λ0), marital status: separated(λ1), level of education: at
least high school(λ2), religion: christian(λ3), tribe: yoruba(λ4), age: 35-49(λ5), 50-
69(λ6), 70+(λ7), occupation: retired(λ8), self employed(λ9). A total of 237 breast can-
cer patients’ data was extracted for analysis in the current study. Of these, 192 cases
accounting for (81.01%) were malignant breast lesions, while 45 cases (18.99%) were
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benign giving a ratio of 4.3:1 for malignant to benign breast lesion. The mean age of
the respondents was 42.2± 16.6 years with 52% of the women aged between 35-49
years. Table 4.9 shows the Heidelberger and Welch stationarity tests for the Bayesian
Markov chain Monte Carlo. This statistic is used to test if the chain is stationary and
convergence had been reached during the burn-in period.
4.3.2 Result of classical logistic regression
Table 4.8 shows the result of a classical logistic analysis of the breast cancer tumors.
The results indicate that the type of breast cancer (malignant) was observed to be
strongly associated with age and educational status. This indicate that women with
at least high school education have a significantly higher risk of being diagnosed
with malignant breast tumors.
Table 4.8: The Result of Classical logistic regression for Patients diagnosed of Benign and
Malignant
Est Std Error z value Pr(>| z |)
λ0 -2.421 1.2308 -1.967 0.0492
λ1 1.2479 0.5976 2.088 0.4459
λ2 0.5926 0.7774 0.762 0.0368
λ3 1.0782 0.6392 1.687 0.0916
λ4 1.2048 0.8515 1.415 0.1571
λ5 1.1952 0.5732 2.085 0.0371
λ6 0.5034 0.8188 0.615 0.5387
λ7 1.0534 1.4439 0.73 0.4656
λ8 0.4823 1.0432 0.462 0.6439
λ9 0.9898 0.5658 1.749 0.0802
4.3.3 Result of Bayesian logistic regression model
For the Bayesian technique, we present MCMC diagnostics for the patients diag-
nosed with benign and malignant breast cancer in Table 4.10. The posterior means
in the Bayesian technique were obtained after a burn-in period of 5000 with Monte
Carlo error less than 2%. The posterior means and medians of the coefficient λ2
(educational status) and λ5 (age) indicate that it was significant. The results of the
posterior provide some evidence about the important variable to be selected while
profiling patients diagnosed with malignant breast cancer (Table 4.10). For educa-
tional level, Table 4.10 shows that those with at least high school education are 1.3
times more likely than others to have benign breast cancer. The results indicate that
women with age ≥ 35 years were at a higher risk of been diagnosed with malignant
breast cancer than those with age < 35 years. Our result showed no indication that
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Table 4.9: Heidelberger and Welch Stationarity and half-width tests for the Bayesian
chains used in the diagnosis of MCMC
Param. Station- P–Value Half–Width Mean Half width
arity Test C1 C2 C3 Test C1 C2 C3 C1 C2 C3
λ0 passed 0.927 0.888 0.308 passed 0.117 0.132 0.129 0.054 0.054 0.055
λ1 passed 0.591 −0.219 0.364 passed −1.148 −1.144 -1.148 0.01 0.009 0.01
λ2 passed 0.0572 0.818 0.204 passed 1.348 1.343 1.35 0.01 0.011 0.011
λ3 passed 0.394 0.51 0.994 passed 0.836 0.838 0.839 0.013 0.012 0.012
λ4 passed 0.915 0.987 0.112 passed 1.22 1.216 1.22 0.016 0.016 0.016
λ5 passed 0.893 0.815 0.313 passed -0.216 −0.226 −0.228 0.044 0.044 0.044
λ6 passed 0.808 0.914 0.237 passed −0.977 −0.977 -0.983 0.038 0.037 0.038
λ7 passed 0.824 0.94 0.507 passed −1.536 −1.55 -1.551 0.044 0.044 0.044
λ8 passed 0.64 0.954 0.163 passed 0.6168 0.613 0.612 0.02 0.042 0.019
λ9 passed 0.40 0.896 0.092 passed 1.054 1.058 1.053 0.009 0.009 0.009
religion, race or marital status could be a major factor for women to be diagnosed
with malignant breast cancer in the western part of Nigeria.
Table 4.10: WinBUGS Posterior Summaries for Breast Cancer Patients
Mean SD MC error 2.5% Median 97.50% start Sample
λ0 0.126 1.973 0.01568 -3.514 0.049 4.251 5000 49749
λ1 -1.147 0.669 0.003012 -2.453 -1.146 0.176 5000 49749
λ2 1.347 0.637 0.002987 0.180 1.316 2.695 5000 49749
λ3 0.838 0.815 0.003789 -0.637 0.796 2.561 5000 49749
λ4 1.219 0.920 0.004805 -0.633 1.224 3.012 5000 49749
λ5 -0.223 1.672 0.001283 3.910 -0.102 4.685 5000 49749
λ6 -0.979 1.523 0.01116 -4.418 -0.836 1.603 5000 49749
λ7 -1.545 1.686 0.01269 -5.250 -1.415 1.371 5000 49749
λ8 0.614 1.133 0.005761 -1.454 0.554 3.002 5000 49749
λ9 1.055 0.590 0.00283 -0.093 1.047 2.241 5000 49749
All the convergence diagnostics tests are obtained using CODA/BOA package in
R software. Diagnostics are computed on 1500000 iterations, thinned by sixty it-
erations, after a 5000 iteration burn-in. The Geweke (Z score) diagnostic suggests
stationarity for all the parameter as all the Z-scores in Table4.11 are less than 1.96.
Heidelberger-Welch and Raftery-Lewis also suggest acceptance by the MCMC al-
gorithm. For the Heidelberger-Welch diagnostic, the p-value is from the Cramer-
Von-Mises test of stationarity. Raftery-Lewis N is the estimated number of MCMC
iterates required in oder to obtain an accurate estimate of the quantile of marginal
posterior density and I is the dependence factor. The dependence factor above five
(5) indicate the presence of high autocorrelation that may occur as a result of poor
choice of starting values for the chains of high posterior correlations ( that is an in-
dicative of convergence failure).
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Table 4.11: Convergence diagnostics MCMC algorithm for two way ANOVA model
Parameter Geweke Z Heidelberger-Welch P Raftery-Lewis
λ0 -0.64 0.92 4567 1.22
λ1 0.29 0.59 3857 1.03
λ2 0.18 0.57 3690 0.99
λ3 1.76 0.39 3708 0.99
λ4 0.39 0.92 3973 1.06
λ5 0.78 0.89 7016 1.87
λ6 0.92 0.81 9406 2.51
λ7 0.80 0.82 10244 2.73
λ8 0.28 0.64 3915 1.05
λ9 -0.72 0.40 3763 1.00
4.3.4 Assessing the performance of Markov Chain Monte Carlo (MCMC)chains
in WinBUGS
When the results of the model are computed, it is necessary to check for the sta-
tionarity of Markov chain Monte Carlo algorithm. The performance of a diagnostic
test can be examined in several ways. The diagnostics examined in this paper are
those of Geweke (Geweke et al., 1991), Heidelberger and Welch (Heidelberger &
Welch, 1983), and Raftery and Lewis (Raftery & Lewis, 1992), which look at conver-
gence of an individual chain, and that of Gelman and Rubin (Gelman & Rubin, 1992),
which bases convergence on analysis of multiple chains. These results are essential
to achieve an adequate estimation of the parameters for the convergence of MCMC
algorithm. After an initial burn-in has been discarded, it is advisable to use only a
subset of the parameters of interest. This process is called thinning and the purpose
is to improve the mixing of the chain. The best way to achieve this is by generating
the autocorrelation for each parameters being sampled. Fig 4.2 was presented to
demonstrate this process and it shows that there is no problem of autocorrelation
among the MCMC chain. Both Fig 4.1 and Fig 4.2 revealed that the chain for each
parameter is stationary and not correlated. A more formal technique for diagnosing
the convergence of MCMC chains is reported in Fig 4.4. The blue and red lines de-
note the variance within and between chains. To support that the chain is converged,
the ratio must converge to unity and the blue and red lines must converge to a stable
value. It also displays the red lines representing the R̂. Hence, Figure 4.4 indicates
that all the R̂→ 1 which suggests that the algorithm converges. Both Figure 4.3 and
Fig 4.4 explain the same thing but one is achieved through CODA/BOA while the
other one is through WinBUGS.
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Figure 4.1. Running Quantiles for the Posterior Parameters in the case of Female Benign
and Malignant Breast Cancer Patients.
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Figure 4.3. The plot of the Brooks-Gelman MPSRF for three chains of 49,749 iterations.
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Figure 4.4. Gelman Rubin convergence diagnosis for independent variables
Result of Geweke plots for some selected parameters is given below. As a rule
of thumb, a significant proportion of Z-scores outside the two-standard deviation
bands is indicative of a chain that has not converged by iteration k. The results in
Figure 4.5 show that all the Z-scores fall within the two-standard deviation bands
for the parameters gender, and age groups 20-24, 25-29 and 30-44 years whereas
there is a negligible proportion for the Z-scores under the intercept and age group
35-39 years that are outside the bands. This is a strong indication of a chain that
has converged by iteration 1,500,000. We also considered the Heidelberger-Welch
diagnostic test. The results of a test with ε = 0.1 show that most of the parameters
have passed the stationarity test except for male, age group 50-54 years, the married
level for marital status, the literate level for literacy and the gender by age group
interaction terms 35-39 :M and 40-44 :M. All the parameters passed the half-width
test indicating that the chain was run sufficiently.
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Figure 4.5. Gelman Rubin convergence diagnosis for independent variables
4.3.5 Discussion and partial conclusion
The present confirm findings from studies conducted in Nigeria over the past years,
on Breast cancer among women in the western Nigeria (OLUGBENGA et al., 2012;
Abudu et al., 2007). All these studies showed that age could be a risk factor for ma-
lignant breast lesion. Similar studies have been documented in other parts of Africa
and the rest of the world (Arora & Simmons, 2009). From the results of analysis,
patients age 35-49 years constituted the majority of patients (52%) in our study, in-
dicating that women age 35-49 have a higher risk of developing breast cancer than
their other counterpart in the group. Therefore, more attention on breast cancer
treatment are necessary for this age group. This agrees with breast cancer facts
and figures released between 2011-2012. However, this corresponds to the work-
ing class population and it is also the child bearing age for many women. This may
be as a result of the use of contraceptive and hormonal imbalance which common
among the women (Onyeanusi, 2015; OLUGBENGA et al., 2012). From the study,
malignant breast lesions appeared to have higher distribution among those who
had at least high school education, an observation which supports previous stud-
ies (Yüksel et al., 2017; Ibrahim et al., 2015), Zaria (Yusufu et al., 2003; Ntekim et al.,
2009). This result was supported by the descriptive statistics which shows that 52.3%
of those diagnosed had at least high school education meaning that that those who
are educated were more interested in presenting their health problems to physicians
(keeping in mind that this is an hospital data) rather than consulting quack medi-
cal doctors. The high proportion of malignant breast lesion might also be attributed
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to lifestyle changes among those class. In addition, this may also be as a result of
their exposure to advancement in life like the nature of occupation, diet, without
observing caution to health management. We found that the mean age of breast
cancer patients in Western is 42years; this is similar to several Nigerian institution
based studies, Adebamowo reported 43 years (Adebamowo & Adekunle, 1999), Ik-
patt et.al 42.7 years (Ikpat et al., 2002) and 44.9 years by Ebughe.et al (Ebughe et al.,
2013a). Although our variables’ interactions did not categorize age and educational
status as components of socioeconomic status (SES), our findings are similar to those
of some studies which showed that higher socioeconomic status (SES) is associated
with higher breast cancer incidence (Pudrovska & Anikputa, 2012; Krieger et al.,
2010; Vainshtein, 2008). Additional studies have provided a possible explanation for
these findings, that women with high SES are more likely to obtain routine breast
cancer screening due to better access to preventive healthcare based on their level
of education, higher income and increasing age, hence, increasing the detection of
breast cancer (Akinyemiju et al., 2015).
Although our study did not investigate the risk factors for breast cancer in associa-
tion with its sub molecular types, a recent study conducted by (Akinyemiju et al.,
2015) evaluated the association between SES and breast cancer subtypes using a
valid measure of SES and the Surveillance, Epidemiology and End Results (SEER)
database. Socioeconomic status based on measures of income, poverty, unemploy-
ment, occupational class, education and house value, were categorized into quin-
tiles and explored. Their findings showed that a positive association between SES
and breast cancer incidence is primarily driven by hormone receptor positive le-
sion. Malignant breast lesions which can be subdivided into non-invasive and in-
vasive tumors are documented to be more commonly diagnosed in postmenopausal
women (Lehmann-Che et al., 2013). A molecular classification of breast cancer, with
more than five reproducible subtypes (basal-like, ERBB2, normal-like, luminal A,
and luminal B) has been defined through gene expression profiling and microarray
analysis (Lønning et al., 2007). In addition, performing the gene set enrichment anal-
ysis (GSEA), a gene set linked to the growth factor (GF) signaling was observed to
be significantly enriched in the luminal B tumors (Loi et al., 2009). Another study
states that multiple pathways were identified by mapping gene sets defined in Gene
Ontology Biological Process (GOBP) for estrogen receptor positive (ER+) or estro-
gen receptor negative (ER-); and among them, in a separate set, pathways related to
apoptosis and cell division or G-protein coupled receptor signal transduction were




Fig 4.2 measures the dependency among the Markov chain samples. The plot of
Gelman Rubin convergence in Fig 4.4 suggesting that the MCMC sequence has con-
verged on the posterior density as red line fall towards one for all parameters. Our
findings are similar to the result obtained by Salameh.et.al (Salameh et al., 2014),
Jackman.et.al (Jackman, 2000). Fig 4.3 shows a plot of the Brooks-Gelman MPSRF
(denoted Rp) along with the maximum PSRF (denoted Rmax) for successively larger
segments of the chains. This plot suggests that although the chains differs signif-
icantly for the first few thousand iterations, they mix together after that and three
chains of 1,500,000 iterations each is probably sufficient to ensure convergence of
the chains (see (Sinharay, 2003) for a better understanding). It also suggests using a
burn-in of about 200,000 each.
Findings from Bayesian and classical inference are not significantly different which
could be due to the covariates or non-informative prior utilized in the model. De-
spite the similarities in their results, it is still difficult to compare the two approaches
because classical inference make use of confidence interval to make decision while
Bayesian uses credible interval. Moreover, when both techniques produce similar
results, findings from Bayesian are given more attention because it is more robust
compared to the classical. It is also possible to assess convergence of models un-
der the Bayesian which could also make its result better than the classical inference.
The second focus of this paper illustrate the importance of assessing convergence of
Markov Chain Monte Carlo methods as well as presenting methods to show whether
convergence has been reached. The model used in this paper updates quickly and
adding complexity will also improve the required time for updating. These diag-
nostics are necessary to ensure that we are actually sampling from a chain that has
converged after a desirable burn-in. Using the posterior mean as a point estimate,
comparison of the classical statistics estimates with the simulation (MCMC) result.
The estimated means and standard errors appear quite close with minimum results
show a reduction of standard errors associated with the coefficients obtained from
the Bayesian approach, hence resulting in higher stability to the coefficients. Other
studies have also shown similar result (Gordóvil-Merino et al., 2010; Acquah, 2013).
We have demonstrated a way to analyze small sample binary data with covari-
ates, and have applied two approaches on breast cancer data. The classical statis-
tics logistic regression model has some shortcomings which can be addressed with
possible alternative approach. The purpose of this study was therefore to intro-
duce Bayesian logistic regression as an alternative approach and demonstrate its
application to parameter estimation in the setting of generalized linear model for
comparative analysis with the classical statistics. Findings of this study shows that
the Bayesian Markov Chain Monte Carlo (MCMC) algorithm proffers an alternative
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framework to breast cancer data. Both the classical approach and Bayesian approach
suggest that age of the patients and those with at least high school education are at
higher risk of being diagnosed with malignant breast lesion than benign breast le-
sion in Western Nigeria. A comparison of the classical and Bayesian approach to
modeling breast cancer reveals lower standard errors of the estimated coefficients in
the Bayesian approach in the setting of generalized linear mixed model. Thus, the
Bayesian approach is more stable. Malignant breast lesion is increasing alarmingly
even though most people lack basic knowledge about its spread. The higher propor-
tion of those affected by malignant breast lesion is found among the educated and
younger women. Therefore, this shows that non-educated women do not patron-
ize these services based on our findings. More efforts are required towards creating
awareness and advocacy campaigns on how the prevalence of malignant breast le-
sions can be reduced, especially among women.
We recommend that governments, non-governmental organizations and other sec-
tors involved in policy making to put in place policies, strategies and sensitization
that target non-educated women to enhance their patronization of breast cancer
screening in the health facilities, so as to access the appropriate management health
assessment as well as providing financially supported treatments for breast cancer
patients.




Breast cancer is one of the most common cancers among women and is the main
cause of death among Nigerian women. Breast cancer treatment strategies in Nige-
ria need urgent strengthening to reduce mortality rate as a result of the disease. The
objective of this study is to determine the relationship between the age at diagnosis
and established the prognostic factors of modality of treatment given to breast can-
cer patient in western Nigeria.
The data was collected for 247 women who had breast cancer in two different hos-
pitals. Model estimation is based on fully Bayesian approach via Markov Chain
Monte Carlo (MCMC). In this study, a multilevel model based on the generalized
linear mixed model is used to estimate the random effect. Considering 0.05 as the
level of significance, the Bayesian data analysis was done using the WinBUGS14
software while SAS was used for the classical statistics.
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The mean age of the patients (at the time of diagnosis) was 42.2 years with 52% of the
women aged between 35-49 years in this study. Bayesian analysis showed a signif-
icant relationship between treatment modality and the age (P=0.04), and malignant
breast lesion (P=0.001). The result also indicate that hospital a breast cancer patient
attends in this part of Nigeria also played a significant role for the treatment modal-
ity.By fitting Bayesian multilevel models the variables age and breast cancer stages
(malignant lesion) were significant.
The results showed that age, breast cancer stages (malignant) and hospital had a sig-
nificant role in the treatment modality of breast cancer patients in Western Nigeria.
The study showed the practicality and flexibility of Bayesian multilevel approach in
analyzing breast cancer data.
Keywords: Bayesian, Bayesian inference, Multilevel, Generalized linear mixed mod-
eling, CODA/BOA.
4.4.1 Introduction
Breast cancer refers to a malignant tumor that has developed from cells in the breast.
Breast cancer cells are normal cells that at some point begin to present structural or
functional alterations in nuclear deoxyribonucleic acid (DNA) and gradually became
abnormal due to uncontrolled cell division. This uncontrolled division leads to the
cells growing at an abnormal, uncontrolled rate. Breast cancer is the most common
cause of malignancy among women worldwide (Ebughe et al., 2013a; Adebamowo
& Ajayi, 1999; Chen et al., 2016), and is a public health challenges among Nigeria
women. Although cancer of the breast is thought to be a disease of the developed
world, literature reveals that almost 58% of deaths that occur as a result of breast can-
cer are traced to less developed countries (Ferlay et al., 2010). Available record by
World Health Organization indicated that 30 Nigerian women died of breast cancer
every day in 2008 and this had risen to 40 women in 2012. Statistics show that over
508 000 of Nigerian women died in 2011 as a result of breast cancer (Torre et al., 2015;
Akarolo-Anthony et al., 2010; AO et al., 2013; Adebamowo & Ajayi, 1999). Moody
et.al (OLUGBENGA et al., 2012) presented a profile of cancer patients attending ter-
tiary health institution in South Western parts of the country. They observed the
occurrence and distribution of cancers among the southwestern citizens, it was con-
cluded that breast cancer alone accounted for 37% of all the cancer cases present in
southwestern of the country.
With advancement in medical technology, treatment for breast cancer advances have
been made regardless of the site of the cancer in Nigeria. Better treatment for breast
88
4.4. DIAGNOSTIC DETERMINANT OF PREFERRED CANCER TREATMENT
cancer patients is difficult to define and the literature has revealed that older women
are sometimes excluded from clinical treatment trials, probably because of their
age (Townsley et al., 2005). Since breast cancer biology differs from patient to patient
with respect to factors like age, variation in response to treatment, and substantial
competing risks of mortality (Biganzoli et al., 2012; Mieog et al., 2012; Kiderlen et al.,
2015), the exclusion of some patients might not be valid. This implies that those
elderly who are included in trials are probably not a true representation for the gen-
eral older population (Jolly, 2015). Consequently, an evidence-based treatment strat-
egy for women with breast cancer is needed. Literature review on epidemiological
studies of risk factors for breast cancer have reported that breast cancer is related
to family history of breast cancer, early menstruation, late onset of menopause, old
age, age at first pregnancy over 30 years, use of contraceptives, hormonal treatment
after menopause, no history of breastfeeding and obesity (Zare et al., 2013).
Although there have been substantial published studies on prognostic factors for
breast cancer in western Nigeria, population-based research is sparse. Therefore,
we sought to determine risk factors for treatment given to female breast cancer in
western Nigeria using generalized linear mixed models. This research focuses on
the justification for the use of the conventional surgery method in the treatment of
cancer, based on data from two understudied hospitals in Southwestern Nigeria,
one federally owned, and the other state-owned. Consequently, the questions in the
minds of people in this region regarding the method of breast cancer treatment em-
ployed by federal hospitals, as against that used by state hospitals, will have been
addressed. Therefore, it is important to explore the relationship between these vari-
ables and treatment modality. Fundamentally, this study presents a comparison of
the classical and Bayesian multivariate generalized linear mixed models.
4.4.2 Materials and Methods
4.4.3 Ethics
Ethical clearance to conduct the study was sought from the Ethical Review Commit-
tee of the Federal Teaching Hospital, Ekiti State, Nigeria. The data was extracted
from the cancer registry of the Federal Medical Teaching Hospital. 237 records and
20 variables of breast cancer data were accessed, each containing patient-related tu-
mor information. Extensive variable selection procedures were performed on the
20 variables, and the records of patients aged 20 years and above were selected for
the analysis. The information collected included age, marital status, educational
level, religion, race, type of breast cancer, occupation, Lab number, case number, site
of the cancer, type of diagnosis, and histological type. With respect to the quality
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of the data obtained, the main concern was the proportion of hospital records in
which some of the relevant variables were absent. Information relating to variables
like weight, height, age at first full term pregnancy, and age at menopause were
missing. Other information recorded was the type of treatment received: surgery,
chemotherapy, hormonal therapy, radiotherapy or a combination of these. For input
variable selection, we tried to limit the number of variables and select only the clin-
ically relevant ones. Exact Logistic regression models were fitted to obtain indepen-
dent estimates of the risk of breast cancer. Modeling started with all the variables,
followed by sequential deletion according to their statistical importance. SAS was
used for classical statistical analysis, while WinBUGS was used for Bayesian anal-
ysis. A GLMM with a logit link function was performed for both classical as well
as Bayesian method since this study considered two levels of analyses (hospitals).
We also examine several diagnostics that have a very wide range of application. The
diagnostics are those of Geweke (Geweke et al., 1991), Heidelberger and Welch (Hei-
delberger & Welch, 1983), and Raftery and Lewis (Raftery & Lewis, 1992), which
look at convergence of an individual chain, and that of Gelman and Rubin (Gelman
& Rubin, 1992), which bases convergence on analysis of multiple chains.
4.5 Results
This section introduces the treatment modality for breast cancer patient in west-
ern Nigeria as well as the results obtained from an analysis for both classical and
Bayesian techniques. We applied the two methods of hierarchical models: classical
multilevel and Bayesian multilevel approach and their results were compared. For
us to fit the classical multilevel logistic model, we used lme4 and glmer package in
R software. For each parameters in our models, we compute the estimates and the
95% confidence intervals (CI) and the deviance for the model were obtained. We
ran Bayesian multilevel logistic models by fitting generalized linear mixed model
(BGLMM) using Markov Chain Monte Carlo (MCMC) techniques in WinBUGS soft-
ware (Ntzoufras, 2011). For each model, 1,500,000 Markov chain Monte Carlo (MCMC)
iterations were ran, with the initial 500,000 discarded to cater for the burn-in pe-
riod and thereafter keeping every 100-th iteration of the remaining one million sam-
ple value. The 1,000,000 iterations left were used for assessing convergence of the
MCMC and parameter estimation. We assessed MCMC convergence of all models
parameters by checking the Gelman-Rubin, trace and autocorrelation plots of the
MCMC output. Our findings are in line with the previous literature by Clèries et al.
(2012); Salameh et al. (2014); Gelman et al. (2003).
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4.5.1 Socio-demographic characteristics of participants
A total of 237 breast cancer female patients extracted from the cancer registry of
Federal Medical Teaching Hospital, Ekiti State, Nigeria, were used. Of these, 192
cases accounting for (81.01%) were malignant breast lesions, while 45 cases (18.99%)
were benign giving a ratio of 4.3:1 for malignant to benign breast lesion. The mean
age of the respondents was 42.2± 16.6 years with 52% of the women aged between
35-49 years. It was observed that 93.67% of those who participated in this study
were Christians while 6.33% were Muslims. The percentage of breast cancer was
higher among Christians. Various prognostic factors are considered which include:
intercept(λ0), breast cancer types: malignant(λ1),age: 35-49(λ2), 50-69(λ3),70+(λ4),
level of education: at least high school(λ5), religion: christian(λ6), tribe: yoruba(λ7),
occupation: site of the cancer(λ8), hospital(λ9).
4.5.2 Result of the classical multilevel logistic regression
Results of the multilevel logistic regression model presented in Table4.12 identified
the following predictors as the statistically significant determinants of treatment
given to breast cancer patients in western Nigeria: age groups, histological type,
type of breast cancer diagnosed. These variables presents a statistical significant in-
fluence on breast cancer treatment at 95% confidence interval (CI) while other vari-
ables did not show any statistical evidence of significant influence at 95% CI. In this
analysis we observed that the risk of breast cancer varies significantly between the
socio economic and medical factors respectively. In addition, to establish the find-
ings of our results beyond the kind of analysis that has been performed on breast
cancer in western Nigeria, there is need to use advanced statistical techniques. To
achieve this, we first performed a model called multilevel logistic regression model
denoted by model A. The main aim of this model is to compare the prognostic factors
associated with treatment given to breast cancer patients.
Findings from model A reveal that age, histological type (infiltrating duct and oth-
ers) may likely be the major factors considered before treatment is given to breast
cancer patient in this part of Nigeria. Results from multilevel logistic regression
model B indicate that the addition of type of breast cancer as well as marital status
in the model did not make histological type to be associated with treatment modality.
Although, both age category (35-50) years and 51+ are now significant. Hence, from
model A and model B, we found that histological type (infiltrating duct and others)
was significant when type of breast cancer was not included in the model. It means
that the influence of the histological type passes through the type of breast cancer
a patients was diagnosed. Results from model A shows that most of the patients
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Table 4.12: Multilevel Logistic Regression: Model A
Variables Estimate Std.Error Z value Exp(B) Pr(> |z|)
Age groups
35-50 -0.7145 0.4488 -1.5920 0.4890 0.1114
51+ -0.9721 0.4608 -2.110 0.3780 0.0349*
Histological type
infiltrating duct -1.8505 0.5528 -3.348 0.157 0.0008***
lobular -0.4617 0.6783 -0.681 0.630 0.4961
others -1.5655 0.5017 -3.121 0.209 0.0018**
Unit
Gynaecology -1.6050 0.5521 -2.907 0.200 0.0036**
Surgical -0.2721 0.5811 -0.468 0.762 0.6396
Unit(mixed) -0.7211 0.5282 -1.365 0.486 0.1723
Site of the cancer
others -0.8707 0.4613 -1.888 0.419 0.0591
Deviance: 209.3, AIC: 231.3, BIC: 269.4
were based on surgical operation. Moreover, the regression model also indicated
that breast cancer type (malignant) is significant with treatment modality. This is an
indication that the treatment given was based on the diagnosis of the breast cancer
type whether benign or malignant lesion. Based on the value of AIC, we can say that
the result of model B fit better than that of model A.
In addition, results of regression model A indicates that women aged 51+ years are
62.2% less at risk of taking surgery treatment than those aged 35-50 years. In case
of model B, it was found to be 69.5% less at risk. The Table 4.13 shows that women
not placed in a surgical unit but diagnosed of breast cancer have 1.4 times more risk
of not surviving than others in this part of Nigeria. Patients with histological type
(lobular) are 84.3% less at risk of surgery treatment than patient with histological
type (others). Findings of model B presented in Table 4.13 (infiltrating duct) show
that women having histological type (lobular) are 3.2 times more at risk of breast
cancer than those with histological type (infiltrating duct and others).
4.5.3 Result of Bayesian multilevel model with non-informative prior
We make use of non-informative prior for the Bayesian multilevel model. The re-
sult is presented in Table4.14. In line with the theory, the results from the Bayesian
analysis with non-informative priors are similar to those of the classical analysis.
In fact, the theory reveals that non informative priors should not have effect on the
posterior. The most significant aspect of the Bayesian statistics is its credible interval
(Cred. I) is quiet different from the confidence interval (CI) for classical statistics.
In addition, the credible interval in Bayesian statistics is more robust than the confi-
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Table 4.13: Multilevel Logistic Regression Model B
Variables B Std.Error Z value Exp(B) Pr(> |z|)
Age groups
35-50 -1.3466 0.6221 -2.165 0.260 0.0304*
51+ -1.1871 0.5935 -2.000 0.305 0.0455*
Histological type
infiltrating duct -0.1158 0.6840 -0.169 0.891 0.8655
lobular 1.1759 0.8134 1.446 3.241 0.1483
others -0.3752 0.6119 -0.613 0.687 0.5398
Type of breast cancer
malignant 6.4056 1.2627 5.073 3.9210e−7 ∗ ∗∗
Unit
Gynaecology -0.5399 0.5958 -0.906 0.583 0.3648
Surgical 0.3429 0.6687 0.513 1.409 0.6081
Unit(mixed) -1.6301 0.8792 -1.854 0.196 0.0637
Site of the cancer
NOS/lower-inner quadrant -0.4938 0.6766 -0.730 0.610 0.465
Marital status
single/separated -0.6899 0.9406 -0.734 0.502 0.4633
Deviance: 142.9, AIC: 168.9, BIC: 214.0
dence interval in classical statistics which is sometimes affected by the sample size.
Considering the credible interval in model M1, results of non informative prior for
Bayesian multilevel model indicate that variables are the only significant predictors
associated with modality of treatment given to breast cancer patient while are not
significant determinants of treatment modality in western Nigeria. Result of model
M2 also shows that patient diagnosed of benign breast cancer are 17.4% (OR= 0.826)
less likely to receive surgery treatment compared with patients diagnosed of ma-
lignant breast lesion. Findings also highlight that patients who their breast lesion
are not malignant in nature are not likely to be subjected to surgical operation unit.
Therefore, model M2 indicates that such patients are normally retained in general
unit section among the two hospitals.
Furthermore, patients with histological type (MORF3) are 1.51 times more likely [β
= 1.51(0.452-2.601)] at risk of taking surgery treatment than others while as age in-
creases, the risk of taking surgery treatment also increases by 1.17 ( see model M1).
Most of the predictors significant in model M1 are no longer significant in model M2
when type of breast cancer was introduced into the model. This indicates that type
of breast cancer is a major factor considered before a patient is being placed on any
treatment in this part of Nigeria.
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Table 4.14: Parameter estimates of models M1 and M2 obtained from WinBUGS
Parameter
Model M1 Model M2
Estimate 2.5% 97.5% Estimate 2.5% 97.5%
Intercept -1.516 -10.650 7.472 -0.258 -4.586 3.664
λ1 0.554 -0.302 1.424 0.822 -0.327 2.019
λ2 1.165 0.274 2.095 1.124 -0.058 2.376
λ3 1.303 0.293 2.416 0.034 -1.095 1.228
λ4 1.510 0.452 2.601 -0.191 -10.690 -4.691
λ5 0.111 -1.027 1.259 0.511 -0.721 1.705
λ6 0.550 -0.462 1.572 -0.246 -1.639 1.155
λ7 0.663 -0.219 1.583 2.099 0.336 4.212
λ 0.614 -0.688 2.054
τ 0.606 0.002 3.062 2.775 0.008 15.50
Table 4.15: Demographic characteristics of women diagnosed with different histologic
types of breast cancer
1 2 3 4
n % n % n % n %
Age groups
20 - 34 58 59.6 10 19.2 14 24.2 4 23.5
35 - 49 23 23.2 22 42.3 18 31.0 7 41.2
50 - 69 14 14.1 7 13.5 5 8.6 - -




68 68.7 21 36.8 3 18.8 21 32.3
Pry& Sec 31 31.3 36 63.2 13 81.3 44 67.7
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Assessing the performance of Markov Chain Monte Carlo (MCMC) chains
in WinBUGS
To further establish the Bayesian results, it is necessary to check for the convergence
of Markov Chain Monte carlo (MCMC) once the results of the models are computed.
This steps is necessary so as to ensure that we are sampling from a better posterior
distributions. Fig 4.6 illustrates the convergence of the Bayesian with non informa-
tive prior. The algorithm converged after 1,500,000 iterations. To avoid autocorrela-
tion, a lag of 60 was chosen which required up to 1,500,000 iterations and the first
500,000 iterations were discarded keeping every 10-th iterations for the remaining
one million iterations. In order to assess whether a chain has converged or not, we
plot the sampled value against its number in the chain. When the time series cen-
tered around a constant mean, it implies that the chain has reached convergence as
reported in Fig 4.6 and have the chains converged to the same solution. Fig 4.7
displays the representation of the parameter behavior after 1,500,000 Monte Carlo
repetitions. It was found that the kernel densities for shape and scale parameters
exhibit approximately symmetric distribution. A more formal technique for diag-
nosing the convergence of MCMC chains is reported in Fig 4.6. The blue and red
lines denote the variance within and between chains. To support that the chain is
converged, the ratio must converge to unity and the blue and red lines must con-
verge to a stable value. Hence, Fig 4.6 indicates that all the R̂ → 1 which suggests
that the algorithm converges.
Figure 4.6. WinBUGS’ output of Gelman Rubin Statistic for some independent variable
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Figure 4.7. Auto-correlation plots for the preferred treatment given to patients.
Model Selection Procedure
Selection of best models from the same dataset can be achieved using summary mea-
sures of fit. The deviance statistic is available for both classical and Bayesian model-
ing, and is equal to minus the log-likelihood written as
deviance = −2 log(L)
where L is the likelihood and is defined as the probability of the data given the
models parameters to be estimated. That is,
L = p(y|θ)
In case of classical statistics, the addition of parameters to the model is assumed
to improve the fit. But if addition of one parameter to a model does not have im-
pact on the model, the expected deviance is reduced by one. In addition, assume
g predictors are added and the deviance is reduced significantly more than g, then
the observed improvement is statistically significant. Moreover, adjusted deviance
= deviance + number of predictors, where the difference between adjusted deviance
and deviance is tested against the χ2 distribution with degrees of freedom set as the
number of extra predictors. In the case of non-nested models the Akaike informa-
tion criterion (AIC) can be used as alternative. This is expressed as
AIC = deviance + 2(number of predictors).
The model with the smallest AIC indicates better fit. Other measures of model se-
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lection is the Bayesian information criteria (BIC) which is represented as
BIC = −2 log(L) + g log(n).
According to (Spiegelhalter et al., 2002), g is the number of estimated parameters
and n is the sample size.
In the concept of Bayesian analysis, (Spiegelhalter et al., 2002) suggested the mean
posterior deviance D̄ = E(D) as a measure of model fit. Where deviance written as
D(θ) is D(θ) = -2log p(y|θ) for a likelihood expressed by p(y|θ). The mean posterior
deviance does not account for the improvement of fit with increasingly complex
models. Bayesian model comparison criteria called deviance information criteria
(DIC) merges goodness of fit and model complexity to estimate the effective number
of parameters denoted by pD. Deviance information criteria (DIC) is represented by
DIC = D(θ̄) + 2pD = D̄ + pD. (4.1)
Models with smaller DIC fit better and are preferred
pD = D̄ −D(θ̄)
where pD is the number of effective parameters, θ̄ is the posterior mean and D(θ̄)
is the deviance for posterior mean. For all models, we initiated three chains with
Table 4.16: WinBUGS output for the evaluation of logistic regression multilevel using pD
and DIC
model Dbar Dhat pD DIC
M1 219.503 210.411 9.092 228.596
M2 152.710 142.208 10.501 163.211
1500000 iterations for each chain. DIC and pD were calculated on the last 500,000
iterations. From above table, we can observe that for model M1 the effective number
of parameters is approximately 9 showing the restrictions among the random effects.
Comparing model M1 with model M2 shows that there is not much evidence for
correlated random effects. This is also supported as can be seen from 95% credible
interval (Cred. I) for τ= [0.0019, 3.062] (see Table ??).
4.5.4 Discussion and partial conclusion
For breast cancer treatment in Nigeria, the reason for surgery treatment on cancer pa-
tients is not clear as reported by Odetunmibi et al. (2013). The present study showed
prognosis factors for breast cancer treatment in southwestern Nigeria. The cancer
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registry of Federal medical teaching hospital is a hospital-based registry, thus the
data are not population-based and may not be representative of all patients with
breast cancer treated in western Nigeria. One of the first thing we noticed was that
the results obtained from both techniques are identical and this result is supported
by previous studies that compared both techniques (Ojo et al., 2017). The key sig-
nificant factors in this section is age group, histologic type, breast cancer type and
unit they placed their patients depending on the type of breast cancer being diag-
nosed. From the previous studies, age has been identified as an important risk factor
for breast cancer (Chen et al., 2016; Alieldin et al., 2014). The study found that the
type of breast cancer a patients is diagnosed also determine the type of treatment
such patients were given. This was expected as patients breast cancer may not have
gotten to malignant nature which may not require serious treatment like surgery.
Patients with at least high school education were found to be positively associated
with treatment modality. The most important biological factor associated with treat-
ment modality is histologic type: patients with this type of histologic were 1.2 times
more likely to be given surgery treatment than their counterpart. Patients age 35-49
years constituted the majority of patients (52%) in our study, indicating that women
age 35-49 have a higher risk of developing breast cancer than their other counterpart
in the group. Therefore, more attention on breast cancer treatment are necessary for
this age group. Considering the effects of age in the treatment modality of breast can-
cer patient, Bayesian findings highlight that age bracket 35-49 years are 0.67 times
more likely to receive surgery treatment than other age categories. This suggests that
younger patients were more likely to be treated with surgery, compared to the older
patients, findings consistent with those of many studies (Chen et al., 2016; Cluze
et al., 2009; Ibrahim et al., 2014). Some studies reported that most of the available
data on breast cancer indicate that young age is associated with a poor prognosis as
a result of more invasive disease (Ibrahim et al., 2014; Chen et al., 2016; Alieldin et al.,
2014; Brandt et al., 2015) and our results indicated that malignant breast lesion was
more common in this region of Nigeria more than benign lesion. We can attribute
this reason to say that this may be the more reason why Southwestern Nigeria con-
sidered age to be a determinant before subjecting their breast cancer patients to any
form of treatment.
From the descriptive statistics, we found that the mean age of breast cancer patients
in southwest is 42 years; this is similar to those of several Nigerian institutions which
have been studies in the literature. Among these studies, Adebamowo reported 43
years (Adebamowo & Adekunle, 1999), Ikpatt et.al 42.7 years (Ikpat et al., 2002) and
44.9 years by Ebughe.et al (Ebughe et al., 2013a). In model 1, age 35-49 and hospi-
tal appears to be a significant determinants for breast cancer treatment in Western
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Nigeria. Similarly, results from model 2 and model 3 are identical in the sense that
only hospital and malignant breast lesion were associated with the modality of treat-
ment given to patients. Also, results of model 2 indicate significance for hospital but
it’s influence passes through model 3 and hospital looses it’s significant as soon as
type of breast cancer diagnosed (malignant) is introduced into the model. This could
means that hospital a patient attended in this part of Nigeria will determine the type
of treatment offered for patients. It could also means that the treatment offered de-
pends on whether such patient have malignant breast lesion or not before placing
their patients on a particular form of treatment.
Although our study did not investigate the risk factors for breast cancer, a recent
study conducted by (Chen et al., 2016) evaluated the effect of age in breast can-
cer prognosis using Surveillance, Epidemiology and End Results (SEER) database.
Their findings showed that younger breast cancer patients exhibit more aggressive
disease than the older patients. Additional studies have provided a possible ex-
planation for these findings, that women with high socioeconomic status (SES) are
more likely to obtain routine breast cancer screening due to better access to preven-
tive healthcare based on increasing age, hence, increasing the detection of breast
cancer (Akinyemiju et al., 2015). Past studies also reported that elderly women
sometimes experience poorer outcomes than younger patients (Yancik et al., 2001;
Schonberg et al., 2010). In Bayesian, once the results of the model are computed,
it is necessary to check for the convergence of Markov Chain Monte Carlo. Fig 4.7
shows the history plot for major independent variables. The mixing look good and
the three chains does not appear to be randomly fluctuating about the same general
region of the parameter space. The chain for the independent parameter exhibits no
autocorrelation. This plot suggests that the MCMC chain has converged. The plot
of Gelman-Rubin in Figure 4.6 suggesting that the MCMC sequence has converged
in the posterior density as red line fall towards one for all parameters. In addition,
the blue and green lines which represent variance within and between chains sug-
gests that the algorithm converges. Our findings are similar to the result obtained
by Salameh.et.al (Salameh et al., 2014; Jackman, 2000).
In case of multilevel datasets, classical regression models may fail to account for the
dependency structure in the data sets while multilevel models do lead to valid infer-
ences. However, multilevel regression model is more complicated than the standard
single-level multiple regression model. One difference is the number of parameters,
which is much larger in the multilevel model. This poses problems when models
are fitted that have many parameters, and in model exploration. Another difference
is that multilevel models often contain interaction effects in the form of cross-level
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interactions. Interaction effects are tricky, and analysts should deal with them care-
fully. Finally, the multilevel model contains several different residual variances, and
no single number can be interpreted as the amount of explained variance. In this sec-
tion two types of the multilevel models have been implemented, which are classical
and the Bayesian multilevel models and then their results were compared. One the
advantage of multilevel models is that, it have a very good ability to accommodate
hierarchical structure. It provide a useful framework for thinking about problems
with samples which have hierarchical structure. One advantage of the multilevel
modeling approach is that it can deal with data in which the times of the measure-
ments vary from subject to subject. In multilevel modeling, variable selections can be
complicated due to predictors. The biggest challenge in multilevel modeling is how
to specify the covariance structure. To the best of our understanding, there are weak-
nesses in the estimation procedure for multilevel. There is no single agreed on the
methods of estimation of multilevel parameters. Many methods of estimation can
be applied, such as, maximum likelihood estimation (MLE), Restricted Maximum
Likelihood Estimation (REML), and Bayesian estimation. One the main issue with
the Bayesian technique is the time spent to run the model when using the Markov
Chain Monte Carlo (MCMC) techniques, particularly when the data sets are large or
probably the variables of the model are too many. It also requires a longer period to
draw a final decision from Bayesian models, which implies that models should be
run with different priors on the model parameters. In addition, in order to ensure
that the prior chosen does not affect the final results, it was mentioned in the liter-
ature that sensitivity analysis should be carried out. In the case of this study, it is
not done because the parameter estimates obtained from the Bayesian method were
similar to that of the classical method.
We have demonstrated a way to analyze small sample binary data with covari-
ates, and have applied two approaches on breast cancer data. The purpose of this
study was therefore to introduce Bayesian multilevel as an alternative approach and
demonstrate its application to parameter estimation in the setting of generalized lin-
ear mixed model for for comparative analysis with the classical multilevel. Findings
of this study shows that the Bayesian multilevel via Markov Chain Monte Carlo
(MCMC) algorithm proffers an alternative framework for modeling breast cancer
data. Both the classical approach and Bayesian approach suggest that age, breast
cancer type is associated with modality of treatment given to breast cancer patients
in Western Nigeria. A comparison of the classical and Bayesian approach to mod-
eling breast cancer reveals lower standard errors of the estimated coefficients in
the Bayesian approach in the setting of generalized linear mixed model. Thus, the
Bayesian approach is more stable.
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4.6 MULTILEVEL MULTINOMIAL LOGIT REGRESSION
MODEL WITH RANDOM EFFECTS
Unlike the model for multilevel discussed in Chapter 3, which assumes the same
effect beta for each cumulative logit, the model considered in this paper deals with
outcome variable with categories more than two; hence, different independent vari-
ables have different slopes, βj for different logits. Because of the nature of the out-
come data, the multilevel multinomial logit model with random effects is needed in
such a case to interpret unobserved within-cluster heterogeneity. Generalized lin-
ear mixed model is a feasible modeling approach for multilevel ordinal response
data by incorporating random effects into the multinomial logistic model, leading to
the multilevel multinomial logit regression model with random effects. This article
discusses the applicability of Bayesian multinomial logistic regression model on the
prediction of histological type to breast cancer patient in two different hospitals in
western Nigeria. It presents two approximate methods on multinomial logistic re-
gression estimation; classical method and Bayesian method, to obtain the marginal
posterior density for the parameters under consideration. A comparison of these
two approaches is carried out to determine the usefulness of Bayesian technique on
multinomial logistic regression estimation. R, SAS and WinBUGS (Bayesian Infer-
ence using Gibbs Sampling) programs have been used to fit the model. As both of
these two methods have suggested; histological type in breast cancer decreases with
educational level and increases with age. In addition, it is also shown that Bayesian
Multinomial logistic regression is useful in direct computations and it produces very
accurate approximations to the posterior density.
4.6.1 Introduction
Breast cancer remains an important caused of death among women both in the de-
veloped and less developed world Adebamowo & Ajayi (1999); Ojewusi & Arulogun
(2016); Oladimeji et al. (2015) and it is a leading malignancy among western women
of Nigeria Ojewusi & Arulogun (2016). Globally, patients diagnosed of breast cancer
were estimated to be 1.7 million in 2012 while the prevalence stood at 6.3 million
women. According to an estimate, breast cancer is reported to be responsible for
close to 508,000 deaths in 2011 and increased to 522,000 in 2012 [WHO] was also
the most frequently diagnosed cancer among women in 140 of 184 countries world-
wide Organization (2013). It is estimated that breast cancer constituted 22.4% of
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new cases of cancer registered in 5 years and this accounted for 35.4% of all cancers
among Nigerian women Afolayan et al. (2012). As a result, breast cancer tumors
continues to be a serious threat to women particularly Africa. Breast cancer risk
factors remains controversial and the data regarding this issue are conflicting as re-
ported by Chen et al. (2016). Some studies have documented that age is an important
prognostic factor for breast cancer Ikpat et al. (2002) but many of these studies have
not been able to explore the role of histological type and histological grade tumor
in relation with socio economic status as an established prognostic factor for breast
cancer.
Moreover, breast cancer patients diagnosed less than 2 years after birth often have
a poor prognosis (Sotiriou et al., 2003; Rakha et al., 2010) and the tumors have also
been found to be higher at time of diagnosis (Rakha et al., 2010; Blamey et al., 2010).
Hormone receptor status as well as other breast cancer clinical tumors have also
been found to differ by histological type (Weigelt et al., 2010). It has been suggested
by past studies on breast cancer that reproductive factors affect the risk of histolog-
ical types of breast cancer differently (Rakha et al., 2010; Ellis et al., 2005; Sundquist
et al., 1999; Simpson et al., 2000). Lobular tumors which are an histological type have
shown a strong correlation with age at first birth than other histological types Rakha
et al. (2010). Few studies have examined whether breast cancer tumors and age at
diagnosis tend to be of a particular histological type or not. Lack of understand-
ing of the risk of prognostic factors associated with breast cancer discourages many
people from seeking early intervention or even to admit that symptoms they may be
experiencing are related to breast cancer. Deeper knowledge about this as well as the
underlying prognostic factors may provide more valuable information for improved
early diagnosis of breast cancer as well as treatment.
Therefore, to bridge the paucity of knowledge on the wider influencing role of socio
economic status (SES) in relation with histological type, this study employed mul-
tilevel multinomial modeling. Multilevel modeling approach allows simultaneous
performance of the role each socio economic has on histological type. Highlight-
ing such would contribute to a greater understanding of early intervention among
women particularly western Nigeria.
4.6.2 Methods
4.6.3 Study participants and methods
Data pertaining to 237 patients who were diagnosed with breast cancer were ex-
tracted from the cancer registry of federal teaching hospital. Extensive variable se-
lection procedures were performed on the 20 variables, and the records of patients
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aged 20 years and above were selected for the analysis. The information collected
included age, marital status, educational level, religion, race, type of breast cancer,
occupation, Lab number, case number, site of the cancer, type of diagnosis, and his-
tological type. With respect to the quality of the data obtained, the main concern
was the proportion of hospital records in which some of the relevant variables were
absent. Information relating to types of patients were eligible for inclusion in this
study: gender, tribe, histological type: infiltrating duct carcinoma or lobular carci-
noma, type of treatment received and histological grade I, II or III. For input variable
selection, we tried to limit the number of variables and select only the clinically rel-
evant ones.
4.6.4 Ethical considerations
This study is based on secondary analysis of existing breast cancer data, with all
personal identifying information removed. The data extracted received ethical per-
mission from the ethical review committee of Federal teaching hospital, Ekiti State,
Nigeria.
Multinomial logistic regression model
Multinomial logistic regression model is a technique of analysis which is applicable
when the dependent variable under study event consists of more than two cate-
gories. The multinomial response could be ordinal (ordered categories) or nomi-
nal (unordered categories). Multinomial logistic regression does necessitate careful
consideration of the sample size and examination for outlying cases. Sample size
guidelines for multinomial logistic regression indicate a minimum of 10 cases per
independent variable (Chan, 2005).
In contrast to binary logistic regression model that compares one dichotomy, multi-
nomial logistic regression model compares a number of dichotomies. Multinomial
approach outputs a number of logistic regression models that make specific compar-
isons of the response categories. Considering a situation that we have j categories
of the response variable, the model consists of j-1 logit equations which are fit si-
multaneously. The probability of a categorical variable in a multinomial model is
estimated using maximum likelihood estimation (Bayaga, 2010).
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Results
4.6.5 Descriptive statistics
Firstly, an analysis using classical multilevel multinomial logistic mixed effects was
performed. Table3.2 summarizes the results from multilevel mixed model for all the
three models set up, some parameters estimates are highly significant (P< 0.00968).
A total of 237 breast cancer patients were enrolled in the current study. The mean
age at diagnosis of breast cancer in Nigeria was 42.2± 16.6 years. The 20-34 year age
group comprised the most patients among the three groups (n= 97, 40.9%), and the≥
70 year age group comprised the fewest patients (n= 17, 7.2%), irrespective of tribe.
Younger patients were more likely to have grade II disease than elderly patients (P<
0.00968).
4.6.6 Result of classical multilevel multinomial model
Table 4.17 presents the results of fitted models with the estimated effects. In Table
4.17, we set up three models in which model 1 is nested under model 2, and model 2
is nested under models. The essence is that, it makes it possible to compare the three
models based on -2LL. Result of model 3 in Table 4.17 shows that there is a posi-
tive/negative, statistically significant relationship between patient’s socio economic
status/ breast cancer stages and their likelihood of having a particular histological
type. Specifically, as patient’s educational status increases, their likelihood of having
infiltrating breast tumors decreases. Model 3 contains three significant covariates
(educational status, age group and breast cancer stage). We find significant effect
of educational status (β̂ = 0.81, p = 0.01), (β̂ = 0.07, p = 0.01) and breast cancer
stages (β̂ = −4.01, p = 0.0001). The estimates for educational status and age group
has positive effect on the log odds, whereas breast cancer stages has a negative ef-
fect. This implies if the educational status increases by one unit, the corresponding
change in the log odds is 0.81. Table 4.17 depicts the odd ratio (OR) from the classical
multinomial multilevel models. A significant association between histological type
and educational status, age group, type of treatment patients received as well as
breast cancer type in western Nigeria (see model M2 and M3). The results indicates
that, age group (35-49) and those with at least high school education had 7% and
81% more likelihood of histological type (model M3) while the likelihood is higher
in model M2 for patients with at least high school education 1 than model M3. From
model M3, patients aged 35 to 49 years are 1.1 times more likely of having infiltrating
duct carcinoma when diagnosed with breast cancer than their counterpart. Women
who are not from this part of geopolitical zone of Nigeria were seen to be 2.4 times
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more likely of developing histologic type more than the yoruba people.
Furthermore, findings reveal that patient with tertiary education are 13% (OR= 0.87)
Table 4.17: Multilevel multinomial model estimates of histological type
Fixed Effects Model 1 Model 2 Model 3
Intercept1 (infiltrating duct) -0.23(-8.050, 7.585) 0.24(-6.312, 6.797) 3.05(-11.578, 17.682)
Intercept2 (lobular) 0.90(-6.608, 9.163) 1.88(-4.805, 8.557) 4.75(-9.970, 19.471)
Social characteristics
Educational level













surgery -1.29(-1.955, -0.628)* -0.15(-0.939, 0.633)
none (ref)




well (I) -0.305(-1.105, 0.496)
moderate (II) 0.230(-0.500, 0.960)
none (ref)
Random effects
Error variance intercept 0.716(0.753) 0.323(0.365) 0.115(0.164)
Model Fit
-2LL 476.71 447.11 417.36
* indicates p<0.05 while ** implies significant likelihood ratio test; ICC= 0.1788
less likely to have infiltrating breast carcinoma tumors compared to those who have
less than tertiary education. In the case of breast cancer stages, results show that
patient who are diagnosed of benign breast tumor are 79% (OR= 0.208) less likely
to suffer infiltrating breast carcinoma tumors compared to those patient who their
breast cancer are malignant in a nature. Based on the result of estimated intercept for
hospital, there exists statistically significant variation between the histological type
among the two hospitals patients attended in Western Nigeria. The covariance pa-
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The result of intraclass correlation coefficient indicates how much of the total varia-
tion in the likelihood of patient having a particular form of histological type between
the two hospitals. The intraclass correlation coefficient is calculated as 0.1788 repre-
senting about 18% of the total variation in the outcome variable is accounted for by
the hospitals.
4.6.7 Bayesian Estimation for Multinomial Logistic Regression
In this section, we present the Bayesian multinomial logistic regression in establish-
ing the relationship of histologic type with socio-demographic and biological factors.
The Bayesian multinomial logistic regression was fitted by using WinBUGS14 soft-
ware (Bayesian Inference using Gibbs Sampling). We ran three chains for 1,500,000
iterations with the first 500,000 discarded as a burn-in period. The WinBUGS re-
Table 4.18: Posterior means, posterior standard deviations and 95% credible intervals
Parameter Mean SD MC error 2.5% 97.50%
alpha[2] 3.774 0.151 0.00104 3.464 4.057
alpha[3] 3.725 0.156 0.00122 3.408 4.019
alpha[2,2] -0.424 0.239 0.00152 -0.899 0.043
alpha[2,3] -0.155 0.229 0.00166 -0.605 0.296
alpha[3,2] -0.617 0.255 0.00153 -1.125 -0.129
alpha[3,3] -0.411 0.247 0.00168 -0.898 0.069
sult in Table4.18 above shows the Bayesian output of multinomial logit model in
which the response variable is histologic type with three categorical level mastocy-
tosis, invasive duct carcinoma and lobular carcinoma, with mastocytosis category
of histologic type as the baseline category. The table also shows Node which is the
name of the unknown quantity equivalent to the model parameter; the approxima-
tion of the mean of the average of the posterior distribution of the unknown quantity
which is the coefficient of model parameter and the credible intervals. The Markov
chain (MC) error is purely technical like round off error. It quantifies the variability
in the estimate that is due to markov chain variability. It also means the estimate
of the difference between mean of the sampled values and the true posterior mean.
Therefore, it should be as small and also less than 5% of the posterior standard de-
viation for a parameter. In addition, the table also reveals that MC errors are low
in comparison to the corresponding estimate posterior standard deviation. This is
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an indication that markov chain has converged. The important aspect of Bayesian
estimation is that posterior standard deviation is used as the standard error of the
parameter estimate while the range between 2.5% and 97.5% percentiles represents
95% Bayesian credible interval.
Figure 4.8 shows posterior density plot, which provides a graphical representation
of the posterior density estimate for each parameter (node). Hence, density plot
shows that posterior distribution of each parameter is almost normally distributed.
Figure 4.8. Posterior probability density plot
Figure 4.9 shows the autocorrelation plots. These plots appear to dampen quickly;
therefore, this provides an evidence of the convergence of the Markov chain and
suggests that it may be appropriate to average Markov chain output.
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Figure 4.9. Sample autocorrelation plots
Figure 4.10 shows quantile plot. Quantile plot shows the median and the 2.5% and
97.5% percentiles for each iteration. Hence, it is a plot running mean with 95% confi-
dence interval against iteration number. Therefore, it clear that the requested quan-
tiles have been stabilized implying that Markov chain has converged in terms of
parameters.
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Figure 4.10. Quantile plots
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Figure 4.11 shows the visual inspection of the time series plot produced by History.
These plots appear to stabilize in. Hence, they suggest that the Markov chain have
converged.
Figure 4.11. Time series plot of MCMC output
4.6.8 Bayesian multilevel multinomial results
In this section we presents the Bayesian approach results we obtained from Win-
BUGS for the multilevel multinomial for two different models, namely BLOCKING
and WITHOUT BLOCKING model. For each model we obtained deviance informa-
tion criteria (DIC) and the effective number of parameters so as to select the best
model. After that we computed the mean estimate, standard error, and the 2.5% and
97.5% quantile credible intervals for the two models. Besides, we also present in this
section some of the convergence diagnostics plots.
Model assessment and comparison
Table 4.19: WinBUGS output for the evaluation of logistic regression multilevel using pD
and DIC
model Dbar Dhat pD DIC
M1 411.893 391.435 20.458 432.351
M2 411.889 391.440 20.449 432.339
Table4.19 presents model diagnostics for all the fitted models in Bayesian paradigm
and it demonstrates that model M2 has the lowest DIC (432.339) which means it is
the best models.
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Table 4.20: Posterior means, posterior standard deviations and 95% credible intervals
Node Mean SD MC error 2.5% Median 97.50% start Sample
alpha[2] 3.7745 0.151 0.00101 3.464 3.778 4.057 10000 7001
alpha[3] 3.725 0.156 0.00122 3.408 3.729 4.019 10000 7001
beta[2,2] -0.424 0.239 0.00152 -0.899 -0.422 0.043 10000 7001
beta[2,3] -0.155 0.229 0.00166 -0.605 -0.156 0.296 10000 7001
beta[3,2] -0.617 0.255 0.00153 -1.125 -0.614 -0.129 10000 7001
beta[3,3] -0.411 0.247 0.00168 -0.898 -0.410 0.069 10000 7001
The WinBUGS result in the Table 4.20 indicates the output of multinomial logistic
model which the outcome variable has three categorical levels and the first category
is set as the baseline category and the explanatory variables of histological grade
has three level of categories with first levels of histological grade set as the base-
line categories. The table shows Node which is the name of the unknown quantity
equivalent to the model parameter; the approximation of the average of the poste-
rior distribution of the unknown quantity which is the model parameter coefficient,
an approximation of the standard deviation of the posterior distribution and com-
putational accuracy of the mean. Furthermore it shows selected percentiles which
are median or 50th percentile of the posterior distribution, the 97.5th percentile or
an approximation of the upper endpoint of the 95% credible interval and the 2.5 per-
centile or an approximation of the lower end point of the 95% credible interval. It
also shows the starting simulation after discarding the start-up and the number of
simulations used to approximate the posterior distribution. The MC error is purely
technical like round-off error. It quantifies the variability in the estimate that is due
to Markov chain variability, in other words it is an estimate of the difference be-
tween the mean of the sampled values and the true posterior mean. Hence it should
be small, less than 5% of the posterior standard deviation for a parameter. Hence it
can be made as small as possible by increasing the number of simulations. It also
suggests that MC errors are low in comparison to the corresponding estimate pos-
terior standard deviation. This is evidence that Markov chain has converged. The
posterior standard deviation is used as the standard error of the parameter estimate.
The range between 2.5th and 97.5th percentiles represents 95% Bayesian confidence
interval and is called a credible interval.
4.6.9 Discussion and partial conclusion
In this section we present the results obtained from the analysis of multilevel multi-
nomial model where we fitted three different models in classical approach and the
best model was selected for further analysis in Bayesian approach using WinBUGS
software. The essence is to be able to compare the result of the classical approach
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with that of Bayesian approach. In Bayesian paradigm, we set up two different
models, namely model with blocking and over-relaxation and model (M1) without
blocking and over-relaxation (denoted M2). It was mentioned in the literature that
model with blocking sometimes aids convergence (Lesaffre & Lawson, 2012), in this
thesis we incorporated blocking with over-relaxation in order to see it’s effect on
blocking. For each model we obtained deviance information criteria (DIC), so as to
select the best model, the model without blocking (M2) appears to be the best model
as it has the lower DIC. This findings are in line with those contained in the literature.
In this study two types of the multilevel models were implemented, namely the fre-
quentist and the Bayesian multilevel models and their results were compared. The
results obtained from both approaches are identical. At the end of this study, the
results showed no significant difference between Bayesian multilevel and classical
multilevel approach. One thing that is unique is that it is difficult to compare the
result from Bayesian and classical because the former make use of credible interval
while the latter uses confidence interval. The non-informative prior models utilized
inn the Bayesian approach could have accounted for the similarities between the
two approaches. The central aim of the current study is to investigate the associa-
tion of SES and biological characteristics for histological type of breast tumor among
patients diagnosed of breast cancer in western Nigeria using multilevel multino-
mial regression analysis. The most significant observation we found in this study
was that age of occurrence of breast cancer in this environment, the mean age of
the patients was 42.2 years, this is similar to those of several Nigerian institutions
which have been studies in the literature. Among these studies, Adebamowo re-
ported 43 years (Adebamowo & Adekunle, 1999), Ikpatt et.al 42.7 years (Ikpat et al.,
2002) and 44.9 years by Ebughe.et al (Ebughe et al., 2013a). But the situation is differ-
ent in countries with substantially mixed blacks and Caucasians like United States
and South Africa, variation is noticed in both incidence and mean age of breast can-
cer occurrence (Fregene & Newman, 2005; Anderson et al., 2006). Previous studies
have mentioned the peculiarities of breast cancer patients among women of African
such as genetic factors and reproductive factors. In our study, there is a correla-
tion between the histological type and histologic grade, breast cancer type as well
as educational status. This simply means that reproductive and biological factors
may determine histologic type of tumors. Other studies have also shown similar
result (Ursin et al., 2005; Okobia et al., 2005; Kotsopoulos et al., 2010). But our re-
sult is contrary to what is obtainable in other part of Nigeria as reported by (Ebughe
et al., 2013b) that reproductive factors may not determine histologic types and bio-
logical behavior. Hence, we can attribute this fact that environmental factors may
have brought about this changes in the context of breast cancer in Nigeria. The pro-
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portions of patients with grade II disease decreased with age, and younger patients
were more likely to be diagnosed with a higher grade in this environment. This may
be attributed to poor breast cancer screening in young women, as the incidence is
high in this age group. In addition, younger patients were more likely to be prone
to infiltrating duct carcinoma than the elderly patients, an observations that is sup-
ported and consistent with other studies (Chen et al., 2016). It was also found that
malignant breast tumor was significant and it happen to be the most prominent type
of breast cancer in this environment. This explain why majority of breast cancer pa-
tients in this environment are subjected to surgery treatment since the cancer has
gotten to a higher level which can only be managed by surgical operation.
The result of Bayesian analysis showed that age group 35-49 years and education
were significantly associated with histologic types. We found that patients with at
least high school are 9.4 times more likely to have one histologic type of tumor dis-
ease than their counterpart. Histologic type of tumor might have resulted from their
exposure in advancement in life without observing caution to health management.
Although, our study did not investigate the influence of education on breast can-
cer, a study conducted by (Hussain et al., 2008) evaluated the effect of education
on in situ and invasive breast cancer risk using Sweden Family-Cancer Database.
Their findings revealed that significant increased risk for in-situ and invasive breast
cancer associated with high educational levels. Additionally, previous studies have
provided possible explanation for these findings, that highly educated women or
women with high socio economic status (SES) are likely to obtain routine breast can-
cer screening as a result of having access to preventive healthcare (Akinyemiju et al.,
2015).
In addition, previous studies also found that a high level of education was signifi-
cantly associated with decreased incidence of high risk ductal breast cancer among
postmenopausal women only. Combining this with our study, these finding indi-
cates heterogeneity in the association between education and breast cancer risk fac-
tors exists not only by histologic type and age at diagnosis, but also tumor charac-
teristics (Dalton et al., 2006).
The current study was not without limitations. A few limitations should be consid-
ered while interpreting the results from this study, as data collected does not con-
tain information regarding regarding adjuvant chemotherapy or endocrine therapy.
Hence, this may have affected our results. In summary, we found that age, his-
tologic grade, breast cancer type were associated with histological type of tumor.
Also, consistent with previous findings, our results indicate that the associations be-
tween biological factors and the risk of breast cancer differ by histological types of
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the tumor. Certain histological types occurred with a significantly higher proportion
shortly after women of this geopolitical zone have given birth, which may be as a
result of exposure to hazard like chemical and radiation. More interesting was that
women with at least high school were more likely to be diagnosed with histologic
type, which is a new and unexpected findings in this part of Nigeria. One explana-
tion for these result may be that women with at least high school education present
their breast cancer cases to medical practitioners than the less educated women hav-
ing it in mind that this study uses hospital data. In addition, Bayesian multilevel
multinomial regression model helps in selecting the most significant factors between
histological type and socio economic status (SES) and biological characteristics of
breast cancer tumors as compared to classical multilevel multinomial.
4.7 SOCIO-ECONOMIC DETERMINANTS OF BREAST CAN-
CER RISK FACTORS IN WESTERN NIGERIA: A MULTI-
NOMIAL MODEL
This subsection is a stand alone research article of multinomial modeling of breast
cancer in Western Nigeria. The aim is to is to better apprehend determinants of
breast cancer by comparing results from three statistics approaches namely; classi-
cal, Bayesian and bootstrapping techniques and compared the findings.
Abstract Breast cancer is the most common malignancy among women globally and
in Nigeria. Advanced late presentation at diagnosis is a common feature of breast
cancer in Nigeria which resulted to poor survival rates. Establishing the prognostic
factors is key to preventing death from this type of cancer among women of west-
ern Nigeria. Fundamentally, this study presents a comparison of the Bayesian ap-
proach with bootstrapping and classical technique in modeling breast cancer. This
study used the breast cancer data extracted from cancer registry of Federal Medical
Teaching Hospital and a simulated data set. The objective of the study is to better
apprehend the socio-economic determinants of breast cancer by comparing results
from 3 statistics approaches. Three approaches of multinomial models was applied,
namely Bayesian, classical and multinomial technique. Findings highlight that both
the classical and the Bayesian model suggest that histologic type is associated with
age and educational status. The results also show that breast cancer patient aged
35-49 years had the highest risk of lobular carcinoma compared to mastocytosis. Pa-
tient with at least high school education have been found at higher risk of lobular
carcinoma and mastocytosis. In addition, the results also highlight that Bayesian
approach presented better result followed by bootstrapping and classical. Our find-
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ings established the factors that are associated with histologic type of breast cancer
patient among women of western Nigeria are age and educational status. It is also
concluded that Bayesian Markov chain Monte Carlo algorithm performs better in
modeling female breast cancer data in western Nigeria.
4.8 Introduction
Breast cancer [BC] is the most common type of cancer among Nigerian women (Oladimeji
et al., 2015; Adebamowo et al., 2003; Adebamowo & Ajayi, 1999; Adebamowo &
Adekunle, 1999; Ebughe et al., 2013a) with an overall age standardized rate [ASR]
of 52.2 per 100,000 as reported by (Jedy-Agba et al., 2017). Previous studies doc-
umented that breast cancer among Nigerian women differs across the states of the
federation. For instance, in Northern part of Nigeria breast cancer is the second most
common diagnosed in women while western part has breast cancer as the most di-
agnosed cancer among their women (Ibrahim et al., 2015). However, several studies
have assessed the risk factors associated with breast cancer in western Nigeria by
using logistic regression model but the current study step further by incorporating
Bayesian and bootstrapping and compared their result with classical approach using
real life data and bootstrapping data. Although some studies have also utilized the
classical multinomial logistic regression in other fields, but no empirical study has
explored the application of the classical logistic regression model and compared it
to the bootstrapping approach using breast cancer data in western Nigeria.
To the best of our knowledge, this is the first study to investigate socio-demographic
and medical factors of breast cancer in two different hospital in western Nigeria us-
ing the three different techniques to established the best method in analyzing cancer
data. Bootstrapping technique is one of the most popular statistical tools used for
assessing uncertainty of unknown quantities in situations where analytical solutions
are not available (Davison & Hinkley, 1997; Rubinstein & Kroese, 2016; Efron, 1979).
This statistical technique is appealing as a result of its simplicity and it is sometimes
regarded as a free distribution technique belonging to a class of non-parametric boot-
strap. In this study our focus is to simulate data set using bootstrapping, and de-
scribes its implementation for statistics. The approach used for bootstrapping in
this study is based on multinomial sampling. The aim of this study is to model
breast cancer data via two approaches namely, the classical, Bayesian and the boot-
strapping approach. Fundamentally, the results were compared and shown which
approach performs better. This paper is organized as follows: classical multinomial
logistic regression model is summarized in the next section. Bootstrapping tech-
nique and Bayesian inference is introduced in Section 3. The data set and the main
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findings are carefully described in Section 4. The diagnostic checking is presented in
Section 5. Finally, the discussion section presents some final remarks, points out that
Bayesian approach performs better than the classical and bootstrapping technique
in analyzing cancer data using a hospital based record.
4.8.1 Ethical Approval
Our study was approved by Ethic Committee of Federal Medical Teaching Hospital,
Ekiti State, Nigeria. All the personal information collected was considered confiden-
tial.
4.8.2 Methods
Basic concept and notation of the multinomial regression model analysis and boot-
strapping are discussed briefly in this section.
4.8.3 Model and Parameters Estimation in Multinomial
This subsection introduces multinomial logistic regression which is applicable when
the response variable under consideration consists of more than two categories. Sup-
posing Z is a categorical response variable with three categories, represented as 1,
2, or 3. Since the outcome variable has three categories, we need two logit models
as the logistic regression model uses for a binary outcome variable which parame-
terizes in terms of the logit z= 1 against z =0. We assume there are k explanatory
variables, x = (x1, . . . , xk) in our model. The logit models for nominal responses pair
each response category to a baseline category and the choice is arbitrary. If we set















= λ20 + λ21x1 + · · ·+ λ2kxk = λ
′
2x (4.3)
Considering the above model, the response probabilities are set up as follows

























with parameters λ= (λ1, λ2) as the unknown. In the context of this study, the out-
come variables is recoded as follows
Z1 = 1, Z2 = 0, Z3 = 0 : Z = 1,
Z1 = 0, Z2 = 1, Z3 = 0 : Z = 2
and
Z1 = 0, Z2 = 0, Z3 = 1 : Z = 3.
Recall that no matter what value Z takes on, the sum of these outcome variables is∑k
i=1 zi=1. The conditional likelihood function given the covariates for independent
















































i=1 zji =1 for each i.
The maximum likelihood estimators are obtained by taking the first partial deriva-
tives of `with respect to each of the unknown parameters and setting these equations
equal to zero. In addition, the estimates of the parameters and variance covariance
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matrix can be obtained by any standard statistical computer packages like SAS, and
R (nnet package).
4.8.4 Bootstrapping technique
In statistics, the use of resampling methods plays a major role especially when the es-
timators under consideration do not possess an explicit formula. The bootstrap was
introduced in 1979 as a computer based method for estimating variance. Accord-
ing to (Boos et al., 2003), bootstrap method is also used to obtain standard errors
for estimators, confidence intervals for unknown parameters. Because of modern
technological break throughs, the bootstrap has been improved because the modern
computer power it requires to simplify intricate calculations (Efron, 1979). The gen-
eral idea of the bootstrap is to create artificial data-sets with the same structure and
sample size as the original data. To create these artificial data-sets, simple random
samples are taken from the original with replacement, so that the same PSU may be
chosen multiple times and included in the same artificial or pseudo sample. Once
the artificial data-sets are chosen, an estimate, θ∗b of the parameter of interest, θ is cal-
culated from each pseudo sample. Then an estimate of the variance of the parameter






(θ∗b − θ∗)2 (4.6)







The issue of how many replicates is required to provide an acceptable variance esti-
mate arises. This problem is not trivial since the precision of the variance estimator
continues to increase as the number of replicates increases, but the resources needed
to carry out the bootstrap method obviously increases as well (Rust & Rao, 1996). It
has been suggested that the number of replicate samples needs to be large. (Efron &
Tibshirani, 1993) states that a large B would be 200 replicates, however if confidence
intervals will be calculated then it has been suggested that B needs to be 1000 (Efron
& Tibshirani, 1993). While most literature when describing the appropriate number
of replicates reference, (Efron & Tibshirani, 1993) who says for just variance estima-
tion B = 200 is efficient, several studies have been done showing that perhaps this
standard is low. (Booth & Sarkar, 1998) published an article that argued that the
118
4.8. Introduction
number of replicates should be determined by the conditional coefficient of varia-
tion. (Efron & Tibshirani, 1993) suggestion is based on the unconditional coefficient
of variation which involves both sampling and resampling variability. (Booth &
Sarkar, 1998) argues that only the resampling variability needs to be considered and





where α and δ values are obtained by
1− α = P
(




< 1 + δ
)
(4.8)
where the term in the middle of the above expression is called relative error due to
resampling. In this case, δ is a user defined positive constant, δ2B is the bootstrap ap-
proximation of the variance, δ is the true variance and Φ is the distribution function
for the standard normal distribution.
This formula requires approximately 800 replicates to achieve a relative error less
than 10% with probability .95 (Booth & Sarkar, 1998). However when considering
confidence intervals, (Booth & Sarkar, 1998) article calculates a required B similar
to (Efron, 1979) B = 1000. This study used B=1000 bootstrap replicates.
Bootstrapping is related with simulation, but with one major difference. In simula-
tion, the data are obtained completely artificially, while bootstrapping obtains a de-
scription of the properties of estimators by using the sample data points themselves,
and involves sampling repeatedly with replacement from the actual data. There are
two major advantages of bootstrap approach over analytical results of traditional
statistical methods.
• Bootstrapping allow individuals to make inferences without making strong
distributional assumptions. The bootstrap involves empirically estimating the
sampling distribution by looking at the variation of the statistic within sample.
Hence, this procedure treating the sample as a population from which samples
can be drawn.
• The bootstrap are more robust than the classical approach which makes it effec-
tive with relatively small samples and preserved the estimator stability during




Suppose yi is a sequence of categorical data (i = 1, 2, . . . , N) and yi is assumed to
take a value in one of the ordered categories given as 0,1,......c. For each category of
J, with 1 ≤ j ≤ c, the probability that yi takes the value J depends on covariates xi.
Hence, the multinomial logit model is represented as






Clearly, equation above is complex which require numerical techniques in order to
obtain the marginal posterior distribution for each of the model parameters. The
alternative approach is the use of Markov chain Monte Carlo (MCMC) techniques.
Markov chain Monte Carlo (MCMC) is a general approach that is employed to gen-
erate samples from a distribution π, the equilibrium distribution, which is known
up to proportionality constant. The main purpose is to construct a Markov chain
that has π as its stationary distribution and then use the chain to estimate functions
of the target distribution. Within the Bayesian paradigm the target is the posterior
distribution of the model parameters π(θ|y). MCMC encompasses a broad range of
algorithms; but this study presents the ones that are relevant to our work. For a
more detailed on the MCMC, as well as theoretical results (Gilks et al., 1995; Brooks
et al., 2011).
4.8.5 Implementations of Markov chain Monte Carlo (MCMC)
The theory of MCMC guarantees convergence to the correct target distribution but
the rate of convergence cannot be typically known in advance. Therefore, it is ad-
visable to examine the output of MCMC in order to check whether the chains have
reached their stationarity. Stationarity can be assessed by visual inspection of trace
plots or using existing formal diagnostic tests such as (Geweke et al., 1991; Gelman
& Rubin, 1992). Moreover, in order to ensure that the samples taken are representa-
tive of the target posterior, the early values in the chain are usually discarded as a
burn-in period. The length of the burn-in generally depends on the starting values
since it will take more iteration to reach stationarity when the initial state of the algo-
rithm is far from the posterior mode. In addition, a further issue concerning MCMC
implementation is the autocorrelation within chains. If the output exhibits strong
autocorrelation then the samples contain less information regarding the desired dis-
tribution compared to when being independent. Also, chains with high autocorrela-
tion may require more iterations to sufficiently explore the parameter space. When
dealing with highly correlated chains, one common practice is to do thinning that is
save the output every k-th iteration. However, it must be noted that there should be
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a balance between the amount of thinning and the cost of sampling.
4.8.6 Bayesian implementation in WinBUGS
We implemented all models in WinBUGS (Spiegelhalter et al., 2003) where the es-
timates were obtained via MCMC simulation using 1,000,000 iterations (including
500,000 burn-in). We checked convergence by visually assessing the history, chains,
and autocorrelation using graphical tools in WinBUGS and using the Geweke method
in the BOA package (Smith et al., 2007). We present all posterior estimates as means
with the 95% highest probability density intervals (HPDIs)
4.9 Results and Discussion
This section introduces the results obtained from an analysis for both classical, Bayesian
and bootstrapping approaches. The aim of this study is to determine significant pre-
dictors of breast cancer in Western Nigeria. Fundamentally, this study presents a
comparison of the classical, bootstrapping and Bayesian approach. To achieve this,
we set up a multinomial logit model for the three approaches and the final outcome
is to find predictors of individuals risks of having breast cancer in western Nige-
ria.To the best of our knowledge, this may be the first study to investigate socio-
demographic determinants of breast cancer in this part of Nigeria using three dif-
ferent approaches. Various predictors including medical factors and socio-economic
factors are included in the model. The predictors (excluding the reference category)
introduced in the model are: Intercept (ψ0), Age group: 35-49 (ψ1), 50-69 (ψ2), 70+
(ψ3), Treatment received (ψ4) and Educational status: at least high school (ψ5).
From descriptive statistics, we found that the percentage of patients with highest
breast cancer is among those who had at least high school education. Also, our re-
sults indicated that age and educational status is a significant predictors of breast
cancer patients with histologic type. In addition, treatment given to breast cancer
patient with mixed histologic type is also a significant predictor.
4.9.1 Classical multinomial model
The proc logistic in SAS is used to fit the classical model. From result in Table 4.21,
the category histologic type = 1 is chosen as the reference category. The results have
two parts, labelled with the categories of response variable. For breast cancer pa-
tients having lobular carcinoma, age and treatment (surgery) are significant while
educational status is not significant. Findings from this model shows that educa-
tional status and age are significant predictors of breast cancer patient with lobular
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carcinoma. Furthermore, findings highlight that breast cancer patient aged 35-49
years are 3.8 times more likely to suffer lobular carcinoma compared with patients
aged 20-35 years. In addition, the odds ratio of patient aged 35-49 years with lob-
ular carcinoma is 0.62. This simply means that the expected risk of having lobular
carcinoma is lower for breast cancer patient in this age group compared to other age
groups. The interesting thing about the result of this multinomial regression model
concerns with treatment modality. This variable appears to be a significant explana-
tory factor of breast cancer patient with mastocytosis. The odd ratio associated to the
treatment modality highlight that women with mastocytosis but aged 50+ are 75%
less at risk of histologic type. The findings of this study support that patient with at
least high school education are prone to mastocytosis compared to those with less
education.
Table 4.21: Comparative results of the estimated parameters and their standard errors




Estimate S.E Estimate S.E Estimate S.E
MORF=2
Intercept -2.99 0.53 0.97 9.99 0.98 10.01
35-49 1.35 0.50 0.03 0.36 0.02 0.18
50-69 1.43 0.70 1.13 0.41 0.12 0.64
70+ 1.44 0.88 -0.19 0.38
treatment 1.90 0.49 -0.39 0.36 -0.19 0.39
education 0.36 0.54 0.16 0.34 -0.21 0.18
MORF=3
Intercept -3.78 0.77
50-69 -0.24 0.89 -0.08 1.45 3.14 3.91
70+ -13.82 676.0 -0.57 0.33
treatment 0.95 0.64 -0.62 0.23 -0.01 1.36
education 2.34 0.80 -0.41 0.25 -0.57 0.34
4.9.2 Bayesian multinomial model
The WinBUGS software is used to fit the Bayesian model and the same covariates
used in classical model are included in the Bayesian model. The Bayesian models
were fitted used non informative prior. The results for the Bayesian model with non
informative prior are given in Table 4.22. The findings of this study show that the
result of the Bayesian model with non informative prior is similar to that of classical
model. From the literature, it was established that non informative priors should not
have effect on the posterior distribution. The most significant part of the Bayesian
inference is that the credible interval is quiet different from the confidence interval
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(CI) of classical statistics.
The findings of the Bayesian model with non-informative prior indicate that the vari-
ables age, educational status and treatment modality are the only significant predic-
tors of the risk of breast cancer patient with histologic type. Considering the effects
of age on the risk of breast cancer patients with histologic type, finding highlight
that age group 35-49 years are 42% (OR=0.58) less likely to have mastocytosis com-
pared to other age group. Our result also indicate that patient treated with surgery
and having mastocytosis are 98.9% (1.10) less at risk of breast cancer than those that
didn’t received surgery treatment. In addition, patient with at least high school ed-
ucation are at higher risk of breast cancer in this part of Nigeria.
As part of the requirement for the Bayesian statistics, it is important to check for
the convergence of Markov chain Monte Carlo (MCMC). Fig4.12illustrates the con-
vergence of the Bayesian model with non-informative prior using the quantiles and
autocorrelation. The algorithm converged after 1,500,000 iterations. In order to re-
move autocorrelation and burn-in period, a lag of 40 was considered which requires
an iterations up to 1,500,000 iterations the first 500, 000 iterations removed to cater
for the burn-in period.
Using the point estimates, Table 4.21 compares the result of classical and Bayesian
with bootstrapping respectively. In a comparison of Bayesian and classical model,
we observed a lower standard errors of the estimated coefficients in the Bayesian
compared to the classical model. An observation that is supported by previous stud-
ies (Acquah, 2013; Gordóvil-Merino et al., 2010).
Similarly, in Table 4.21, we found that the estimated means and standard errors






Estimate MC error 95% Cred.I Estimate MC error 95% Cred.I
Intercept 0.97 0.014 (-18.65, 20.54) Intercept 0.014 0.003 (-18.65, 20.54)
ψ1 2.70 0.004 (0.69, 4.75) ψ1 -0.86 0.004 (-3.11, 1.32)
ψ2 2.35 0.007 (0.68, 4.75) ψ2 -0.08 0.007 (-2.94, 2.74)
ψ3 3.15 0.014 (-3.23, 9.81) ψ3 -1.29 0.013 (-7.74, 5.34)
ψ4 -3.74 0.001 (-5.65, -1.94) ψ4 -4.57 0.002 (-6.74, -2.61)
ψ5 1.72 0.004 (-0.22, 3.68) ψ5 2.72 0.005 (0.70, 4.79)
differs between the Bayesian and bootstrapping. The results show a reduction of
standard errors associated with the coefficients obtained from the Bayesian model,
thus bringing higher stability to the coefficients.
Fig 4.13 provides a graphical representation of the posterior density estimate for
each parameter. This plot indicate normality for the posterior distribution of each
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Figure 4.12. WinBUGS’ output autocorrelation
Figure 4.13. WinBUGS’ output autocorrelation
parameter.
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4.9.3 Discussion and partial conclusion
At the end of this study, our results suggest that there is a significant difference be-
tween the three approaches. The model with histologic type as the outcome variable
and age, educational status and treatment modality as the covariates was estimated
for both the Bayesian, classical and bootstrapping multinomial logistic regression
model. A comparison between the three approaches to better apprehend the socio-
economic determinants of breast cancer highlights lower standard errors of the esti-
mated coefficients in the Bayesian multinomial logistic regression model. Thus, the
Bayesian multinomial logistic regression is more stable. On the other hand, the re-
sults from Bayesian approach and classical statistics are difficult to compare because
both utilized different tools for decision-making. Moreover, when both approaches
produce similar results, findings from Bayesian model are given preference because
the technique is more robust and precise than the classical statistics. Our results also
give some support to previous findings (Acquah, 2013; Gordóvil-Merino et al., 2010).
Addition of priors will actually reduce the variance of the model and thereby lead
to a better model in the Bayesian approach. Based on the prior definition and the
result from our analysis we concluded that Bayesian approach give better result.
Conclusion
Findings of this paper highlight that age, educational status and treatment modality
are the major socio-economic determinants in this study. On the other, the study
reveals that Bayesian approach performs better than the bootstrapping and classical






5.1 Summary of Discussion
In this chapter, an overall outline of our results, their implications in terms of pre-
vious findings, and meaning in the context our study is presented. We also explore
their implications in the light of the extant literature. We begin this chapter with the
determinants of breast cancer types through data analysis. Thereafter, we proceed
to a look at a diagnostic determinant of preferred cancer treatment. The comparison
between bootstrapping techniques and classical statistics in assessing breast cancer
prognostic factors is also discussed in this chapter.
This study has focused on the comparison between two major statistical methods
for analyzing breast cancer data. Specifically, we have been concerned with sta-
tistical techniques for binary response data, which are gaining more popularity in
biostatistics and epidemiological studies. Logistic regression models are most com-
monly used, but ignore the hierarchical structure typical of such data. This usually
leads to biased estimates of parameters, standard errors, wide condence intervals
and misleading statistical tests. The main hindrance to using logistic regression anal-
ysis is how to incorporate the hierarchical levels into the estimation procedure. In
this study, we endeavor to give deep insight into statistical techniques for analyzing
data when the response variable is binary. These techniques have been presented
with in-depth analysis of a real-life dataset with a binary outcome. This study used
cancer data with a binary outcome variable and explanatory variables classied as
socio-demographic and medical/biological factors of breast cancer. In order to ana-
lyze the dataset, three models have been applied, namely: classical multilevel model,
Bayesian multilevel models and bootstrapping methods. Both classical and Bayesian
multilevel models were used to model the binary response variable, and for each pa-
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rameter in the classical and Bayesian models, we calculate the odd ratio (OR) and
95% condence interval/credible interval, as the case maybe. The results from our
findings agreed with previous studies to some extent. The modeling starts with a
classical multilevel model because it takes into account the hierarchical structure in
the dataset as is the case of our data. For instance, individual patients are nested
within the hospital. We then applied the Bayesian approach with the aim of com-
paring the results of the classical analysis with those of the Bayesian in order to see
the best approach between the two methods. We finally proceeded to compare both
approaches with bootstrapping methods. The models fitted were Generalized Lin-
ear Models (GLM) and Generalized Linear Mixed Models (GLMM). In the case of
the Bayesian multilevel multinomial, we used Markov Chain Monte Carlo (MCMC)
to estimate the parameters of the Bayesian models in the presence of model with
blocking and without blocking. In order to select the best model, we used Deviance
Information Criteria (DIC), and established that the model without blocking is the
best model because it has the smallest DIC.
The overall mean age of the respondents was 42.2± 16.6 years for the entire study.
For more detailed analysis on the modeling of breast cancer, MCMC diagnosis were
also computed and presented in the second section of chapter 4. The study es-
tablished that out of 237 breast cancer patients’ records extracted for analysis, 192
cases, accounting for 81.01%, were malignant in nature, while 45 cases, representing
18.99%, were benign breast lesions. From this, we established that malignant breast
lesions were more prominent in this region of Nigeria compared to other regions
within Nigeria.
The results show that breast cancer risk factors in western Nigeria are dependent on
age at diagnosis, educational status, and breast cancer type. The outstanding medi-
cal factor associated with breast cancer diagnosis among women in western Nigeria
was grade tumor. The findings indicated that women with lobular carcinoma were
at higher risk, compared to those who had mastocytosis and mixed histologic types.
Our findings add to the larger volume of previous studies which report that grade
tumor has an effect on breast cancer diagnosis.
This study also showed that the classical logistic regression estimation model has
some important limitations, which can be overcome through an alternative tech-
nique. Fundamentally, this study introduces the performance of Bayesian analysis
as an alternative technique and shows its practicality for the parameter estimation
of logistic regression models for comparative analysis with the classical statistics.
The study found that the Bayesian Markov Chain Monte Carlo algorithm proffers
an alternative framework for estimating the logistic regression model using breast
cancer data. Both the classical and Bayesian model suggest that age at diagnosis as
well as educational status are risk factors for breast cancer, but a comparison of the
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two techniques reveals that the result from Bayesian is more robust than the classical
statistics.
Another finding of this study is that the likelihood of breast cancer is higher among
women with at least high school education. This is an unexpected finding in this
part of Nigeria. This finding may be attributed to two reasons: Foremost, those who
are educated may be interested in presenting their health problems to physicians
rather than consulting quack medical health practitioners, and as such, be entered
into the hospital’s patient records. Secondly, the higher proportion of breast cancer
in this class of people may be because of the advancement in lifestyle without the
observation of proper health management practices. In another development, the
Bayesian analysis results indicated that those who had at least high school educa-
tion were 1.3 times more likely to have malignant breast lesions compared to those
with less education. It was also found that a significant increased risk for in-situ and
invasive breast cancer is associated with a high level of education. Other studies
have also shown similar results (Akinyemiju et al., 2015). The possible explanation
for this is that highly-educated women or women with high socio-economic status
(SES) are likely to obtain routine breast cancer screening, as a result of having access
to preventive health care.
The second approach was a multilevel logistic regression model that assumed that
the data structure in the population was hierarchical. We considered a two-level
model for our analysis. This second approach considered the results from classical
and Bayesian multilevel models. Bayesian techniques provide a better accurate esti-
mate of the parameters and the uncertainty associated with them than the classical
approach. The third approach used was a multilevel multinomial model as well as
multinomial model approach where model parameters were estimated under the
classical and Bayesian approach paradigms. The results of this approach was com-
pared with the bootstrapping technique.
Bayesian inference was carried out via Markov Chain Monte Carlo (MCMC) sim-
ulation. Markov Chain Monte Carlo was implemented through the Metropolis-
Hastings algorithm using the WinBUGS14 statistical software, which is considered
as a very powerful tool for Bayesian computation. In Bayesian analyses, the stan-
dard problems in MCMC simulation are the assessment of convergence and the de-
termination of the length of the burn-in period. We employed several graphical tools
and the Brooks-Gelman-Rubin (BGR) convergence statistic from WinBUGS and the
CODA/BOA package in R to assess convergence and determine the length of the
burn-in period. In addition, we present all posterior estimates as means with the
95% highest probability density intervals (HPDIs).
In conclusion, this study provides a closer look at the prevalence of breast cancer in
Nigeria, specifically with regard to the Western region. The findings are useful in
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terms of identifying risk factors of breast cancer, and for strengthening prevention,
sensitization, policy making, and treatment strategies.
5.2 Limitations of the study
The limitation of this thesis can be broken down in two major ways: data and
methodological limitations.
5.2.1 Data Limitations
This study uses data extracted from breast cancer patient records in an hospital.
These types of data are otherwise known as hospital-based cancer registries. Hospital-
based cancer registries are mainly concerned with the recording of information on
the cancer patients seen in a particular hospital. Therefore, these types of data can-
not provide measures of the occurrence of cancer in a defined population, which put
a limit on the level of analysis we could perform in the current study. With respect
to the quality of the data extracted from the patient records, the major challenge was
the proportion of records in which some of the relevant variables were not recorded
or missing. Information regarding variables like age at menarche, weight, height, or
age at first term pregnancy were missing. In spite of these limitations however, the
data had several merits which made it useful.
5.2.2 Methodological Limitations
The focus of this thesis is on the performance of the Bayesian approach in analyzing
breast cancer data. The major limitation of Bayesian analysis is the time needed to
run models via Markov Chain Monte Carlo (MCMC) methods of estimation, par-
ticularly when the datasets are very large or when many variables are included in
the model. Bayesian multilevel model fitting via MCMC simulation is computer-
intensive. However, Integrated Nested Laplace Approximation (INLA) can be em-
ployed instead. All the Bayesian analyses in this thesis were carried out in WinBUGS
via MCMC, resulting in models which took many days to fit. Also, another limita-
tion is that models should be run with different priors on the parameters, which
may increase the time taken to draw final conclusions from Bayesian models. Nev-
ertheless, one can extends this work to compare the methods used to analyze cross
sectional data by computer simulation to show which model is the effective. One
can also fit the models and estimates to the parameters using INLA and MCMC and
compare both approaches. In addition, multilevel method can be applied to meta
analysis, because meta analysis can be viewed as a special case of multilevel analy-
sis. Another future application in multilevel models is applying bootstrap technique
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in the framework of hierarchical linear modeling. Also, small area estimation from
unit level in a data with generalized linear mixed model can be used considered as
possible direction for future work.
5.3 Scientific papers and articles
From this thesis, four articles have been sent for publication. These are;
• Ogunsakin RE. and Siaka Lougue (2017): Bayesian Inference on Malignant
Breast Cancer in Nigeria: A Diagnosis of MCMC Convergence. Asian Pacific
Journal of Cancer Prevention (Published)
• Ogunsakin RE. and Siaka Lougue (2017): Bayesian generalized linear mixed
modeling of Breast Cancer in Nigeria. Iranian Journal of Public Health, Paper
accepted for publication (In press).
• Ogunsakin RE. and Siaka Lougue (2017): Multilevel Multinomial Logit Model
for the Bayesian analysis of Breast Cancer data. Sent for publication (Under
review).
• Ogunsakin RE. and Siaka Lougue (2017): Socio-Economic Determinants of
Breast Cancer risk factors in Western Nigeria: A multinomial model
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Introduction
Breast cancer is the commonest cause of mortality 
and morbidity among women worldwide, and currently 
the most common cancer among Nigerian women 
(Adebamowo and Ajayi, 1999; Ebughe et al., 2013; 
Ojewusi and Arulogun, 2016; Oladimeji et al., 2015; 
Banjo, 2004). The human breast is a pair of mammary 
glands composed of specialized epithelium and stroma 
in which both benign and malignant lesions can occur 
(Dauda et al., 2011). Benign breast constitutes the 
larger of the breast lesions but much concern is given to 
malignant lesions of the breast since breast cancer is the 
most frequent malignancy in the majority of the women 
(Uwaezuoke and Udoye, 2014). Globally, breast cancer 
accounts for 18.4% of cancers associated with women. In 
2012, (Jedy-Agba et al., 2012) reported that the incidence 
of breast cancer in Nigeria has risen significantly with the 
incidence in 2009-2010 reported to be at 54.3 per 100 
000, thereby representing a 100% increase within the last 
decade. The report about patients diagnosed with breast 
cancer in eastern Nigeria suggested that every 1 out of 5, 
representing 23%, are malignant in nature (Yusufu et al., 
2003). From literature, we found that previous studies 
Abstract
Background: There has been no previous study to classify malignant breast tumor in details based on Markov Chain 
Monte Carlo (MCMC) convergence in Western, Nigeria. This study therefore aims to profile patients living with benign 
and malignant breast tumor in two different hospitals among women of Western Nigeria, with a focus on prognostic 
factors and MCMC convergence. Materials and Methods: A hospital-based record was used to identify prognostic 
factors for malignant breast cancer among women of Western Nigeria. This paper describes Bayesian inference and 
demonstrates its usage to estimation of parameters of the logistic regression via Markov Chain Monte Carlo (MCMC) 
algorithm. The result of the Bayesian approach is compared with the classical statistics. Results: The mean age of the 
respondents was 42.2 ±16.6 years with 52% of the women aged between 35-49 years. The results of both techniques 
suggest that age and women with at least high school education have a significantly higher risk of being diagnosed with 
malignant breast tumors than benign breast tumors. The results also indicate a reduction of standard errors is associated 
with the coefficients obtained from the Bayesian approach. In addition, simulation result reveal that women with at 
least high school are 1.3 times more at risk of having malignant breast lesion in western Nigeria compared to benign 
breast lesion. Conclusion: We concluded that more efforts are required towards creating awareness and advocacy 
campaigns on how the prevalence of malignant breast lesions can be reduced, especially among women. The application 
of Bayesian produces precise estimates for modeling malignant breast cancer.
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only focused on benign breast cancer (Abudu et al., 2007; 
Adesunkanmi and Agbakwuru, 2000; Forae et al., 2014; 
Guray and Sahin, 2006; Kumar et al., 2014; Anyikam et 
al., 2008; Godwins et al., 2011; Ochicha et al., 2002).
The application of the Bayesian technique and its 
usage to analyze cancer data has proliferated in recent 
years. Several researchers such as (Acquah, 2013) studied 
the comparison of Bayesian and classical and found that 
Bayesian gave a better result than the classical statistics. 
Other studies have also shown similar result (Yu and 
Wang, 2011; Mila and Michailides, 2006; Albert, 1996; 
Congdon, 2014; Marrelec et al., 2003; Daíz and Batanero, 
2016; Lozano-Fernández, 2008; Gordóvil-Merino et 
al., 2010). In general, studies comparing both methods 
find that Bayesian technique proffers a better solution 
compared to classical statistics. The Bayesian technique 
assumes model parameters as random variables and not 
as constants, while the probability of the unascertained 
parameters can be obtained via Bayes theorem (Congdon, 
2005; O’Neill, 2002; O’Neill et al., 2000; Wong and 
Ismail, 2016). This provides information regarding 
parameter uncertainty that might be very difficult to obtain 
using the classical technique. Classical technique fits the 
logistic regression by means of an iterative approach 
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and in some cases, as a result of this iterative approach, 
convergence may be difficult to achieve. The robustness 
and accuracy of the results produced by Bayesian approach 
makes its gain popularity in data analysis.  As such, this 
paper investigates the significant predictors as well as 
characterizing patients diagnosed of benign and malignant 




Ethical approval was obtained from the ethics 
committee of the Federal Medical Teaching Hospital, 
Ekiti State, Nigeria. This data was extracted from cancer 
registry of the Federal Medical Teaching Hospital. We 
accessed 237 records and 20 variables of breast cancer 
data. Some of these variables describe socio- demographic 
and cancer-specific information of an incidence of breast 
cancer. Extensive variable selection procedures were 
performed on the 20 variables. The records of patients 
aged 20 years and above were sorted out for this analysis. 
Information collected includes age, marital status, 
educational level, religion, race, type of breast cancer, 
occupation, Lab number, case number, site of the female 
breast cancer, type of diagnosis and histological type. 
Other information recorded was the modality of treatment 
received: surgery, chemotherapy, hormonal therapy, 
radiotherapy. The software R was used for the classical 
statistical analysis and the software WinBUGS14 for 
the Bayesian analysis. As a requirement of the Bayesian 
approach, several diagnostics tests were performed to 
answer convergence of the Markov chain Monte Carlo 
(MCMC) algorithm and the true reflection of the posterior 
distribution.
Bayesian Binary Logistic Regression
Bayesian logistic regression, which applies Bayesian 
inference, has the formulation of a logistic equation and 
includes both continuous and categorical explanatory 
variables. Binary regression model is used to describe the 
probability of a binary response variable as function of 
some covariates. The logistic regression model belongs 
to the class of Generalized Linear Models. Generalized 
linear models generalize the standard linear model:
( ) Tin τ λΦ =                       (1)
Binary logistic regression model is represented as:
| ~ ( )i i iBinπ η η        (2)
If the response under consideration is observed, we 
have 1iπ =  for the ith individual and zero otherwise. And 
iπ  is the probability that the ith individual presents the 
response under consideration, λ  is the j vector of unknown 
parameters, ( 1,......, )Ti i i jτ τ τ=  represent vector of known 
covariates associated to the ith individual. Therefore, 
G is now define as any transformation assuming values 
between 1 and 0. Since function G can be any arbitrary 
cumulative distribution, this study consider only the 













The link function defines the linear predictor as 
expressed below
1
1( ) _1 ......i i i j ijGϕ η λ τ λ τ
−= = + +                              (3)
Suppose 
iη  denotes the probability of having 
malignant or benign breast lesion, the logit transformation 
is expressed as
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For the Bayesian analysis, it is important to provide 
a joint prior distribution over the parameter space. The 
preferred prior for logistic regression parameters is a 
multivariate normal distribution and is given by (Ojo et 
al., 2017; Ntzoufras, 2011):
2
0 0~ ( , )k N bλ Σ       (6)
where 1 1 11 0 ML
− − −Σ = Σ +Σ  and 
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The latter part of expression (8) can be regarded as 
normal distribution for parameters  and it has no closed 
form. Posterior distribution is usually of high dimension 
and analytically intractable which sometimes required 
knowledge of powerful integration. In order to overcome 
these difficulties, Markov chain Monte Carlo (MCMC) 
algorithm is needed (Ngesa et al., 2014). MCMC technique 
is among of the technique employed to generates the 
estimates of unknown parameters  and corrects the 
values generated in order to have a better estimate of the 
desired posterior distribution,  (Ojo et al., 2017; 
Ntzoufras, 2011). When MCMC is employed to generate a 
sample of , there is need to check that the MCMC 
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Convergence is monitored when  → 1.  is called the 
estimated potential scale reduction factor (PSRF).  Brooks 
and Gelman (Gelman et al., 2014a) proposed an alternative 
approach that generalizes the initial method to consider 
more than one parameter concurrently. The estimate of 




      
and
 
     
denote the  -dimensional within and between 
covariance matrix estimates of the  -variate. It then imply, 
if  is the highest eigen value of, hence
 (9)
Where  is the multivariate potential scale reduction 
factor (MPSRF). Convergence is attained when 
multivariate shrink factor converges to 1. 
Heidelberger and Welch’s: In order to test the 
hypothesis of stationarity, we first propose that we have 
a sequence  from a covariance 
stationary process with unknown spectral density,  
Therefore, for, 
      
and
    
    (10)
algorithm converges to the desired posterior distribution 
(Ojo et al., 2017).
Assessing Bayesian Markov Chain Monte Carlo and 
Convergence 
In this study, non-informative prior were assumed 
in order not to influence the posterior distribution and it 
was assumed that . All the Bayesian 
analysis was carried out using WinBUGS 14 (Ntzoufras, 
2011). We ran 1,500,000 Markov chain Monte Carlo 
(MCMC) iterations, with the initial 200,000 discarded 
to cater for the burn-in period. The 5,000 iterations left 
were used for assessing convergence of the MCMC. We 
assessed MCMC convergence of our model parameters by 
checking Heidelberger-Welch diagnostic, autocorrelation 
plot, Gelman-Rubin plots (Gelman et al., 2014a), and 
running quantiles of the MCMC output.
Gelman-Rubin
The diagnostic of Gelman and Rubin requires two 
or more chains from over-dispersed starting points by 
computing the within and between chains variability 
respectively. Large deviation between two variances 
implies non-convergence of the chain. If all the chains 
have converged as expected, the posterior marginal 
variance estimate is expected to be very close within the 
chain variance. The test statistics for the Gelman-Rubin 





where  is the number of iterations of the chains.
  
Param. Stationarity Test P–Value Half–width Mean Half width
C1 C2 C3 Test C1 C2 C3 C1 C2 C3
λ0 passed 0.927 0.888 0.308 passed 0.117 0.132 0.129 0.054 0.054 0.055
λ1 passed 0.591 −0.219 0.364 passed −1.148 −1.144 -1.148 0.01 0.009 0.01
λ2 passed 0.0572 0.818 0.204 passed 1.348 1.343 1.35 0.01 0.011 0.011
λ3 passed 0.394 0.51 0.994 passed 0.836 0.838 0.839 0.013 0.012 0.012
λ4 passed 0.915 0.987 0.112 passed 1.22 1.216 1.22 0.016 0.016 0.016
λ5 passed 0.893 0.815 0.313 passed -0.216 −0.226 −0.228 0.044 0.044 0.044
λ6 passed 0.808 0.914 0.237 passed −0.977 −0.977 -0.983 0.038 0.037 0.038
λ7 passed 0.824 0.94 0.507 passed −1.536 −1.55 -1.551 0.044 0.044 0.044
λ8 passed 0.64 0.954 0.163 passed 0.6168 0.613 0.612 0.02 0.042 0.019
λ9 passed 0.4 0.896 0.092 passed 1.054 1.058 1.053 0.009 0.009 0.009
Table 1. Heidelberger and Welch Stationarity and Half-Width Tests for the Bayesian Chains Used in the Diagnosis of 
MCMC
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 is approximately distributed as a Brownian 
bridge for large , where
 
Hence, the null hypothesis for stationarity is now 
tested using Cramer-von Mises statistic.
Results
Socio-demographic profile of participants
The main goal of this paper is to investigate the 
significant predictors as well as characterizing patients 
diagnosed of benign and malignant breast cancer lesion 
and presents diagnosis of MCMC convergence in western 
Nigeria, comparing the classical approach and Bayesian 
approach. Various prognostic factors are considered which 
include: intercept ( ), marital status: separated ( ), level 
of education: at least high school ( ), religion: Christian 
( ), tribe: yoruba ( ), age: 35-49 ( ), 50-69 ( ), 70+ 
( ), occupation: retired ( ), self employed ( ). A total of 
237 breast cancer patients’ data was extracted for analysis 
in the current study. Of these, 192 cases accounting for 
(81.01%) were malignant breast lesions, while 45 cases 
(18.99%) were benign giving a ratio of 4.3:1 for malignant 
to benign breast lesion. The mean age of the respondents 
was 42.2 ±16.6 years with 52% of the women aged 
between 35-49 years. Table1 shows the Heidelberger and 
Welch stationarity tests for the Bayesian Markov chain 
Monte Carlo. It shows the stationarity and convergence 
during the burn-in period.
Table 2 present the result of MCMC diagnostics for 
the patients diagnosed with benign and malignant breast 
cancer. The posterior means were obtained after a burn-in 
period of 5,000 with Monte Carlo error less than 2%. 
The posterior means and medians of the coefficient   and 
indicate significance. The results of the posterior provide 
some evidence about the important variable to be selected 
while profiling patients diagnosed with malignant breast 
cancer. For , Table 2 shows that those with at least high 
school education are 1.3 times more likely than others 
to have benign breast cancer. The results indicate that 
women with age ≥ 35 years were at a higher risk of been 
diagnosed with malignant breast cancer than those with 
age < 35 years. 
Table 3 shows the result of a classical logistic analysis 
of the malignant breast cancer. The results indicate that 
malignant was observed to be strongly associated with age 
and educational status. This indicates that women with 
Table 3. Result of Classical Logistic Regression for 
Patients Diagnosed of Benign and Malignant
Est Std Error z value Pr(>| z |)
λ0 -2.421 1.2308 -1.967 0.0492
λ1 1.2479 0.5976 2.088 0.4459
λ2 0.5926 0.7774 0.762 0.0368
λ3 1.0782 0.6392 1.687 0.0916
λ4 1.2048 0.8515 1.415 0.1571
λ5 1.1952 0.5732 2.085 0.0371
λ6 0.5034 0.8188 0.615 0.5387
λ7 1.0534 1.4439 0.73 0.4656
λ8 0.4823 1.0432 0.462 0.6439
λ9 0.9898 0.5658 1.749 0.0802
Table 2. WinBUGS Posterior Summaries for Breast Cancer Patients
Mean SD MC error 2.50% Median 97.50% start Sample
λ0 0.126 1.973 0.01568 -3.514 0.049 4.251 5,000 49,749
λ1 -1.147 0.669 0.003012 -2.453 -1.146 0.176 5,000 49,749
λ2 1.347 0.637 0.002987 0.18 1.316 2.695 5,000 49,749
λ3 0.838 0.815 0.003789 -0.637 0.796 2.561 5,000 49,749
λ4 1.219 0.92 0.004805 -0.633 1.224 3.012 5,000 49,749
λ5 -0.223 1.672 0.001283 3.91 -0.102 4.685 5,000 49,749
λ6 -0.979 1.523 0.01116 -4.418 -0.836 1.603 5,000 49,749
λ7 -1.545 1.686 0.01269 -5.25 -1.415 1.371 5,000 49,749
λ8 0.614 1.133 0.005761 -1.454 0.554 3.002 5,000 49,749
λ9 1.055 0.59 0.00283 -0.093 1.047 2.241 5,000 49,749
Figure 1. Running Quantiles for the Posterior Parameters 
in the Case of Female Benign and Malignant Breast 
Cancer Patients
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at least high school education have a significantly higher 
risk of being diagnosed with malignant breast tumors.
Assessing the performance of Markov Chain Monte Carlo 
(MCMC) chains in WinBUGS
When the results of the model are computed, it is 
necessary to check for the stationarity of Markov chain 
Monte Carlo algorithm. Both Figure 1 and Figure 2 
were presented to demonstrate that there is no problem 
of autocorrelation among the MCMC chain. The blue 
and red lines in Figure 4 denote the variance within and 
between chains. To support that the chain is converged, 
the ratio must converge to one and the blue and red lines 
must converge to a stable value. It also displays the red 
lines representing the potential scale reduction factor 
Figure 2. Auto-Correlation Plots for the Female Benign and Malignant Breast Cancer Patients
Figure 3. The Plot of the Brooks-Gelman MPSRF for 
Three Chains of 49,749 Iterations
Figure 4. Gelman Rubin Convergence Diagnosis for Independent Variables
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denoted by . Hence, Figure 4 indicates that all the  →1 
which suggests that the algorithm converges. Both Figure 
3 and Figure 4 explain the same thing but one is obtained 
through CODA/BOA and the other through WinBUGS.
Discussion
The present confirm findings from studies conducted 
in Nigeria over the past years, on Breast cancer among 
women in the western Nigeria (Olugbenga et al., 2012; 
Abudu et al., 2007). All these studies showed that age 
could be a risk factor for malignant breast lesion. Similar 
studies have been documented in other parts of Africa 
and the rest of the world (Arora and Simmons, 2009). 
From the results of analysis, patient’s age 35-49 years 
constituted the majority of patients (52%) in our study, 
indicating that women age 35-49 have a higher risk 
of developing malignant breast cancer than their other 
counterpart in the group. Therefore, more attention on 
breast cancer treatment are necessary for this age group. 
This agrees with breast cancer facts and figures released 
between 2011-2012. However, this corresponds to the 
working class population and it is also the child bearing 
age for many women. This may be as a result of the use 
of contraceptive and hormonal imbalance which common 
among the women (Onyeanusi, 2015; Olugbenga et al., 
2012). From the study, malignant breast lesions appeared 
to have higher distribution among those who had at least 
high school education, an observation which supports 
previous studies (Yuksel et al., 2017; Ibrahim et al.,¨ 
2015, Yusufu et al., 2003; Ntekim et al., 2009). This result 
was supported by the descriptive statistics which shows 
that 52.3% of those diagnosed had at least high school 
education meaning that those who are educated were more 
interested in presenting their health problems to rather 
than consulting fake medical doctors. The high proportion 
of malignant breast lesion might also be attributed with 
lifestyle changes among those educated. In addition, this 
may also be as a result of their exposure to advancement 
in life like the nature of occupation, diet, without 
observing caution to health management. We found that 
the mean age of breast cancer patients in western is 42 
years; this is similar to several Nigerian institution based 
studies, Adebamowo reported 43 years (Adebamowo and 
Adekunle, 1999), Ikpatt et.al 42.7 years (Ikpat et al., 2002) 
and 44.9 years by Ebughe.et al (Ebughe et al., 2013). 
Although our variables’ interactions did not categorize age 
and educational status as components of socioeconomic 
status (SES), our findings are similar to those of some 
studies which showed that higher socioeconomic status 
(SES) is associated with higher breast cancer incidence 
(Pudrovska and Anikputa, 2012; Krieger et al., 2010; 
Vainshtein, 2008). Additional studies have provided a 
possible explanation for these findings that women with 
high SES are more likely to obtain routine breast cancer 
screening due to better access to preventive healthcare 
based on their level of education and increasing age, hence, 
increasing the detection of breast cancer (Akinyemiju et 
al., 2015).
Although our study did not investigate the risk factors 
for breast cancer in association with its sub molecular 
types, a recent study conducted by (Akinyemiju et al., 
2015) evaluated the association between SES and breast 
cancer subtypes using a valid measure of SES and the 
Surveillance, Epidemiology and End Results (SEER) 
database. Socioeconomic status based on measures of 
income, occupational class, education and house value, 
were categorized into quintiles and explored. Their 
findings showed that a positive association between 
SES and breast cancer incidence is primarily driven 
by hormone receptor positive lesion. Malignant breast 
lesions which can be subdivided into non-invasive and 
invasive tumors are documented to be more commonly 
diagnosed in postmenopausal women (LehmannChe et 
al., 2013). A molecular classification of breast cancer, 
with more than five reproducible subtypes (basal-like, 
ERBB2, normal-like, luminal A, and luminal B) has been 
defined through gene expression profiling and microarray 
analysis (Lønning et al., 2007). In addition, performing the 
gene set enrichment analysis (GSEA), a gene set linked 
to the growth factor (GF) signaling was observed to be 
significantly enriched in the luminal B tumors (Loi et al., 
2009). Another study states that multiple pathways were 
identified by mapping gene sets defined in Gene Ontology 
Biological Process (GOBP) for estrogen receptor positive 
(ER+) or estrogen receptor negative (ER-); and among 
them, in a separate set, pathways related to apoptosis 
and cell division or G-protein coupled receptor signal 
transduction were associated with the metastatic capability 
of ER+ or ER- tumours, respectively (Jack et al., 2007).
The plot of Gelman Rubin convergence in Fig 4 
suggesting that the MCMC sequence has converged on 
the posterior density as red line fall towards one for all 
parameters. Our findings are similar to the result obtained 
by Salameh.et.al (Salameh et al., 2014), Jackman.et.al 
(Jackman, 2000). Figure 3 shows a plot of the Brooks-
Gelman MPSRF (denoted  ) along with the maximum 
PSRF (denoted  ) for successively larger segments of the 
chains. This plot suggests that although the chains differs 
significantly for the first few thousand iterations, they mix 
together after that and three chains of 1,500,000 iterations 
each is probably sufficient to ensure convergence of the 
chains. It also suggests using a burn-in of about 200,000 
each. The result in Table 2 shows that each parameter 
passes the stationarity and half-width test respectively. 
This suggests that for the current study, the stationarity of 
the Markov chain and the sample size obtained is adequate 
for the estimation of mean values of the three iterations. 
Findings from Bayesian and classical inference are 
not significantly different which could be due to the non-
informative prior utilized in the Bayesian model. When 
both techniques produced similar results, findings from 
Bayesian are given more attention because it is more 
robust compared to the classical. The model used in this 
paper updates quickly and adding complexity will also 
improve the required time for updating. This diagnostic 
are necessary to ensure that we are actually sampling 
from a chain that has converged after a desirable burn-
in. Using the posterior mean as a point estimate, Table3 
compares the classical statistics estimates with the 
simulation (MCMC) result. The estimated means and 
standard errors appear quite close with minimum results 
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show a reduction of standard errors associated with the 
coefficients obtained from the Bayesian approach, hence 
resulting in higher stability to the coefficients. Other 
studies have also shown similar result (Gordóvil-Merino 
et al., 2010; Acquah, 2013).
Findings of this study shows that age of the patients 
and those with at least high school education are at 
higher risk of being diagnosed with malignant breast 
lesion than benign breast lesion in Western Nigeria. The 
higher proportion of those affected by malignant breast 
lesion is found among the educated and younger women. 
Therefore, this shows that non-educated women do not 
patronize these services based on our findings. More 
efforts are required towards creating awareness and 
advocacy campaigns on how the prevalence of malignant 
breast lesions can be reduced, especially among women.
We recommend that governments, non-governmental 
organizations and other sectors involved in policy making 
to put in place policies, strategies and sensitization that 
target non-educated women to enhance their patronization 
of breast cancer screening in the health facilities, so as 
to access the appropriate management health assessment 
as well as providing financially supported treatments for 
breast cancer patients.
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Abstract
Background: Multinomial regression analysis has seen rapid usage in many fields,
especially medical and social sciences. Many of these studies make use of multi-
nomial regression, this study step further by incorporating the hierarchical struc-
ture as related to multinomial regression via Bayesian techniques. In this study, we
develop a multilevel multinomial regression model in WinBUGS and the model is
applied to breast cancer data in western Nigeria.
Methods: Multilevel multinomial logistic regression analysis was applied to breast
cancer data using two approaches, namely the frequentist multilevel and the
Bayesian approach and compared their results. This study used data extracted two
different hospitals in western Nigeria to identify key socio-demographic, and bio-
logical factors associated with histological types. Several multilevel models have
been compared, and a final model was decided based on deviance information cri-
teria.
Results: The mean age at diagnosis of breast cancer in Nigeria was 42.2 years.
Bayesian multilevel multinomial model indicated that grade tumor, age group (35-
49), patient with at least high school and breast cancer type were all associated
with histological types. The results of the two approaches were compared, and the
results are similar but preference are given to Bayesian because the approach is
more robust than the frequentist. Findings of models from Bayesian revealed that
women having invasive duct carcinoma are 2.9 times more at risk of breast cancer
than others.
Conclusions: This study identifies key factors associated with histological types in
Nigeria. The findings suggest that differences in biological factors like grade tumor
and socio-demographic factors such as age at diagnosis and education are more
important in assessing risk for breast cancer in western Nigeria. However, as the
life expectancy of breast cancer women over the age group 35-49 years increases,
treatment should also be based on histological prognostic features of the grade
tumor rather than age alone.
1Corresponding Author: Discipline of Statistics, University of KwaZulu Natal, Westville Campus, Durban,
South Africa; E-mail: 215082165@stu.ukzn.ac.za
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Introduction
Breast cancer remains an important caused of death among women both in the developed
and less developed world (Adebamowo and Ajayi, 1999; Ojewusi and Arulogun, 2016;
Oladimeji et al., 2015) and it is a leading malignancy among western women of Ni-
geria (Ojewusi and Arulogun, 2016). Globally, patients diagnosed of breast cancer were
estimated to be 1.7 million in 2012 while the prevalence stood at 6.3 million women.
According to an estimate, breast cancer is reported to be responsible for close to 508,000
deaths in 2011 and increases to 522,000 in 2012 [WHO] was also the most frequently dia-
gnosed cancer among women in 140 of 184 countries worldwide (Organization, 2013).
It is estimated that breast cancer constituted 22.4% of new cases of cancer registered in
5 years and this accounted for 35.4% of all cancers among Nigerian women (Afolayan
et al., 2012). As a result, breast cancer tumors continues to be a serious threat to women
particularly Africa. Breast cancer risk factors remains controversial and the data regard-
ing this issue are conflicting (Chen et al., 2016). Some studies have documented that
age is an important prognostic factor for breast cancer (Ikpat et al., 2002) but many of
these studies have not been able to explore the role of histological type and histological
grade tumor in relation with socio economic status as an established prognostic factor
for breast cancer.
Moreover, breast cancer patients diagnosed less than 2 years after birth often have a poor
prognosis (Sotiriou et al., 2003; Rakha et al., 2010) and the tumors have also been found
to be higher at time of diagnosis (Rakha et al., 2010; Blamey et al., 2010). Hormone re-
ceptor status as well as other breast cancer clinical features tumors have also been found
differed by histological type (Weigelt et al., 2010). It has been suggested by past studies
on breast cancer that reproductive factors affect the risk of histological types of breast
cancer differently (Rakha et al., 2010; Ellis et al., 2005; Sundquist et al., 1999; Simpson
et al., 2000). Lobular tumors which is an histological type have shown a strong correla-
tion with age at first birth than other histological types (Rakha et al., 2010). Few studies
have examined whether breast cancer tumors and age at diagnosis tend to be of a par-
ticular histological type or not. Lack of understanding of the risk of prognostic factors
associated with breast cancer discourages many people from seeking early intervention
or even to admit that symptoms they may be experiencing are related to breast cancer.
Deeper knowledge about this as well as the underlying prognostic factors may provide
more valuable information for improved early diagnosis of breast cancer as well as treat-
ment.
Therefore, to bridge the paucity of knowledge on the wider influencing role of socio
economic status (SES) in relation with histological type, this study employed multilevel
multinomial modeling. Multilevel modeling approach allows simultaneous performance
of the role each socio economic has on histological type. Highlighting such would con-
tribute to a greater understanding of early intervention among women particularly west-
ern Nigeria.
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Methods
Study participants and methods
Data pertaining to 237 patients who were diagnosed with breast cancer were extracted
from the cancer registry of federal teaching hospital. Extensive variable selection pro-
cedures were performed on the 20 variables, and the records of patients aged 20 years
and above were selected for the analysis. The information collected included age, marital
status, educational level, religion, race, type of breast cancer, occupation, Lab number,
case number, site of the cancer, type of diagnosis, and histological type. With respect to
the quality of the data obtained, the main concern was the proportion of hospital records
in which some of the relevant variables were absent. Information relating to types of
patients were eligible for inclusion in this study: gender, tribe, histological type: invasive
duct carcinoma or lobular carcinoma, type of treatment received and histological grade I,
II or III. For input variable selection, we tried to limit the number of variables and select
only the clinically relevant ones.
Ethical considerations
This study is based on secondary analysis of existing breast cancer data, with all personal
identifying information removed. The data extracted received ethical permission from
the ethical review committee of Federal teaching hospital, Ekiti State, Nigeria.
Statistical Analysis
In the present study we employ both classical and Bayesian techniques to identify the
socio-economic factors thats are associated with histological types in breast cancer pa-
tients. Therefore, the hierarchical structure of our dataset where individual patients are
nested within hospitals warrants the use of multilevel multinomial modeling approach.
Full details of the statistical models employed are discussed extensively. All analysis
were performed using SAS 9.4 (Inc, 2014) and WinBUGS 14 Ntzoufras (2011). In this
study, the intra clusters correlation (ICC) was used as a measure of random effects.
Multinomial logistic regression model
Multinomial logistic regression model is a technique of analysis which is applicable
when the dependent variable under study event consists of more than two categories. The
multinomial response could be ordinal (ordered categories) or nominal (unordered cat-
egories) but in the current study, the object of interest is not mainly in the ordered categor-
ies. Multinomial logistic regression does necessitate careful consideration of the sample
size and examination for outlying cases. Sample size guidelines for multinomial logistic
regression indicate a minimum of 10 cases per independent variable (Chan, 2005).
In case of binary logistic regression model that compares one dichotomy, multinomial
logistic regression model compares a number of dichotomies. Multinomial approach out-
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puts a number of logistic regression models that make specific comparisons of the re-
sponse categories. Considering a situation that we have j categories of the response vari-
able, the model consists of j-1 logit equations which are fit simultaneously. The probabil-
ity of categorical variable in a multinomial model is estimated using maximum likelihood
estimation (Bayaga, 2010).
Model formulation
Multinomial logistic regression models pairs each outcome category with a reference
category. The last category or probably the most common category is assumed to be
picked as reference Agresti and Kateri (2011). Suppose xi = (xi0, . . .xim)T denote the
explanatory variables for individual 1≤ i≤ n and β j = (β j0,β j1 . . .β jm), (1≤ j≤ J−1),
a row vector, represent the regression parameters for the jth reference category. Suppose
yi = (yi1,yi2 . . .yiJ) denote a multinomial trial for individual 1 ≤ i ≤ n. The trial yi j is
equal to one whenever a trial occurs in category j. Let π j(xi) = Pr((yi j = 1)|xi) be the
probability that the ith trial occurs in category j given a set of covariates xi. Then the




= β Tj xi j = 1, .......J−1 (1)
With the logit link we can interpret the coefficients. The exponential of the coefficient,
exp(β j), represents the odds of a trial falling into the category j against category J, all
other things equal. A odds greater than one represents that a trial is more likely to occur
in category j than J and by symmetry if it is less than one it is more likely to occur
in category J than j. If the odds is equal to one, there is independence between y and
covariates. Using the logit link we have response probabilities
π j(x) =
exp(β Tj x)
1+∑J−1c=1 exp(β Tc x)
(2)
In order to fit the multinomial logit regression model we need to derive the log likelihood
for regression parameters. For the log likelihood of the regression parameters we use
notation from (Agresti and Kateri, 2011). The likelihood of the regression coefficients is








π j(xi)yi j (3)
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putting the response probabilities in expression (3) into expression (4) results in the log






































We consider multilevel multinomial logistic regression model to established prognostic
factors for breast cancer in Western Nigeria. Attempts were made to predict the likeli-
hood of patient having some particular histological type. The preliminary analysis star-
ted with classical statistics where we set up three models. We consider random intercept
model where the model is fitted with only the intercept (model 1). Model 1 is also called
unconditional model (i.e model containing no predictors). We used it to calculate the in-
traclass correlation coefficient (ICC) between hospitals. In model 2, we add educational
status and treatment while model 3 include more variables. Based on the values of -2LL,
model 3 appears to fits significantly than other models. We therefore resort to model 3 for
further analysis in Bayesian analysis technique. The PROC GLIMMIX in SAS is used to
fit the classical model and the result is given in table 1. The Bayesian models are fitted
using WinBUGS software.
Multilevel multinomial logistic regression model
Suppose ηi denote an ordinal categorical response of a patient i in an hospital j. We then
assume that the cumulative probability of ηi taking on a particular value is structured as
following
logit(ηki j) = β0 j +β1 jXi j +bk (7)
where ηki j is an ordinal categorical outcome for individual i in hospital j, estimated by
the overall intercept β0 j plus an individual-level error term, bk. Multilevel models are
simple extensions of ordinary regression models, which account for the nesting of data
within higher order units. The need for multilevel statistical models is firmly rooted in
both theoretical and methodological rationales.
When dealing with multinomial outcomes, multiple logits are simultaneously estimated
(i.e M-1 logits, where M is the number of response categories). In our own case where we
have three categories of response, there will be three logits and their corresponding in-
tercepts simultaneously estimated, each of them indicating the probability of responding
at a particular category. The model for level-1 may be written as:
η1i j = log
(
p(ϕi j ≤ k)
1− p(ϕi j ≤ k)
)
= β0 j +β1 jXi j, k = 1,2, . . .k−1 (8)
A random intercept multinomial multilevel logistic model was used to determine factors
that were associated with histological tumor in breast cancer patients by considering a
2-level analyses (i.e. hospital level). Multilevel multinomial logistic regression analysis
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was performed with histological type as the outcome variable, and considering a 2-level
analyses was included for the multilevel modeling analysis. Suppose ηi jk represent the
status of patient j in hospital i and the associated covariate. The model for level-k may
then be expressed as
ηi jk = log
(
p(ϕi j ≤ k)
1− p(ϕi j ≤ k)
)
= β0 j +β1 jXi j +bk (9)
We assumed that the intercept β0 j is random and β1 j is the slope coefficient correspond-
ing to Xi j that measures the increase in the log odds of patients being at a given age per
unit change in the level-1 predictor. And p(ϕi j ≤ k) represents the probability of patient
being at or below the kth level of the outcome variable, and bk represents the difference
between the kth category and the preceding one. Normally, for k =1, b1=0. Therefore, we
consider intercept to be random having the form of model
β0 j = γ00 +ω0 j
Where γ00 is the average log odds of a particular patient being in the hospital, and ω0 j is
the random error term expressed as ω0 j ∼ N(0,σ00). Hence, the model in (9) becomes
ηi jk = log
(
p(ϕi j ≤ k)
1− p(ϕi j ≤ k)
)
= γ00 +β1 jXi j +bk +ω0 j (10)
Furthermore. model (10) gives log odds when fitted to data and the probability of the




Model Building Strategies and Diagnostics
The multilevel multinomial modeling analysis was performed using WinBUGS 14 soft-
ware. A random intercept multinomial multilevel logistic model was used to determine
factors that were associated with histological type tumor in breast cancer patients by
considering a 2-level analyses. Different models were constructed and compared in Win-
BUGS 14. A model with blocking and over-relaxation was specified to aid convergence
of the Markov chain. In the next model, blocking and over-relaxation was not included.
We consider multilevel multinomial logistic regression model to evaluate the effect of
age on breast cancer prognosis. The steps of the model building process are done using
Bayesian approach and the result are presented in TABLE 3. The multilevel multinomial
are fitted using the same predictors. Model with blocking is specified as model M1 while
the one without blocking is called model M2.
The ability to fit complex multilevel models using Markov Chain Monte Carlo (MCMC)
techniques presents a need for methods to compare alternative models. The standard
model comparison techniques such as AIC, and BIC, require the specification of the
number of parameters in each model. For multilevel models which contain random ef-
fects, the number of parameters is not generally obvious and as such an alternative tech-
nique of comparison is demanded. The most widely used of such alternative technique
is the Deviance information criteria (DIC) as suggested by (Spiegelhalter et al., 2002).
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Deviance information criteria (DIC) statistic is a generalization of the AIC, and is based
on the posterior mean of the deviance, which is also a measure of model complexity and
fit. The deviance is defined as
D(θ) =−2log f (y|θ)
since DIC is a measure of model complexity, it considers a measure of the effective
number of parameters in a model, and is defined by
pD = D̄(θ)− ˘(θ)





and ˘(θ) is the deviance evaluated at some estimate θ̆ of θ . Therefore, we now define the
deviance information criteria (DIC) by
DIC = D̄(θ)+ pD (11)
Where D̄ is the posterior mean of the deviance that measures the goodness of fit and pD
represent the effective number of parameters in the model. In the case of Bayesian and
bootstrapping model, low values of D̄ implies a better fit while small values of pD implies
a parsimonious model. pD is higher for a more complex model and DIC appears to select
the correct model. The best fitting model is one with the smallest Deviance Information
Criterion as suggested by (Spiegelhalter et al., 2002; Lesaffre and Lawson, 2012).
Bayesian parameters estimation
A full classical and Bayesian approach in estimation were used in the current study. In
the case of Bayesian approach, prior distributions were assigned to all the parameters as
discussed below:
Prior distribution
For the prior distribution, this study uses a non-informative. Non informative priors are
employed since we want prior information to play a very little role in our analysis which
makes the data to remain influential in the analysis. For the purpose of this study, we use
a multivariate normal prior on β .
β0 ∼ N(b0,Σ20) (12)
The variance (σ2) is needed to be transformed before introduced into the model. Hence,
we now use τ =0.001 as the transformed variance. In the case of Bayesian multilevel
regression model, each random effect uses a gamma distribution with α =0.1 and β
= 0.01. This study utilizes multivariate normal (b0,Σ0) prior density for the parameter
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vector β . We also assumed that the prior for the ith component be normal (b1,S21) while




















Hence, we can therefore write the general formula for prior distribution as follows:












Since multivariate normal prior doses not have to be made up from independent com-







b1 = Σ1|Σ−1ML|β̂ML +Σ1|Σ−10 |b0
where ΣML is the covariance matrix of the maximum likelihood estimate (MLE) vector
and its inverse is represented as
Σ−1ML = XΣ
−1X
while β̂ML is the maximum likelihood vector and Σ−10 is the prior precision matrix.
Posterior distribution refers to the distribution of the parameters after observing the data.
The estimates of Bayesian inference is obtained by sampling from the posterior distribu-
tion. In terms of Bayesian approach, we can write posterior distribution as
p(β |yi) ∝ p(yi|β )p(β ) (14)
where p(yi|β )p(β ) is the likelihood function and is expressed as:











Considering the fixed effects alone, the posterior distribution for a multinomial logistic
regression is expressed as:
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Because of the complexity of the posterior distribution which makes it difficult to directly
sample from and it becomes complicated when random effects is included in the model.
Clearly expression (14) is a complex function which required numerical techniques to
obtain the marginal posterior distribution for each of the model parameters. We now
employed Markov Chain Monte Carlo (MCMC) approach for simulation of the random
numbers from the posterior distribution. In reality, posterior distribution is often of higher
dimension and analytically intractable and when the posterior distribution comes from
a distribution that is complex, MCMC approach offers a better alternative to summarize
the posterior distribution. The quality of MCMC sample depends on how quickly the
sampling procedure explore the posterior distribution.
MCMC approach
To estimate the parameters in the models described above, we used a Bayesian approach.
In Bayesian approach, the prior knowledge about the parameters is combined with the
observed data (likelihood) to yield the posterior distribution. We obtained the posterior
summary measures of the parameters by using the MCMC sampling approach (e.g.,
(Lesaffre and Lawson, 2012; Best, 1996)). We performed the MCMC calculations in
WinBUGS14 (Lunn et al., 2000). We used non-informative priors expressing that we
do not have prior information on the parameters. For the regression coefficients, we as-
sumed vague independent priors to follow a normal distribution with mean 0 and large
variance, that is, β ∼N(0, 10000). There were 1500000 iterations, discarding the first
500000 iterations keeping every 100-th iteration of the remaining one million iterations.
We assessed MCMC convergence of all models parameters by checking trace plot, ker-
nel density, Gelman Rubin plot (Salameh et al., 2014; Gelman et al., 2003). The scale
reduction factor, also known as Gelman-Rubin convergence diagnostic (Clèries et al.,
2012) was calculated for model parameter to assess convergence and adequate mixing
of the chains. For the model parameter, the scale reduction factor should be close to
1 when convergence is achieved (Clèries et al., 2012). We checked the convergence of
these MCMC by using the CODA package in R (Plummer et al., 2010). In particular,
we used the Gelman and Rubin’s diagnostics measure R̂ (Plummer et al., 2010), and this




Firstly, an analysis using classical multilevel multinomial logistic mixed effects was per-
formed. Table1 summarizes the results from multilevel mixed model for all the three
models set up, some parameters estimates are highly significant (P< 0.00968). A total of
237 breast cancer patients were enrolled in the current study. The mean age at diagnosis
of breast cancer in Nigeria was 42.2± 16.6 years. The 20-34 year age group comprised
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the most patients among the three groups (n= 97, 40.9%), and the ≥ 70 year age group
comprised the fewest patients (n= 17, 7.2%), irrespective of tribe. Younger patients were
more likely to have grade II disease than elderly patients (P< 0.00968).
Result of classical multilevel multinomial model
Table1 presents the results of fitted models with the estimated effects. In Table1, we
set up three models in which model 1 is nested under model 2, and model 2 is nested
under models. The essence is that, it makes it possible to compare the three models
based on -2LL. Result of model 3 in Table1 shows that there is a positive/negative, stat-
istically significant relationship between patient’s socio economic status/ breast cancer
stages and their likelihood of having a particular histological type. Specifically, as pa-
tient’s educational status increases, their likelihood of having invasive breast tumors de-
creases. Model 3 contains three significant covariates (educational status, age group and
breast cancer stage). We find significant effect of educational status (β̂ = 0.81, p= 0.01),
(β̂ = 0.07, p = 0.01) and breast cancer stages (β̂ = −4.01, p = 0.0001). The estimates
for educational status and age group has positive effect on the log odds, whereas breast
cancer stages has a negative effect. This implies if the educational status increases by one
unit, the corresponding change in the log odds is 0.81. Table1 depicts the odd ratio (OR)
from the classical multinomial multilevel models. A significant association between his-
tological type and educational status, age group, type of treatment patients received as
well as breast cancer type in western Nigeria (see model 2 and model 3). The results
indicates that, age group (35-49) and those with at least high school education had 7%
and 81% more likelihood of histological type (model 3) while the likelihood is higher
in model 2 for patients with at least high school education 1 than model 3. Furthermore,
findings reveal that patient with at least high school education are 13% (OR= 0.87) less
likely to have invasive breast carcinoma tumors compared to others. In the case of breast
cancer stages, results show that patient who are diagnosed of benign breast tumor are
79% (OR= 0.208) less likely to suffer invasive breast carcinoma tumors compared to
those patient who their breast cancer are malignant in nature. Based on the result of es-
timated intercept for hospital, there exists statistically significant variation between the
histological type among the two hospitals patients attended in Western Nigeria. The co-






The result of intraclass correlation coefficient indicates how much of the total variation
in the likelihood of patient having a particular form of histological type between the two
hospitals. The intraclass correlation coefficient is calculated as 0.1788 representing about
18% of the total variation in the outcome variable is accounted for by the hospitals.
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Table 1. Multilevel multinomial model estimates of histological type
Fixed Effects Model 1 Model 2 Model 3
Social characteristics
Educational level













surgery -1.29(-1.955, -0.628)* -0.15(-0.939, 0.633)
none (ref)




well (I) -0.305(-1.105, 0.496)
moderate (II) 0.230(-0.500, 0.960)
none (ref)
Random effects
Error variance intercept 0.716(0.753) 0.323(0.365) 0.115(0.164)
Model Fit
-2LL 476.71 447.11 417.36
* indicates p<0.05 while ** implies significant likelihood ratio test; ICC= 0.1788
Bayesian approach
For the Bayesian method, WinBUGS (Bayesian Inference using Gibbs Sampling) is used
to fit the model. The WinBUGS result in Table2 indicates the output of multilevel multi-
nomial logit model. Considering the credible interval, result of Bayesian multilevel mul-
tinomial model indicate that histological grade, age at diagnosis, educational status and
breast cancer type are the only significant predictors associated with histologic type of
tumor. Patients aged 35-49 years are 3.32 times more at risk of histological type than
their counterpart. Regarding the association of grade tumor on patient having histologic
Ebenezer and Lougue /
Table 2. Multilevel-multinomial model estimates of histological type of breast cancer
Parameter
Model M1 Model M2
Estimate 95% Cred.I Estimate 95% Cred.I
ψ2(grade2) -1.215 [-3.110, 0.624] -1.223 [-3.112, 0.617]
ψ2(grade3) -1.503 [-4.628, 1.591] -1.510 [-4.641, 1.580]
ψ2(35−49) 2.934 [0.737, 5.209] 2.932 [0.722, 5.20]
ψ2(50−69) 3.125 [-0.037, 6.350] 3.120 [-0.053, 6.344]
ψ2(70+) 4.213 [-2.624, 11.450] 4.197 [-2.648, 11.43]
ψ2(treatment) 0.690 [-1.866, 3.314] 0.684 [-1.878, 3.307]
ψ2(education) 1.097 [-1.038, 3.258] 1.101 [-1.02, 3.258]
ψ2(tribe)7 8.360 [-7.821, 27.940] 8.337 [-7.831, 27.80]
ψ2(malignant) -27.12 [-59.560, -9.464] -27.110 [-59.51, -9.468]
ψ3(grade2) -1.832 [-3.702, -0.018] -1.8406 [-3.71, -0.023]
ψ3(grade3) -1.309 [-4.339, 1.695] -1.314 [-4.352, 1.68]
ψ3(35−49) -0.789 [-3.199, 1.560] -0.794 [-3.219, 1.565]
ψ3(50−69) 0.547 [-2.544, 3.633] 0.537 [-2.579, 3.630]
ψ3(70+) -0.553 [-7.404, 6.576] -0.582 [-7.444, 6.517]
ψ3(treatment) -0.537 [-3.342, 2.211] -0.541 [-3.34, 2.187]
ψ3(education) 2.231 [0.069, 4.457] 2.237 [0.076, 4.478]
ψ3(tribe) 7.295 [-8.90, 27.79] 7.474 [-9.23, 27.88]
ψ3(malignant) -10.01 [-17.95, -4.203] -10.01 [-17.970, -4.197]
τ .Hosp 3.385 [0.011, 17.430] 3.41 [0.014, 17.54]
type, findings highlight that women with grade 2 tumor are 17% (OR=0.83) less likely
to have histologic type (i.e.other form) than others with grade 1 or 3. Results also show
that patient with at least high school are 9.02 times more at risk to have invasive duct
than others. Furthermore, patient with grade 2 tumor are 16.5% (OR=0.835) less likely of
having other forms of histologic type of tumor than their counterpart with grade 3 tumor.
One of the key features of Bayesian over classical statistics is its ability to check for the
convergence of each model. In this study, we checked convergence of the Markov Chain
Monte Carlo (MCMC) chain using the Brooks-Gelman-Rubin (BGR) approach in Win-
BUGS. This approach compares within-chain and between-chain variability for multiple
chains starting at over dispersed initial values. Convergence of the chain is monitored by
a ratio close to unity (i.e. one).
Multilevel multinomial regression analysis
In this section the multilevel multinomial model with only random intercept was con-
sidered. We assessed convergence to ensure how closer we are to the true posterior distri-
bution. Diagnostics tools such as autocorrelation plots, running mean and trace plot and
formal test like Gelman-Rubin and Raftery-Lewis were examined. All diagnostic plots
for the regression parameter estimated are checked. They indicated that the sampling was
done in almost independent manner. The chains did not depend on their initial values and
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stationarity was achieved. In general all plots showed good convergence as well as good
mixing rate. Potential scale reduction factor for all parameters were less than one, in-
dicating convergence to posterior was achieved. Based on informal and formal tests, we
can conclude that the burn-in of 1,500,000 was enough to forget the initial values, there
were no dependence of iterations, stationarity and higher mixing rate were achieved. This
means that the estimates were derived from the true posterior distribution.
Model assessment and comparison
Table 3. WinBUGS output for the evaluation of logistic regression multilevel using pD and DIC
Model Dbar Dhat pD DIC
M1 411.893 391.435 20.458 432.351
M2 411.889 391.440 20.449 432.339
Table3 presents model diagnostics for all the fitted models in Bayesian paradigm. Model
with a small DIC value provides a better fit. Comparison of the goodness of fit and
complexity of the models, model M2 is the preferred model.
Discussion
In this study two types of multilevel models were implemented, namely the frequentist
and the Bayesian multilevel models and their results were compared. The results ob-
tained from both approaches are identical. At the end of this study, the results showed
no much significant difference between Bayesian multilevel and classical multilevel ap-
proach. One thing that is unique is that it is difficult to compare the result from Bayesian
and classical because the former make use of credible interval while the latter uses con-
fidence interval. The non-informative utilize in the Bayesian approach could have ac-
counted for the similarities between the two approaches. The central aim of the current
study is to investigate the association of SES and biological characteristics for histolo-
gical type of breast tumor among patients diagnosed of breast cancer in western Nigeria
using multilevel multinomial regression analysis. The most significant observation we
found in this study was that age of occurrence of breast cancer in this environment, the
mean age of the patients was 42.2 years, this is similar to those of several Nigerian in-
stitutions which have been studies in the literature. Among these studies, Adebamowo
reported 43 years (Adebamowo and Adekunle, 1999), Ikpatt et.al 42.7 years (Ikpat et al.,
2002) and 44.9 years by Ebughe.et al (Ebughe et al., 2013a). But the situation is dif-
ferent in countries with substantially mixed blacks and Caucasians like United States
and South Africa, variation is noticed in both incidence and mean age of breast cancer
occurrence (Fregene and Newman, 2005; Anderson et al., 2006). Previous studies have
mentioned the peculiarities of breast cancer patients among women of African such as
genetic factors and reproductive factors. In our study, there is a correlation between the
histological type and histologic grade, breast cancer type as well as educational status.
This simply means that reproductive and biological factors may determine histologic
type of tumors. Other studies have also shown similar result (Ursin et al., 2005; Okobia
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et al., 2005; Kotsopoulos et al., 2010). But our result is contrary to what is obtainable
in other part of Nigeria as reported by (Ebughe et al., 2013b) that reproductive factors
may not determine histologic types and biological behavior. Hence, we can attribute this
fact that environmental factors may have brought about this changes in the context of
breast cancer in Nigeria. The proportions of patients with grade II disease decreased with
age, and younger patients were more likely to be diagnosed with a higher grade in this
environment. This may be attributed to poor breast cancer screening in young women,
as the incidence is high in this age group. In addition, younger patients were more likely
to be prone to invasive duct carcinoma than the elderly patients, an observations that is
supported and consistent with other studies (Chen et al., 2016). It was also found that
malignant breast tumor was significant and it happen to be the most prominent type of
breast cancer in this environment. This explain why majority of breast cancer patients
in this environment are subjected to surgery treatment since the cancer has gotten to a
higher level which can only be managed by surgical operation.
The result of Bayesian analysis showed that age group 35-49 years, educational status
and grade tumor were significantly associated with histologic types. We found that pa-
tient with at least high school are 9.4 times more likely to have one histologic type of
tumor disease than their counterpart. Histologic type of tumor might have resulted from
their exposure in advancement in life without observing caution to health management.
Although, our study did not investigate the influence of education on breast cancer, a
study conducted by (Hussain et al., 2008) evaluated the effect of education on in situ
and invasive breast cancer risk using Sweden Family-Cancer Database. Their findings
revealed that significant increased risk for in-situ and invasive breast cancer associated
with high educational levels. Additionally, previous studies have provided possible ex-
planation for these findings, that highly educated women or women with high socio eco-
nomic status (SES) are likely to obtain routine breast cancer screening as a result of
having access to preventive healthcare (Akinyemiju et al., 2015). In addition, previous
studies also found that a high level of education was significantly associated with de-
creased incidence of high risk ductal breast cancer among postmenopausal women only.
Combining this with our study, these finding indicates heterogeneity in the association
between education and breast cancer risk factors exists not only by histologic type and
age at diagnosis, but also tumor characteristics (Dalton et al., 2006). The grade tumor
of disease was also seen to be significant with histologic types. Majority of the tumors
were seen to be of high grade tumors as reported from our analysis. An observation that
is supported by previous studies (Ikpatt and Ndoma-Egba, 2003; Ebughe et al., 2013b).
Moreover, most of the breast cancers occur in the age group less than 50 years, accord-
ing to previous studies (Henson et al., 2003; Rosen et al., 1984) this is age group where
the tumors are expected to be more predominant. Hence, this observation needs proper
monitoring and studied in this part of Nigeria in order to unravel the scientific reason.
The current study was not without limitations. A few limitations should be considered
while interpreting the results from this study, as data collected does not contain inform-
ation regarding regarding adjuvant chemotherapy or endocrine therapy. Hence, this may
have affected our results. In summary, we found that age, grade tumor, educational status
and breast cancer type were associated with histological type of tumor. Also, consist-
ent with previous findings, our results indicate that the associations between biological
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factors and the risk of breast cancer differ by histological types of the tumor. Certain
histological types occurred with a significantly higher proportion shortly after women of
this geopolitical zone have given birth, which may be as a result of exposure to hazard
like chemical and radiation. More interesting was that women with at least high school
were more likely to be diagnosed with histologic type, which is a new and unexpected
findings in this part of Nigeria. One explanation for these result may be that women with
at least high school education present their breast cancer cases to medical practitioners
than the less educated women having it in mind that this study uses hospital data. How-
ever, this study suggests that as the life expectancy of breast cancer women over the age
group 35-49 years increases, treatment should also be based on histological prognostic
features of the grade tumor rather than age alone. In addition, Bayesian multilevel mul-
tinomial regression model helps in selecting the most significant factors between his-
tological type and socio economic status (SES) and biological characteristics of breast
cancer tumors as compared to classical multilevel multinomial.
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A.1 Diagnostic plots for the fixed and random effects for
Bayesian multilevel model with blocking
Figure 5.1. WinBUGS’ output of Gelman Rubin Statistic for some independent variable
Fig 5.2 showed the posterior distribution of the random effect part of the model
with blocking, based on the analysis of 1500000 iterations, 5000000 burn in period,
and with thin=40 in MCMCglmm.
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Appendix A
Figure 5.2. WinBUGS’ output of posterior density for some independent variable
Figure 5.3. WinBUGS’ output of time series for some independent variable
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Appendix B
B.1 Diagnostic plots for the fixed and random effects for
Bayesian multilevel multinomial model without blocking
Figure 5.4. WinBUGS’ output of Gelman Rubin Statistic for some independent variable
Fig 5.5 provides a graphical representation of the posterior density estimate for each




Figure 5.5. WinBUGS’ output of posterior density for some independent variable
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Appendix B
Figure 5.6. WinBUGS’ output of time series for some independent variable
Fig 5.6 shows the time series plots and the plots suggest stability which is an indica-
tion that the Markov chain have converged.
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C Diagnostic plots for Bayesian multilevel logistic regres-
sion model
Figure 5.7. WinBUGS’ output of Gelman Rubin Statistic
Fig 5.7 illustrates the convergence of the Bayesian approach with non-informative
prior using Gelman-Rubin diagnostic test. The algorithm converged after 1,500, 000
iterations. The output of Gelman-Rubin convergence diagnostic test displays the
red lines representing the R̂. The graph shows that all the R̂ → 1. Also, the blue
and green lines which represent the within sample variance and the pooled poste-
rior variance, are stationary. Thus, the Gelman-Rubin Convergence Diagnostic test
suggests that the algorithm converges.
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Figure 5.8. WinBUGS’ output autocorrelation
Fig 5.8 illustrates the convergence of the Bayesian approach with non-informative
prior. The algorithm converged after 1,500, 000 iterations. We took a lag of 40 in
order to remove the autocorrelation which requires an iterations up to 1,500,000 it-
erations and the first 500, 000 iterations removed to cater for the burn-in period.
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Figure 5.9. WinBUGS’ output autocorrelation
The time series plot in Fig 5.9 suggests that the chain is wandering through the same
region of the parameter space and has found the stationarity.
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